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ABSTRACT
Transition metal centers possessing an octahedral geometry are useful for understanding
the natural role of metal ions in biology. Complexes based on such metals might improve upon
the widely used square planar Pt(II) anticancer drug cisplatin, cis-[Pt(NH3)2Cl2]. The octahedral
triaquatricarbonylrhenium(I) cation, fac-[Re(CO)3(H2O)3]+, has been shown to possess
anticancer activity. Furthermore, Re(I) complexes containing unstable rhenium isotopes have
found utility as radiodiagnostic and radiotherapeutic agents. Thus, this work focuses on
elucidating the fundamental coordination chemistry of fac-[Re(CO)3(H2O)3]+.
Adducts formed in reactions of nucleoside mono-, di-, and triphosphates with fac[Re(CO)3(H2O)3]OTf are examined by using a combination of 1D and 2D multinuclear nuclear
magnetic resonance (NMR) spectroscopy, circular dichroism (CD) spectroscopy, and molecular
modeling techniques. Mixtures containing fac-[Re(CO)3(H2O)3]+ and nucleotides attain
equilibrium, in contrast to cisplatin, and the nature of the adduct formed depends on the number
of phosphate groups and the base present.
Nucleoside di- and triphosphate adducts consist of diastereomers having distinct, sharp
NMR signals, thus allowing accurate measurement of 1H and

31

P NMR chemical shifts and

coupling constants. Re(I) coordination at N7 is observed for all adducts with guanine bases, and
the reactions proceed to near completion. {N7,Pβ} and {N7,Pβ,Pγ} macrochelates are formed for
5′-GDP and 5′-GTP, respectively, but only N7 binding is observed for 5′-GMP. The lack of Pα
binding for 5′-GTP indicates that formation of an N7–Re–Pα chelate ring is sterically
unfavorable. When methionine and 5′-GMP are allowed to compete for fac-[Re(CO)3(H2O)3]+,
the N7-bound Re/5′-GMP 1:1 adduct is the kinetic product, while the S-bound Re/methionine
adduct is thermodynamically favored, a result opposite to that typically found for cisplatin.
xix

No base interaction was noted for adducts with uridine bases, and these reactions were
incomplete at equilibrium. fac-[Re(CO)3(H2O)3]+ forms {Pα,Pβ} and {Pα,Pβ,Pγ} phosphato
chelates with 5′-UDP and 5′-UTP, respectively, but no significant reaction occurred with 5′UMP. Notably, fac-[Re(CO)3(H2O)3]+ forms both an {N7,Pβ,Pγ} macrochelate and a {Pα,Pβ,Pγ}
phosphato chelate with 5′-ATP, suggesting that the fac-[Re(CO)3]+ core could provide a model
for the kinetically labile biorelevant [Mg(ATP)] complex. These results offer hope that
(radio)pharmaceuticals based on Re(I) could be developed with lower toxicity than drugs based
on Pt(II).

xx

CHAPTER 1.
INTRODUCTION
1.1

Metals in Medicine
Inorganic compounds have found use in a variety of medicinal applications.1 Examples

include the anticancer agent cisplatin (cis-[Pt(NH3)2Cl2])2, the antirheumatic agent auranofin (an
organogold compound), magnetic resonance imaging (MRI) contrast agents (usually based on
Gd(III)), and radiotherapeutic and radiodiagnostic agents containing radionuclides such as 99mTc
and 186/188Re (Figure 1.1).3
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Figure 1.1. Molecular structures of (A) cisplatin, (B) auranofin, (C) Gd-DOTA, and (D)
sestamibi (Cardiolite)

1.2

99m

Tc-

Cisplatin, cis-[Pt(NH3)2Cl2]
First approved by the FDA for use in humans in 1978, cisplatin has been the mainstay for

chemotherapeutic treatment of ovarian, testicular, and head and neck tumors for nearly thirty
years.4 Upon cellular uptake, the two chloro ligands of cisplatin are displaced by water ligands,
as the intracellular chloride concentration is much lower than the extracellular chloride

1

concentration. For this reason, the cytotoxic species in vivo is believed to be the diaqua cation
cis-[Pt(NH3)2(H2O)2]2+. Within the cell, cis-[Pt(NH3)2(H2O)2]2+ reacts with a variety of
biomolecules, such as proteins, nucleic acids, and peptides. However, DNA is now generally
accepted to be the ultimate target of cis-[Pt(NH3)2(H2O)2]2+; cis-[Pt(NH3)2(H2O)2]2+ binds to the
N7 atoms of two adjacent purine residues, forming a 1,2-intrastrand crosslink.5 The 1,2intrastrand crosslink causes local unwinding and destacking of DNA base pairs, thus causing the
DNA strand to bend at an angle between 30º and 60º (Figure 1.2). The platinated DNA lesion is
then recognized by HMG-domain proteins, which then bind to the lesion and effectively shield
the lesion from DNA repair mechanisms.6 However, upon attempting to replicate the DNA in
preparation for cellular division, the DNA replication machinery simply stops upon encountering
the lesion, and the lack of replicated genetic material eventually leads to cell death.

cisplatin

Figure 1.2. Models of (left) a 9-mer with native B-DNA structure and (right) a 9-mer containing
a 1,2-intrastrand cross-link effected by cisplatin. Model structures were determined using
distances obtained by NMR methods.2
2

The incredible success of cisplatin in cancer therapy has led to the development of similar
chemotherapeutic agents based on Pt(II). However, the overall success of agents based on Pt(II)
is limited by toxic side effects, believed to be the result of reaction of Pt(II) with the soft sulfur
atoms in cysteine, methionine, and other intracellular thiols and thioethers.7 Thus, the search for
other potential chemotherapeutic agents has expanded to include inert, redox-stable metal centers
with octahedral geometry, such as Ru(III) and Rh(II), and most recently, Re(I).8-20
Triaquatricarbonylrhenium(I), fac-[Re(CO)3(H2O)3]+

1.3

Another application of metals in medicine involves the use of radioactive metal
complexes for molecular and functional imaging, diagnosis, and radiotherapy. The nuclear
properties of

99m

Tc and

186/188

Re are amenable for use as radiodiagnostic and radiotherapeutic

agents, respectively (Table 1.1).21 In addition,

99m

Tc and

188

Re are readily available from

generator systems that can be kept and maintained at medical facilities.
Table 1.1. Selected Nuclear Properties of some Tc and Re Radionuclides
Isotope
Half-life
Emissions
Comments
99m

Tc

6.0 h

γ, 143 KeV
no β-

99

Tc

2.1 x 105 y

no γ

Generator produced, “no
carrier added”
Available in gram quantities

β-, 0.292 MeV
186

188

Re

Re

90 h

17 h

β-, 1.07, 0.93 MeV

Reactor produced; contains
carrier 185Re and 187Re;
contaminated with 188Re

γ, 155 KeV

Generator produced,

β-, 2.12 MeV

“no carrier added”

γ, 137 MeV

3

Routine investigations into the coordination chemistry of unstable Re and Tc isotopes
(“hot” radionuclides) often first take place with model complexes containing stable, “cold” metal
centers.

185/187

Re, the stable isotopes of rhenium, are used as a model for “hot”

(man-made) second-row congeners,

99

Tc and

186/188

Re and the

99m

Tc. One such model complex, fac-

[Re(CO)3(H2O)3]+, possesses particularly attractive properties, as the metal center is in the low
+1 oxidation state, resulting in a kinetically inert d6 electronic configuration.22 Re (and Tc) are
not often found in the +1 oxidation state; however, the low oxidation state is stabilized by the
presence of three π-backbonding CO ligands. The CO ligands withdraw electron density from
the metal center, effectively creating an electronic environment emulating that of a higher
oxidation state. The fac-[Re(CO)3]+ core is small in size, compact and nearly spherical; these
characteristics lessen the steric impact of the metal center.22 In addition, the three facial water
ligands are readily substituted by a variety of donor atoms, thus providing available sites for
cross-linking interactions with DNA bases.23,24
Interest in the coordination chemistry of fac-[Re(CO)3(H2O)3]+ has increased
significantly since 2000, when Hall et al. demonstrated that the hydroxo-bridged dirhenium
complex [Re2(CO)6(μ-OH)3]– was effective at suppressing the growth of murine and human
leukemias and lymphomas in vitro.17 It was then discovered that [Re2(CO)6(μ-OH)3]– is readily
cleaved under protic conditions to yield the mononuclear fac-[Re(CO)3(H2O)3]+, thus leading to
the suggestion that the cation may be the active species in vitro (Figure 1.3).25
H
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Zobi et al. found that the fac-[Re(CO)3]+ core preferred to bind to the N7 atoms of two
guanine base derivatives, such as guanosine, 2-deoxyguanosine, and 9-methylguanine, in a
stepwise fashion.18,19 This finding led these researchers to propose that a cisplatin-like binding
mechanism (Figure 1.4) could be responsible for the cytotoxic activity displayed by compounds
containing the fac-[Re(CO)3]+ core 18,19
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Figure 1.4. fac-[Re(CO)3(H2O)3]+ binds two guanosine (R = ribosyl) or 9-methylguanine (R =
methyl) ligands in a stepwise fashion.

However, compared to Pt(II) compounds, the fac-[Re(CO)3]+ core may have a higher
affinity for oxygen donors23 and its binding equilibria are likely to be more dynamic and less
complete. Thus, interactions between the fac-[Re(CO)3]+ core and the phosphate groups in the
sugar-phosphate backbone of DNA, and the phosphate groups in nucleoside mono-, di- and
triphosphates, are likely to be important factors in the coordination behavior of the fac[Re(CO)3]+ core.
To our knowledge, interactions between the fac-[Re(CO)3]+ core and nucleotides have
not been investigated. Thus, the current study features fundamental investigations into the
coordination chemistry of fac-[Re(CO)3(H2O)3]+ with purine and pyrimidine nucleotides in
aqueous solution using multinuclear NMR spectroscopic methods. In addition, the synthesis and
characterization of complexes containing the fac-[Re(CO)3]+ core and various biologically
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relevant N-donor ligands (such as benzimidazole and bipyridine) are reported, with the intention
of increasing insight into the coordination chemistry of the fac-[Re(CO)3]+ core.
1.4
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CHAPTER 2.
fac-[Re(CO)3(H2O)3]+ NUCLEOSIDE MONOPHOSPHATE ADDUCTS INVESTIGATED
IN AQUEOUS SOLUTION BY MULTINUCLEAR NMR SPECTROSCOPY*
2.1

Introduction
The success of cisplatin (cis-[Pt(NH3)2Cl2]) in the treatment of various cancers has led to

intensive efforts to determine its mode of action in order to guide development of other metalbased chemotherapeutic drugs.1,2 The primary intracellular target of cisplatin is DNA, with the
major DNA lesion being an intrastrand N7–Pt–N7 cross-link between two adjacent guanine
residues.3-6 The anticancer activity of cis-[PtA2X2] compounds (A2 = two amines or a diamine
carrier ligand; X = anionic leaving group) correlates with the number of NH groups. Models
have suggested to us that this correlation could be related to the small size of the hydrogen atom
rather than its hydrogen-bonding ability.6 Indeed, as the bulk of the diamine carrier ligand
increases, anticancer activity decreases.5,7 Carrier-ligand bulk also influences the relative
stability of single-strand vs duplex forms of oligonucleotides with the intrastrand cross-link.8
The great long-term clinical success of cisplatin makes it imperative to continue the
search for other potential inorganic chemotherapeutic agents. This search has focused primarily
on Pt(II), a square-planar, inert, and redox-stable metal center and one of a limited number of
metal centers having all of these properties. Metal centers forming inert, redox-stable complexes
typically have an octahedral geometry. Octahedral complexes are generally more bulky and more
sterically crowded than square-planar complexes.9 As mentioned, bulk decreases the anticancer
* Reproduced with permission from American Chemical Society: Adams, K. M., Marzilli, L. G.,
“fac-[Re(CO)3(H2O)3]+ Nucleoside Monophosphate Adducts Investigated in Aqueous Solution
by Multinuclear NMR Spectroscopy,” Inorganic Chemistry, 2007, 46, 4926-4936. Copyright
2007 American Chemical Society.

8

activity of cis-[PtA2X2] compounds.5 Octahedral complexes do not bind so well as Pt(II)
compounds to DNA and have a high propensity to bind to biomolecular targets other than
cellular DNA; protein binding over nucleic acid binding can cause considerable toxicity,
preventing the use of octahedral metal complexes as anticancer agents.5 Several octahedral metal
complexes do, however, have modest anticancer properties, with some of the most promising
complexes containing Re(I), Ru(II), Ru(III), or dinuclear Rh(II)/Rh(II) metal centers.9-21
With the goal of gaining a better understanding of the coordination chemistry of
octahedral metal complexes relevant to nucleic acid binding, we chose to investigate the fac[Re(CO)3(H2O)3]+ cation. Dinuclear complexes, such as [Re2(CO)6(μ-OH)3]– and [Re2(μ-OH)(μOPh)2(CO)6]–, suppressed the growth of murine and human leukemias and lymphomas in cell
culture studies.19 Subsequent mass spectrometry studies demonstrated that [Re2(CO)6(μ-OH)3]–
is readily cleaved under protic conditions to yield the fac-[Re(CO)3(H2O)3]+ cation, leading to a
suggestion that this cation may be the species possessing anticancer properties.22 The three water
ligands in fac-[Re(CO)3(H2O)3]+ are readily substituted by a variety of donor atoms, thus
providing available sites for cross-linking interactions with DNA bases.23,24 Notable similarities
in the reactions/adducts of cisplatin and fac-[Re(CO)3(H2O)3]+ include the following: First, both
form M/G 1:1 and 1:2 adducts with 9-methylguanine (9-MeG), guanosine (Guo) and 2deoxyguanosine (dGuo).9,21 Second, both bind these guanine derivatives at N7, and the bases in
1:2 adducts adopt both head-to-head (HH) and head-to-tail (HT) orientations.9,21 Third, the rate
constant for the binding of Guo to fac-[Re(CO)3(H2O)3]+ is very similar to that for Guo binding
to cis-[Pt(NH3)2(H2O)2]2+.21 Fourth, both readily bind N- and/or S-containing ligands such as
Guo and thiourea.9,21,24
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However, compared to Pt(II) compounds, the fac-[Re(CO)3(H2O)3]+ cation may have a
higher affinity for oxygen donors,23 and its binding equilibria are likely to be more dynamic and
less complete.25-30 Therefore, the likelihood that an investigation of the interaction of fac[Re(CO)3(H2O)3]+ with 6-oxopurine nucleotide monophosphates (NMPs) would prove to be
informative led us to study the binding of guanosine 5′-monophosphate (5′-GMP) and guanosine
3′-monophosphate (3′-GMP). We also performed studies with inosine monophosphates (5′-IMP
and 3′-IMP) and 2′-deoxyguanosine 5′-monophosphate (5′-dGMP) to assess the effect of the C2–
NH2 substituent and/or N7 basicity (Figure 2.1).
2.2

Experimental Section
2.2.1

Materials and Sample Preparation

Stock solutions (50 mM and 200 mM) of fac-[Re(CO)3(H2O)3]OTf in water were
prepared by published procedures and maintained at pH ~1.8.31 5′-GMP, 3′-GMP, 5′-IMP, 3′IMP and 5′-dGMP (disodium salts) and D2O (99.9%) (Sigma-Aldrich) were used as received.
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The H8 of 5′- or 3′-GMP was exchanged to D8 by incubating a solution of the nucleotide in D2O
at 100 °C for 5 h.32 The solution was then filtered and taken to dryness by rotary evaporation,
yielding solid D8–5′-GMP (d-5′-GMP) or D8–3′-GMP (d-3′-GMP) as the disodium salt.
Except as noted, a typical preparation involved treatment of an appropriate amount of
NMP in 0.3 mL of H2O with 0.4 mL of fac-[Re(CO)3(H2O)3]OTf (~50 mM or ~10 mM,
depending on required final concentration); a small amount (0.1 mL) of D2O was added to
establish a lock signal. Dilute HCl or NaOH stock solutions (in H2O) were used to adjust the pH
(uncorrected) of the samples to ~3.6 in the NMR tubes as required.
2.2.2

NMR Spectroscopy

All NMR spectra were obtained on either a Bruker DPX400 spectrometer (400.1 MHz) or
a Varian INOVA500 spectrometer (500.1 MHz); both were equipped with a variable-temperature
probe that was equilibrated at 25 °C unless otherwise indicated. 1D 1H NMR spectra were
referenced to the residual HOD peak, and presaturation was used to reduce the residual HOD
peak. Each FID was accumulated for 64 transients, each containing 16K data points. Before
Fourier transformation, an exponential apodization window function with a 0.2 Hz line
broadening was applied. 1D proton-decoupled
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P NMR spectra ({1H}–31P) were referenced to

external trimethyl phosphate (TMP); each FID was accumulated for 64 transients, each
containing 32K data points. Before Fourier transformation, an exponential apodization window
function with a 2 Hz line broadening was applied. One hundred twenty-eight scans per block
(256 blocks) were collected in a 2D rotating frame nuclear Overhauser effect spectroscopy
(ROESY) experiment conducted at 32 °C by using a spectral width of ~4000 Hz and a 500 ms
mixing time. All NMR data were processed with either XWINNMR (Bruker) or VnmrJ (Varian)
software.
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2.2.3

Circular Dichroism (CD) Spectroscopy

CD samples were prepared from the respective NMR samples and diluted to ~1 mM
GMP with deionized water (pH ~3.6). Three acquisitions, collected from 400 to 200 nm on a
JASCO J-710 CD spectropolarimeter at a scan speed of 50 nm/min, were averaged to improve
the signal-to-noise ratio.
Although NMR data indicate that the exchange rate is slow, we employed a set of
additional experiments to determine if the re-equilibration after dilution would affect the CD
results. For this, an aliquot (5 μL) of a Re/NMP NMR sample ([fac-[Re(CO)3(H2O)3]+] = 25
mM, r = 1:2) was added to 0.3 mL of H2O (pH ~3.6) and the sample immediately transferred to
the CD instrument. Ten acquisitions, collected from 280 to 230 nm, were averaged to improve
the signal-to-noise ratio. CD spectra were recorded from 2 min to 2 days after dilution. The CD
spectrum of the diluted sample did not change significantly from 2 min to 3 h after dilution. At 6
h after dilution, the CD spectrum had changed considerably. These results indicate that CD
spectra measured promptly after dilution are representative of the NMR solution and can be used
to assess the chirality of the dominant HT conformer.
2.3

Results and Discussion
2.3.1

Characteristic Features of Metal–NMP Adducts

Shift changes of the 1H and
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P NMR signals of the NMP upon coordination are

informative. Extensive studies with cis-[PtA2G2] complexes indicate that, upon coordination via
N7 to Pt, the G H8 singlet shifts downfield more for a Pt/NMP 1:1 adduct than for a 1:2 adduct
with cis nucleotides.3 This pattern can be explained by an inductive effect of the metal, causing
H8 deshielding that is offset somewhat by H8 shielding from the anisotropic cis purine bases in
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1:2 adducts.3 Upon formation of a 1:1 adduct, the H1′ doublet shifts downfield slightly (inductive
effect); conversely, the H1′ doublet shifts upfield upon formation of a 1:2 adduct (base
anisotropic effect). An {N7,Pα} macrochelate, in which the 5′-nucleotide is coordinated via both
N7 and Pα, has an H1′ singlet because the sugar pucker is forced to be virtually 100% N.33-35
However, this {N7,Pα} macrochelate is rare, occurring for 5′- but not for 3′-monophosphates.35-37
Direct inner-sphere coordination of phosphate oxygen to Pt causes the Pα 31P NMR signal to shift
~4 to 12 ppm downfield.24,34,35,38,39
At pH ~3.6 (used here) the Pα group (Figure 2.1) of the free NMP is protonated and
carries a single negative charge, the same as that of the phosphodiester group in DNA. Also,
because deprotonation of fac-[Re(CO)3(H2O)3]+ begins around pH 4, the choice of pH ~3.6
avoids formation of fac-[Re(CO)3(H2O)2(OH)] and fac-[Re(CO)3(H2O)(OH)2]– species.23
The fact that the guanine base bound to a metal is not C2 symmetrical with respect to
rotation about the M–N7 bond allows for rotamers. For square-planar metal geometries, there are
two distinct rotamers at most for a given M/G 1:1 adduct. When the metal moiety lacks high
symmetry, these rotamers are not equivalent, and thus there are two conformers. Introduction of
a chiral sugar at the G N9 also influences the number of conformers. For octahedral or squareplanar M/G 1:2 adducts with two cis N7-coordinated identical G’s, head-to-head (HH) and headto-tail (HT) conformers are possible. HH conformers and HT conformers have the two H8 atoms
on the same and opposite sides, respectively, of the N7–M–N7 plane. When the starting complex
has high symmetry, one HH and two HT conformers are possible. An additional HH conformer
can exist if the complex has lower symmetry (as in the adducts studied here, see Figure 2.2) or if
the two G’s are not identical, such as in d(GpG) adducts.40,41 If the starting complex has lower
symmetry and the two G’s are not identical, two 1:2 adducts with two cis N7-coordinated
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nonidentical G’s can form, each having 2 HH and 2 HT conformers; hence, a solution having a
total of 4 HH and 4 HT conformers could be created.

Figure 2.2. (top) Diagram showing coordination positions relative to each other; (bottom) HHa,
ΛHT, HHb and ΔHT orientations for an octahedral metal center. NMPs in coordination positions
1 and 2 are distinct and all four conformers can interchange only if the type of NMP is identical
in both coordination positions.
In typical cis-[PtA2G2] models with non-bulky amines, the rate of rotation about the Pt–
N7 bonds is too rapid to detect distinct NMR signals for the conformers.42 By using chiral carrier
ligands with sufficient bulk to slow rotation, G H8 signals for the HH and HT rotamers could be
observed, and the ΔHT and ΛHT absolute conformations could be established by NOE crosspeaks between the G H8 signals and the carrier ligand signals.41,43,44 In turn, the CD signatures
for these conformations were characterized.44 For these adducts, the dominant HT conformer
appears to be stabilized by hydrogen bonding of the phosphate group of one G with the N1H of
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the cis G and these “second-sphere” interactions, or SSC, have been identified as important
factors that stabilize the ΛHT and ΔHT conformers in 5′-GMP and 3′-GMP complexes,
respectively.43,45-49 In addition, such studies with cis-[PtA2G2] complexes with unlinked G
nucleotides has shown that, while the HH conformer does form, the two HT conformers, ΔHT
and ΛHT, are typically favored.42,43,50-56 In addition, Pt/5′-GMP 1:2 adducts adopt the HH
conformation more readily than do Pt/3′-GMP 1:2 adducts.47,48,57
Overview of Products Formed by fac-[Re(CO)3(H2O)3]+ and NMPs

2.3.2

In describing the

1

H and
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P NMR spectral results for NMP binding to fac-

[Re(CO)3(H2O)3]+, we state the nature of the adducts formed before presenting all the evidence
and the reasoning for such designations. In general for a given NMP, two principal adducts were
formed:

a

1:1

adduct,

fac-[Re(CO)3(H2O)2(NMP)],

and

a

1:2

adduct,

fac-

[Re(CO)3(H2O)(NMP)2]– having inequivalent NMPs (Figure 2.2). We also found evidence for
the formation of both a dinuclear 2:1 complex, fac-[Re2(CO)6(H2O)4(NMP)] (in which a
phosphate oxygen and N7 are each bound to a fac-[Re(CO)3(H2O)2]+ moiety), and a trinuclear
3:1 complex, fac-[Re3(CO)9(H2O)6(NMP)]+ (in which two phosphate oxygens and N7 are each
bound to a fac-[Re(CO)3(H2O)2]+ moiety). When two different NMPs (NMP and N′MP) were
present in the reaction mixture, two 1:2 adducts, fac-[Re(CO)3(H2O)(NMP)(N′MP)]–, formed, as
expected because the coordination positions are not equivalent (Figure 2.2).
2.3.3

5′-GMP Reaction Products

Upon treatment of fac-[Re(CO)3(H2O)3]+ with 5′-GMP ([Re] = 25 mM, r = 1:1), four new
H8 singlets appeared (although one H8 singlet is very small, Figure 2.3). These signals are
relatively downfield and are insensitive to pH from 3.6 to 1.4, properties indicating that the
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signals are from adducts with Re bound to 5′-GMP via N7. The predominant H8 signal appears
immediately after mixing and dominates the spectrum, even at long reaction times. Because this
major adduct signal has no partner H8 signal, it could arise from either a 1:1 or 1:3 Re/nucleotide
adduct (Figure 2.4). The following observations demonstrate that this major product is the 1:1
adduct, fac-[Re(CO)3(H2O)2(5′-GMP)]: First, the intensity of the predominant H8 signal
decreases upon addition of more 5′-GMP (vide infra), whereas the intensity of this signal could
increase only if it were due to the 1:3 adduct. Second, the downfield shifts of the H8 singlet
(~0.4 ppm) and the H1′ doublet (~0.1 ppm) of this major adduct relative to free 5′-GMP are
consistent with a 1:1 adduct (Table 2.1). Third, the 3JH1′–H2′ coupling constant decreases from ~6
Hz (free GMP) to ~3.6 Hz, a feature consistent with metal coordination at N7 (Table 2.1 and
Appendix A). Fourth, the chemical shift of the Pα signal of this adduct is similar (Table 2.1) to
that for 5′-GMP, ruling out the only other 1:1 adduct with 5′-GMP bound via N7, a macrochelate
(Figure 2.4) expected to have a Pα signal shifted downfield by 4–12 ppm.24,34,35,38,39 These
results, as well as those obtained at r values higher than 1:1 and with a mixture of nucleotides
(vide infra), establish beyond question that when r = 1:1, the predominant adduct formed is fac[Re(CO)3(H2O)2(5′-GMP)], with 5′-GMP bound only through N7.
The next most abundant adduct in the r = 1:1 solution is fac-[Re(CO)3(H2O)(5′-GMP)2]–.
This 1:2 adduct has two closely spaced H8 singlets of approximately equal intensity (Figure 2.3).
Relative to free 5′-GMP, the H8 signals are shifted ca. 0.2 ppm downfield, the two H1′ doublets
are shifted slightly upfield, and neither of the two corresponding Pα signals is shifted
significantly (Table 2.1, Figure 2.3). Two H8 singlets of equal intensity are expected for a 1:2
adduct. A 1:2 adduct lacks both a plane of symmetry (because of a chiral sugar) and a C2 axis
(because the fac-[Re(CO)3(H2O)]+ moiety lacks C2 symmetry). Addition of another equivalent of
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5′-GMP (r = 1:2) resulted in a higher intensity for these H8 signals relative to that of fac[Re(CO)3(H2O)2(5′-GMP)]; therefore, these signals undoubtedly arise from the 1:2 adduct, fac[Re(CO)3(H2O)(5′-GMP)2]–.

(C)

(B)

(A)

Figure 2.3. H8 (left), H1′ (center) and Pα (right) NMR signals of equilibrated mixtures of fac[Re(CO)3(H2O)3]+ (25 mM) and 5′-GMP at pH 3.6. (A) Re/GMP r = 4:1, (B) r = 1:1, (C) r =
1:2. The red arrow points to the small amount of 2:1 adduct in spectrum (B). See text for
conditions and spectral assignments for signals not identified in Figure.
The third most abundant adduct in the r = 1:1 solution is fac-[Re2(CO)6(H2O)4(5′-GMP)].
This dinuclear adduct gives a small H8 singlet (Figure 2.3) downfield from the H8 singlet of fac[Re(CO)3(H2O)2(5′-GMP)]; the H1′ signal of this adduct is obscured by the H1′ signals of other
adducts. The corresponding Pα signal is ca. 5 ppm downfield from the Pα resonance of 5′-GMP.
Taken together, these results indicate that both N7 and Pα are coordinated to Re in this minor
product in the r = 1:1 solution (Table 2.1). Three conceivable and reasonable adducts with 5′GMP coordinated via both N7 and Pα can explain the observation of one H8 and one Pα signal
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for this third product. The first possibility is a C2-symmetric cyclic dimeric 2:2 adduct with two
5′-GMP’s linking two fac-[Re(CO)3(H2O)]+ moieties (Figure 2.4). The abundance of this dimer
relative to the 1:1 adduct should remain constant above r = 1:1 at a given GMP concentration
because each contains one 5′-GMP per Re. The other two conceivable adducts have less than one
5′-GMP per Re. These are a dinuclear 2:1 adduct with N7 bound to one Re and Pα bound to a
second Re, and a trinuclear 3:1 adduct with N7 bound to one Re and Pα bound to two different
Re’s (Figure 2.4). At a given GMP concentration, increasing the Re concentration above r = 1:1
would increase the abundance of both the di- and trinuclear adducts relative to the 1:1 adduct.

Table 2.1. 1H and 31P NMR Shifts (ppm) and 3JH1′–H2′ Coupling Constants (Hz, in parentheses)
of Nucleotides and Complexes Formed with fac-[Re(CO)3(H2O)3]+ a
δ 1H

δ 31P

complex

H8

H1′

Pα

5′-GMP

8.12

5.90 (6.1)

–2.74

fac-[Re(CO)3(H2O)2(5′-GMP)]

8.50

5.99 (3.7)

–3.02

fac-[Re(CO)3(H2O)(5′-GMP)2]–

8.32, 8.30

5.88 (5.1), 5.86 (3.9)

–2.69, –2.91b

fac-[Re2(CO)6(H2O)4(5′-GMP)]

8.55

c

1.62d

fac-[Re3(CO)9(H2O)6(5′-GMP)]+

c

c

5.17

8.00

5.93 (6.0)

–3.00

8.52

6.00 (3.6)

–3.06

fac-[Re(CO)3(H2O)(3′-GMP)2]

8.40, 8.34

5.90 (3.8), 5.90 (3.8)

–3.04

fac-[Re2(CO)6(H2O)4(3′-GMP)]

8.53

6.02 (4.0)

1.63d

fac-[Re3(CO)9(H2O)6(3′-GMP)]+
M-5′-GMPe
M-3′-GMP

8.54
8.48
8.38

6.04 (3.9)
5.90c
5.90c

5.09
–3.11b
–3.04b

m-5′-GMP

8.40

5.90c

–3.11b

m-3′-GMP

8.14

5.90c

–3.04b

3′-GMP
fac-[Re(CO)3(H2O)2(3′-GMP)]
–

a

[Re] = 25 mM, pH 3.6, 32 °C. bSignal assigned to adduct only. cSignal obscured by other
signals. dShift highly dependent on pH (see text). eM and m = major and minor adducts,
respectively.
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Figure 2.4. Possible Re/GMP adducts.
To distinguish among these possibilities for the third product, we performed the
formation reaction twice more but by using different total concentrations and different r values.
At high concentrations (100 mM) of both Re and 5′-GMP, the intensities of 1H and
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P NMR

signals of the third product relative to those of the 1:1 adduct were the same as those found in the
25 mM r = 1:1 reaction. At the higher r = 4:1 ([Re] = 25 mM) the H8 and Pα signals of the third
product had a higher intensity relative to the 1:1 adduct signals. Thus, there is more than one Re
bound per 5′-GMP. The third product with the ca. 5 ppm downfield Pα signal cannot be a cyclic
dimeric 2:2 adduct.
The nature of the third product was established in this r = 4:1 experiment. A small
additional Pα signal (Figure 2.3) was found ~8 ppm downfield from the Pα resonance of free 5′19

GMP. Because the Pα signal of the fourth product appears only at higher r values and is onefourth the size of the Pα signal of the third product, the fourth product contains more Re per 5′GMP than the third product. Most reasonably, the third and fourth products are the 2:1 and 3:1
adducts. Although no H8 signal could be located for the 3:1 adduct, we should note that in 3′GMP reactions at r = 4:1, both the H8 and Pα signals of this fourth product are evident (vide
infra, Figure 2.5).
To assess our conclusions, we examined the effect of low pH on the
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P NMR shifts

(Appendix A). When the pH of a solution containing the 1:1, 1:2, 2:1, and 3:1 adducts was
decreased from 4 to 2, the Pα signal of the 1:1 adduct (with a shift similar to that of free 5′-GMP)
did not shift significantly, consistent with the Pα group being uncoordinated and monoprotonated
throughout the pH range. However, the Pα signal of the 2:1 adduct (shifted 5 ppm downfield
from that of free 5′-GMP) shifted significantly upfield (ca. 3.5 ppm) over this pH range,
consistent with a coordinated deprotonated Pα group becoming protonated. The pKa of this Pα
group is thus about 3.2, a value much lower than the pKa for 5′-GMP (~6.3).57-60 The much lower
pKa of the phosphate group in fac-[Re2(CO)6(H2O)4(5′-GMP)], compared to N7–bound Pt
adducts,61-64 is undoubtedly due to the direct binding of Re to this Pα group.35,38,39 The very
downfield Pα signal of the fourth adduct was insensitive to changes in pH between 4 and ~3 (this
Pα signal disappeared below pH ~3); this lack of pH dependence, indicating a phosphate group
pKa below 2, is consistent with such a 3:1 adduct with two Re moieties bound to the Pα group.
The binding of the second Re is expected to be weak, and thus it does not compete well with the
proton as the pH drops below the pKa of the 2:1 adduct. However, because two Re’s are bound to
it, the Pα group is always deprotonated in the 3:1 adduct.
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The coordination of N7 of a nucleotide to inert metal centers can be demonstrated by
addition of Cu2+ ions. The paramagnetic Cu2+ ion binds to N7 of the free nucleotide, causing the
broadening and eventual disappearance of the H8 resonance.65 Alternatively, if N7 of the
nucleotide is bound to another metal, such as Pt or Re, Cu2+ coordination at N7 is blocked and
the H8 resonance remains sharp.35 Addition of a Cu2+ solution to 5 μM to an r = 1:1 solution
([Re] = 5 mM) caused the H8 and Pα signals of free 5′-GMP to disappear. The H8 signals of the
1:1 and 1:2 adducts remained sharp and the Pα signals of these adducts were still present but
broadened considerably. Addition of Cu2+ solution to 50 μM did not cause broadening of the H8
signals of the 1:1 and 1:2 adducts; however, no 31P signals were detected. These results thus
confirm that N7 is bound to Re in both the fac-[Re(CO)3(H2O)2(5′-GMP)] 1:1 and fac[Re(CO)3(H2O)(5′-GMP)2]– 1:2 adducts.
2.3.4

3′-GMP Reaction Products

To evaluate the effect of phosphate group position on the adducts formed, we examined
3′-GMP reactions. Treatment of fac-[Re(CO)3(H2O)3]+ with 3′-GMP ([Re] = 25 mM, r = 1:1) led
to the appearance of three new H8 singlets (Figure 2.5, Table 2.1); these signals can be attributed
to the 1:1 adduct, fac-[Re(CO)3(H2O)2(3′-GMP)], and the 1:2 adduct, fac-[Re(CO)3(H2O)(3′GMP)2]–, for reasons given above for adducts of 5′-GMP. Signals arising from the 1:2 adduct
were confirmed with an r = 1:2 experiment. In solutions initially 25 mM in fac[Re(CO)3(H2O)3]+, the downfield shoulder on the H8 signal of fac-[Re(CO)3(H2O)2(3′-GMP)]
and the downfield Pα signal at ~5 ppm were relatively larger in an r = 4:1 reaction mixture than
in an r = 1:1 reaction mixture (Figure 2.5). The third product is clearly the dinuclear 2:1 adduct,
fac-[Re2(CO)6(H2O)4(3′-GMP)]. A fourth product with an H8 signal just downfield from the H8
signal of fac-[Re(CO)3(H2O)2(3′-GMP)] and with an Pα signal ~8 ppm downfield from the Pα
21

signal of free 3′-GMP is the 3:1 trinuclear adduct, fac-[Re3(CO)9(H2O)6(3′-GMP)]+. As was
found for 5′-GMP, a 100 mM, r = 1:1 experiment supported this interpretation by ruling out the
cyclic dimeric 2:2 adduct. To summarize, for both 3′-GMP and 5′-GMP, four products were
found: two abundant products, fac-[Re(CO)3(H2O)2(GMP)] and fac-[Re(CO)3(H2O)(GMP)2]–,
and two minor products, fac-[Re2(CO)6(H2O)4(GMP)] and fac-[Re3(CO)9(H2O)6(GMP)]+.

(C)

(B)

(A)

Figure 2.5. H8 (left), H1′ (center) and Pα (right) NMR signals of equilibrated mixtures of fac[Re(CO)3(H2O)3]+ (25 mM) and 3′-GMP at pH 3.6. (A) Re/GMP r = 4:1, (B) r = 1:1, (C) r =
1:2. See text for conditions and spectral assignments for signals not identified in Figure.
2.3.5

Further Aspects of the GMP Reactions

Reactions at r = 1:1 and r = 1:2 of both 5′- and 3′-GMP with fac-[Re(CO)3(H2O)3]+ (at 5
mM, a concentration at which H8 signals did not overlap) at 1 h and at 6 days were compared
(Table 2.2). The solutions were at equilibrium after 6 days, as no spectral changes occurred
between 4 and 6 days. At 1 h, the 1:1 adduct was the predominant product at r = 1:1; however,
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more 1:1 adduct was present at 1 h for 5′-GMP than for 3′-GMP. In the normal nucleotide anti
conformation, the 5′-phosphate group is closer to N7 than the 3′-phosphate group. In an initial
ion pair interaction of the nucleotide with the metal cation, the stabilizing electrostatic and H–
bonding interactions of the phosphate group with the cation place the N7 in a position closer to
the metal center for a 5′-nucleotide than for a 3′-nucleotide. We attribute the faster reaction of 5′GMP to this proximity.
At equilibrium (6 days), the 1:1 adduct remained the predominant product for 5′-GMP at
both r = 1:1 and at r = 1:2, but for 3′-GMP this was the case only at r = 1:1. At r = 1:1, more 1:1
adduct was present in the 5′-GMP reaction than in the 3′-GMP reaction (Table 2.2). The factors
(H–bonding and electrostatic interactions) facilitating the formation of fac-[Re(CO)3(H2O)2(5′GMP)] also stabilize the 1:1 adduct. These factors are either absent (H–bonding) or weaker
(electrostatic) in fac-[Re(CO)3(H2O)2(3′-GMP)], accounting for its lower abundance at r = 1:1.
However, at equilibrium, the amount of fac-[Re(CO)3(H2O)(3′-GMP)2]– formed was greater than
the amount of fac-[Re(CO)3(H2O)(5′-GMP)2]– formed under both r = 1:1 and r = 1:2 conditions
(Table 2.2).
Factors favoring the Re/5′-GMP 1:1 adduct are less likely to be important in contributing
to the stability of the Re/5′-GMP 1:2 adduct. First, fac-[Re(CO)3(H2O)(5′-GMP)2]– has only one
coordinated H2O for H–bonding to phosphate. Second, the greater conformational freedom for
the 5′-phosphate group will lead to some electrostatic repulsion between the bound nucleotides.
In contrast, because the 3′-phosphate groups of fac-[Re(CO)3(H2O)(3′-GMP)2]– are directed
away from the center of the complex, electrostatic repulsion is less in this 1:2 adduct. Although
the 3′-phosphate group cannot participate in H–bonding interactions with the coordinated H2O,
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this group can form stabilizing H–bonds with N1H of the cis 3′-GMP.66 Thus, differences in the
relative abundance of the 1:1 adduct and 1:2 adduct between 5′-GMP and 3′-GMP are explained.
Table 2.2. Concentrations (mM) of 1:1, 1:2 and Dinuclear Adducts of 5′-GMP, 3′-GMP, 5′IMP, and 3′-IMP at Different Nucleotide Concentrations and Times after Mixing with fac[Re(CO)3(H2O)3]+ a
r = 1:1
complex

1h

6d

1h

6d

5′-GMP
fac-[Re(CO)3(H2O)2(5′-GMP)]

2.6
2.3

0.9
3.2

6.2
3.0

3.6
2.9

fac-[Re(CO)3(H2O)(5′-GMP)2]–

0.1

0.5

0.4

1.8

3′-GMP

4.3

1.1

8.6

2.9

fac-[Re(CO)3(H2O)2(3′-GMP)]

0.7

2.2

1.2

2.3

–

fac-[Re(CO)3(H2O)(3′-GMP)2]

b

0.8

0.1

2.3

fac-[Re2(CO)6(H2O)4(3′-GMP)]

b

0.2

b

0.2

2.8

0.6

5.7

3.1

2.1

3.5

3.1

3.5

b

0.5

0.6

1.7

3.7

1.7

5.8

4.7

1.3

5′-dGMP
fac-[Re(CO)3(H2O)2(5′-dGMP)]
–

fac-[Re(CO)3(H2O)(5′-dGMP)2]
5′-IMP
fac-[Re(CO)3(H2O)2(5′-IMP)]

a

r = 1:2

3.0

4.0

4.0

–

fac-[Re(CO)3(H2O)(5′-IMP)2]

b

0.2

b

0.7

fac-[Re2(CO)6(H2O)4(5′-IMP)]

b

b

0.2

b

3′-IMP

4.2

2.2

8.6

4.6

fac-[Re(CO)3(H2O)2(3′-IMP)]

0.9

2.0

1.4

3.2

fac-[Re(CO)3(H2O)(3′-IMP)2]–

b

0.4

b

1.0

fac-[Re2(CO)6(H2O)4(3′-IMP)]

b

0.2

b

0.3

[Re] = 5 mM. bNot observed.

To understand better the role of phosphate group H–bonding to N1H of the cis GMP, we
must consider which conformers are likely to be present. As mentioned above, the number of
conformers depends on the symmetry of the complex. For a fac-[Re(CO)3(H2O)(NMP)2]– adduct,
two HH (HHa and HHb) and two HT conformers (ΔHT and ΛHT, Figure 2.2) are possible.
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Distinguishing between HH and HT conformers in solution is best accomplished by using
NOESY techniques, as the two H8 protons are normally close enough to give an NOE cross-peak
for an HH conformer but too far to give a cross-peak for an HT conformer.41,51,67-69 No H8–H8
NOE cross-peaks were observed for fac-[Re(CO)3(H2O)(5′-GMP)2]– or fac-[Re(CO)3(H2O)(3′GMP)2]–, thus providing evidence that these adducts exist mainly as HT conformers.
Because of rapid rotation about the Re–N7 bond, the NMR signal detected for each
coordinated NMP is a weighted average of the respective signals for all conformers but the
signals reflect mainly the HT conformers. For a dynamic adduct, differentiating between the
ΔHT and ΛHT conformers is best accomplished by using CD methods.48 It has been established
that the CD signals of both 1:1 adducts and of HH conformers of 1:2 adducts are weak, while the
CD signal of the HT conformers is much stronger.69 Therefore, the sign of the CD spectrum
reflects the conformation of the major HT conformer present. The CD signal of a ΔHT
conformer has negative features at ~227 and ~285 nm and a positive feature at ~252 nm, while
the CD signal of a ΛHT conformer has positive features at ~227 and ~285 nm and a negative
feature at ~252 nm.69 At pH ~3.6, CD spectra of equilibrated solutions ([Re] = 25 mM, r = 1:2,
pH ~3.6) containing both the 1:1 and 1:2 adducts of 5′-GMP or 3′-GMP were recorded. The 5′GMP solution exhibited a negative feature at ~267 nm and a positive feature at ~238 nm (Figure
2.6). A similar pattern was observed for the 3′-GMP solution (Figure 2.6). This pattern in both
cases is indicative of the ΔHT conformer; therefore, we can conclude that both fac[Re(CO)3(H2O)(5′-GMP)2]– and fac-[Re(CO)3(H2O)(3′-GMP)2]– exist primarily as ΔHT
conformers. Past studies have found that the ΔHT conformation allows favorable phosphate
interligand H–bonding to the carrier ligands for 5′-GMP adducts and to the N1H of the cis 3′GMP for 3′-GMP adducts.43,45-48 In the ΔHT conformation, only one phosphate group is well
25

positioned to form H–bonds (to the coordinated H2O) for 5′-GMP but both phosphate groups are
positioned to form H–bonds (to the cis GMP) for 3′-GMP; thus, the preference for the ΔHT
conformation for 3′-GMP is explained, as is the higher amount of 1:2 adduct for 3′-GMP than for
5′-GMP. However, the preference for the ΔHT conformation for the 5′-GMP 1:2 adduct was
unexpected because two favorable N1H–5′-phosphate H–bonds are possible for the ΛHT
conformer of 5′-GMP 1:2 adducts.
2.5

-1
-1
Δε (M cm )

1.5

1:2 Re/3'-GMP

0.5

1:1:1 Re/5'-GMP/3'-GMP

-0.5

-1.5

-2.5
200

1:2 Re/5'-GMP

250

300
nm

Figure 2.6. CD spectra recorded soon after dilution of equilibrated NMR solutions ([Re] = 25
mM, pH 3.6) of 5′-GMP (r = 1:2, red line), 3′-GMP (r = 1:2, blue line) and mixed 5′-GMP/3′GMP (r = 1:1:1, black line).
2.3.6

Mixed Nucleotide Approach

Mixed 5′-GMP/3′-GMP experiments were performed to elucidate the properties of 1:2
adducts, particularly the preference for the ΔHT conformation by the 5′-GMP 1:2 adduct. In such
mixtures, two Re/5′-GMP/3′-GMP 1:1:1 adducts are expected (Figure 2.8), in addition to the
previously identified adducts containing 5′-GMP or 3′-GMP. Three r = 1:1:1 solutions at pH 3.6,
all starting with [Re] = 5 mM, were studied. In one, 3′-GMP and 5′-GMP were added initially. In
the other solutions, one GMP was added initially, the solution was allowed to equilibrate, and
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then the other GMP was added. All three solutions gave identical NMR spectra. The H8 signals
of previously discussed adducts were observed, as expected. In addition, three new H8 singlets
(8.48, 8.38, and 8.14 ppm, Figure 2.7) were observed. Because the conformers of each adduct
will interchange rapidly on the NMR time scale, four new H8 singlets are expected. We deduced
that one new H8 singlet was overlapped with a previously discussed signal; consequently, we
exchanged H8 with deuterium, preparing d-3′-GMP and d-5′-GMP.32 The mixed nucleotide
experiment utilizing one of these deuterated nucleotides allows assignment of all H8 signals
arising from the undeuterated nucleotide.

Figure 2.7. H8 NMR signals of equilibrated
mixtures (r = 1:1:1, pH 3.6) of fac[Re(CO)3(H2O)3]+ with the NMPs indicated.
See text for signal assignments.
Figure 2.8. (top) Diagram showing
coordination
position
numbering;
(bottom) The pairs of HT conformers of
each of the two possible fac[Re(CO)3(H2O)(5′-GMP)(3′-GMP)]–
adducts. In the pair on the left, the ΔHT
conformer can form a favorable
phosphate-to-coordinated water H–
bond.
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In a typical experiment, 1 equiv of 5′-GMP was added to an equilibrated sample
containing equimolar concentrations of d-3′-GMP and fac-[Re(CO)3(H2O)3]+ (5 mM, r = 1:1:1)
at pH 3.6. New H8 singlets (at 8.48 and 8.40 ppm, Figure 2.7) can be assigned to the 5′-GMP’s
in the two Re/5′-GMP/3′-GMP 1:1:1 adducts. In the competition experiment with d-5′-GMP, the
H8 singlets (at 8.38 and 8.14 ppm, Figure 2.7) can be assigned to the 3′-GMP’s in these two
Re/5′-GMP/3′-GMP adducts. The relative intensity of the H8 signals from the Re/5′-GMP/3′GMP adducts permits pairing of signals arising from the same complex. In this way, it was
determined that the more abundant 1:1:1 adduct (M, 60%) has a 5′-GMP H8 signal at 8.48 ppm
and a 3′-GMP H8 signal at 8.38 ppm, while the minor adduct (m) has a 5′-GMP H8 signal at 8.40
ppm and a 3′-GMP H8 signal at 8.14 ppm. At equilibrium (6 days, r = 1:2), the stability order
was M, fac-[Re(CO)3(H2O)(3′-GMP)2]–, m, and fac-[Re(CO)3(H2O)(5′-GMP)2]– (Table 2.3).

Table 2.3. Concentrations (mM) of 1:1, 1:2 and Mixed Bis Adducts of 5′- and 3′-GMP at
Different Nucleotide Concentrations and Times after Mixing with fac-[Re(CO)3(H2O)]+ a
r = 1:1
complex

1h

6d

1h

6d

5′-GMP
fac-[Re(CO)3(H2O)2(5′-GMP)]
fac-[Re(CO)3(H2O)(5′-GMP)2]–

2.0

0.4

3.9

1.4

0.5

1.6
0.1

1.2

1.8
0.4

3′-GMP
fac-[Re(CO)3(H2O)2(3′-GMP)]

2.3

0.6

4.2

1.6

0.3

1.1

0.7

1.0

fac-[Re(CO)3(H2O)(3′-GMP)2]–

b

0.2

b

0.6

0.3

b

0.8

0.2

b

0.5

m

b

c

b

c

b

M
a

r = 1:2

b

b

c

[Re] = 5 mM. Not observed. M and m refer to the major and minor forms, respectively, of
fac-[Re(CO)3(H2O)(5′-GMP)(3′-GMP)]–.
The two Re/5′-GMP/3′-GMP 1:1:1 adducts can have a total of four HT conformers. Each
adduct has a pair of ΔHT and ΛHT conformers (Figure 2.8). The conformers in each pair rapidly
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interchange. The CD pattern of an equilibrated solution containing the 1:1:1 adducts retains the
ΔHT–type signal, indicating that M most likely favors the ΔHT conformation (Figure 2.6).
While for both fac-[Re(CO)3(H2O)(5′-GMP)(3′-GMP)]– adducts, the ΔHT conformer can
be stabilized by an N1H–3′-phosphate H–bond between the cis nucleotides, only the ΔHT
conformer of the 1:1:1 adduct with 5′-GMP in coordination position 1 can form a favorable H–
bond to the coordinated water (Figure 2.8, left). An idealized model of the ΔHT conformer of
this preferred adduct (Appendix A) reveals that, in addition to these two H bonds, an O6 to
coordinated water H–bond is also possible. Therefore, we suggest that adduct M is the adduct in
which 5′-GMP occupies coordination position 1 and 3′-GMP occupies coordination position 2.
Because M is more stable than the 3′-GMP 1:2 adduct (which has two N1H–3′-phosphate H–
bonds), the results suggest that phosphate–water H–bonding is more favorable than N1H–3′phosphate H–bonding. The strength of this bond appears to be sufficient to overcome the normal
preference of 5′-GMP 1:2 adducts to favor the ΛHT conformation.
2.3.7

Effects of Modifying the Nucleotides

To assess the effect of the exocyclic amino group at the C2 position of the guanine ring,
we conducted some studies with 5′-IMP and 3′-IMP (Table 2.4, Figure 2.1). In general, we found
products similar to those found above for 5′- and 3′-GMP. At equilibrium, the relative amounts
of 1:1 vs 1:2 products formed with IMP’s were similar to those with GMP. Therefore, we
suggest that the exocyclic amino group of GMP does not contribute to the relative stability of the
1:1 vs 1:2 adducts. This conclusion agrees with a previous report with Pt adducts which indicate
that the exocyclic amino group of GMP does not form H–bonds to the cis nucleotide.48 The
overall amount of 1:1 and 1:2 adducts formed with 5′-IMP and 3′-IMP was slightly less than the
amount formed with 5′-GMP and 3′-GMP (data not shown). We believe that the less favorable
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formation of adducts by 5′- and 3′-IMP is related to the low N7 basicity of the hypoxanthine base
of the IMP’s versus that of 5′-GMP.70,71
The rate of reaction of 5′-dGMP and cis-[Pt(NH3)2(H2O)2]2+ was reported to be ~10 times
faster than that of 5′-GMP and cis-[Pt(NH3)2(H2O)2]2+.72 This "anomalous" behavior was
explained by the lack of flexibility in the ribose ring as compared to the 2′-deoxyribose ring due
to the presence of a bulky –OH group on the former.72 If this explanation were correct, the
difference between 5′-GMP and 5′-dGMP should be even larger for the reactions with the fac[Re(CO)3(H2O)3]+ cation, which is somewhat bulkier than the cis-[Pt(NH3)2(H2O)2]2+ cation.
Therefore, we decided to study the reaction of fac-[Re(CO)3(H2O)3]+ with 5′-dGMP at r = 1:1
and r = 1:2 (Table 2.4). We found types of products similar to those found for 5′-GMP. In
addition, we performed a mixed experiment with both 5′-GMP and 5′-dGMP at r = 1:1:1 ([Re] =
5 mM, pH 3.6). The 5′-dGMP 1:1 adduct formed to about the same extent as the 5′-GMP 1:1
adduct at 1 h (Figure 2.9). Also, the 5′-GMP 1:2 adduct, the 5′-dGMP 1:2 adduct, and the two
mixed 5′-GMP/5′-dGMP 1:1:1 adducts are present to about the same extent at equilibrium. These
results are an indication that the 2′-substituent of the ribose ring does not exert a great effect on
the binding affinity of N7, and the results call into question the proposed effect of the 2′-OH in
the reactions of cis-[Pt(NH3)2(H2O)2]2+ with 5′-dGMP and 5′-GMP.
Figure 2.9. H8 and H1′ NMR signals of a
mixture containing fac-[Re(CO)3(H2O)3]+ (5
mM), 5′-GMP (5 mM), and 5′-dGMP (5
mM) at pH 3.6 and 1 h after mixing.
Symbol alone denotes signals due to free
nucleotide. In this r = 1:1:1 experiment,
only trace amounts of 1:2 adducts are
formed at 1 h; these adducts account for the
weak signals observed just above the
baseline.
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Table 2.4. 1H and 31P NMR Shifts (ppm) and 3JH1′–H2′ Coupling Constants (Hz, in parentheses)
of 5′-GMP, 3′-GMP and 5′-dGMP and Complexes Formed with fac-[Re(CO)3(H2O)3]+ at
Different Times after Mixing with fac-[Re(CO)3(H2O)]+ a
δ 1H
H8

H1′

H2

5′-IMP

8.41

6.10 (6.0)

8.17

fac-[Re(CO)3(H2O)2(5′-IMP)]

8.78

6.21 (3.0)

8.26

fac-[Re(CO)3(H2O)(5′-IMP)2]–

8.62, 8.49

6.09 (3.5), 6.08 (3.0)

8.17, 8.15

3′-IMP

8.30

6.07 (6.0)

8.16

fac-[Re(CO)3(H2O)2(3′-IMP)]

8.83

6.17 (3.5)

8.25

fac-[Re(CO)3(H2O)(3′-IMP)2]–

8.68, 8.63

b

8.16, 8.14

6.31 (7.0)
6.37 (6.5)

—

fac-[Re(CO)3(H2O)2(5′-dGMP)]

8.16
8.45

fac-[Re(CO)3(H2O)(5′-dGMP)2]–

8.34, 8.20

6.22 (6.0), 6.30 (6.5)

—

5′-dGMP

a

—

[Re] = 5 mM, r = 1:2, pH 3.6, 25 °C. bSignal obscured by other signals.

2.3.8

Competition and Challenge Reactions Using Methionine and 5′-GMP

The well-known toxicity of Pt drugs has been attributed partially to reactions with sulfurcontaining biomolecules.73 In methionine vs GMP competition reactions with Pt complexes, Pt
binds first to S of methionine, and over time this S-bound product converts to an N7-bound GMP
adduct.73,74 To assess the binding affinity of 5′-GMP for fac-[Re(CO)3(H2O)3]+, we used a
competition reaction in which equimolar amounts of 5′-GMP, methionine, and fac[Re(CO)3(H2O)3]+ ([Re] = 5 mM, r = 1:1:1) were present in the reaction mixture. Shortly after
mixing (~30 min), approximately half of the 5′-GMP had reacted with fac-[Re(CO)3(H2O)3]+ to
form fac-[Re(CO)3(H2O)2(5′-GMP)], while very little methionine had reacted to form products
(Table 2.5). After 2 days the reaction mixture contained primarily fac-[Re(CO)3(H2O)2(5′-GMP)]
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(2.8 mM) and fac-[Re(CO)3(H2O)x(methionine)] (1.4 mM, x = 1 or 2, Table 2.5). At 1 month
after mixing, the reaction mixture contained mostly free 5′-GMP (3.5 mM) and fac[Re(CO)3(H2O)x(methionine)] (3.4 mM). No signals providing evidence for the formation of
mixed 5′-GMP/methionine adducts were detected. Therefore, the kinetic product of such a
competition reaction is fac-[Re(CO)3(H2O)2(5′-GMP)]; however, the thermodynamic product is
fac-[Re(CO)3(H2O)x(methionine)].

Table 2.5. Concentrations (mM) of 1:1 and 1:2 Adducts of 5′-GMP and Methionine at Different
Times after Mixing with fac-[Re(CO)3(H2O)3]+ a in a Competition Reaction
5′-GMP
fac-[Re(CO)3(H2O)2(5′-GMP)]
fac-[Re(CO)3(H2O)(5′-GMP)2]–
Methionine
fac-[Re(CO)3(H2O)x(methionine)]

conc at 30 min
2.6
2.0
b
4.7
0.3

conc at 2 d
1.6
2.8
0.6
3.6
1.4

conc at 1 month
3.5
1.0
0.5
1.6
3.4

a

[Re] = 5 mM, r = 1:1:1. bNot observed; amount of 5′-GMP present at 30 min not equal to 5
mM due to formation of ca. 0.4 mM fac-[Re2(CO)6(H2O)4(5′-GMP)]; no fac[Re2(CO)6(H2O)4(5′-GMP)] was detectable ca. 3 h after mixing.

These results are the opposite of what occurs in similar competition reactions of typical
Pt(II) complexes with methionine and 5′-GMP.74 To compare the results found here to those of a
typical Pt complex, we carried out a Pt/methionine/5′-GMP competition reaction74 under the
conditions used here ([Pt] = 5 mM, r = 1:1:1, pH = 3.6). Again, the methionine adduct was the
kinetic product, and this product converted over time to the N7-bound 5′-GMP thermodynamic
product (unpublished data). Therefore, even under our low pH conditions, a typical Pt(II)
complex has kinetic and thermodynamic preferences opposite to those found here for fac[Re(CO)3(H2O)3]+.
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2.4

Conclusions
For NMP = GMP or IMP, fac-[Re(CO)3(H2O)3]+ forms the Re/5′-NMP 1:1 adduct more

rapidly than the Re/3′-NMP 1:1 adduct. This result most likely arises from the stabilization of the
5′-NMP 1:1 adduct precursor, which we envision as being an encounter ion pair having inter-ion
H–bonding between the 5′-phosphate and a coordinated water molecule. This finding agrees with
results for reactions of aquated cis-[PtA2X2] complexes with 5′- and 3′-NMPs.
In contrast to the normal situation for reactions of cis-[PtA2X2] complexes with 5′- and
3′-NMPs, the reactions of fac-[Re(CO)3(H2O)3]+ with 5′- and 3′-NMPs do not go to completion
under normal conditions in the presence of 2 equiv of NMP. At equilibrium both 1:1 and 1:2
adducts are present, indicating that the 1:2 adduct may be disfavored because of steric crowding.
Adducts with IMP are less stable than those with GMP, a result undoubtedly related to the
decreased electron-donating capability of the hypoxanthine base of the IMP’s.
The NMR data confirm that all of these adducts have purine bases that rotate rapidly
about the Re–N7 bond. This dynamic interchange of rotamers is attributed to the small size of
the cis CO and H2O ligands. NOESY data show that HH conformers are not present in
significant amounts, and these data plus CD measurements suggest that the Re/NMP 1:2 adducts
favor the ΔHT conformation.
Normally, 5′-GMP 1:2 adducts favor the ΛHT conformation.45 However, it is proposed
that favorable H-bonding interactions of the 5′-GMP phosphate with the coordinated water
increases the stability of the ΔHT conformer over the ΛHT conformer. This interaction with
coordinated water also explains why for 1:1 adducts, the 5′-NMP 1:1 adduct is favored over the
3′-NMP 1:1 adduct. In the latter, the 3′-phosphate group cannot interact with coordinated water.
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In contrast, Re/3′-NMP 1:2 adducts are favored over Re/5′-NMP 1:2 adducts. This
preference most likely stems from the presence in the Re/3′-NMP 1:2 adducts of stabilizing H–
bonds between the N1H of each 3′-NMP with the phosphate group of the cis-bound 3′-NMP.
This type of stabilizing interaction is most favorable in the ΔHT conformation.
Mixed nucleotide experiments, in which two different NMPs are present to react with
fac-[Re(CO)3(H2O)3]+, reveal the formation of mixed 1:1:1 adducts; for example, two new mixed
Re/5′-GMP/3′-GMP adducts were formed in a 60(M):40(m) ratio. The most favored mixed
species, M, was more favored than even the Re/3′-GMP 1:2 adduct. This behavior is attributed to
a favorable ΔHT conformer of the 1:1:1 adduct with 5′-GMP in coordination position 1. Only in
this 1:1:1 adduct does one expect to have a ΔHT conformer with both phosphate groups
participating in stabilizing H–bonds.
A 5′-GMP/methionine competition experiment indicated that fac-[Re(CO)3(H2O)3]+ binds
faster to the harder 5′-GMP nitrogen atom, forming fac-[Re(CO)3(H2O)2(5′-GMP)] as a kinetic
product, but with time, the softer sulfur atom of methionine is preferred; thus, fac[Re(CO)3(H2O)x(methionine)] is the thermodynamic product. This relationship of kinetic and
thermodynamic preferences is opposite to that for typical Pt complexes. The results offer hope
that an anticancer drug based on Re(I) compounds could be developed with lower toxicity than
drugs based on Pt.
2.5
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CHAPTER 3.
REACTIONS OF fac-[Re(CO)3(H2O)3]+ WITH NUCLEOSIDE DIPHOSPHATES AND
THIAMINE DIPHOSPHATE IN AQUEOUS SOLUTION INVESTIGATED BY
MULTINUCLEAR NMR SPECTROSCOPY*
3.1

Introduction
The participation of nucleotides in a large variety of biochemical processes, usually as

metal ion complexes, has prompted a large number of investigations of metal-ion binding to
nucleotides in solution.1-4 Most of the literature is focused on nucleoside mono- and
triphosphates. Because of the dynamic conformational changes characteristic of nucleotides and
the lability of most biologically important metals such as Mg2+, nucleotide coordination
propensity is often assessed by using inert metal centers, which usually afford definitive results.59

However, the binding of nucleoside diphosphates to metal centers has been the subject of very

few studies, particularly with inert metal complexes.8,10,11
In recent years, the importance of Pt anticancer drugs has led to many informative
investigations of Pt(II) complexes of nucleoside mono- and triphosphates.12-16 However, the
octahedral geometry is more relevant to natural biological processes. More recently, we and
others have recognized that the octahedral fac-[Re(CO)3(H2O)3]+ cation is another inert, redoxstable metal center that can be used to study metal interactions with nucleotides.17-19 Compared
to Pt(II) compounds, the fac-[Re(CO)3(H2O)3]+ cation may have a higher affinity for oxygen
donors.20 Previous work demonstrated that reactions of fac-[Re(CO)3(H2O)3]+ and nucleoside
monophosphates (NMPs) attained equilibrium, forming predominantly Re/NMP 1:1 complexes
* Reproduced with permission from American Chemical Society: Adams, K. M., Marzilli, P. A.,
Marzilli, L. G., “Reactions of fac-[Re(CO)3(H2O)3]+ with Nucleoside Diphosphates and
Thiamine Diphosphate in Aqueous Solution Investigated by Multinuclear NMR Spectroscopy,”
Inorganic Chemistry, 2007, 46, 9172-9181. Copyright 2007 American Chemical Society.
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with Re(I) bound via N7 of the NMP; no {N7,Pα} macrochelate-type complexes were
identified.17 However, the second phosphate group of monoester diphosphates (MDPs) provides
additional binding sites for the fac-[Re(CO)3]+ center; thus, different products could result.

Figure 3.1. TDP (top). Base portion of 5′-UDP (middle left) and 5′-GDP (middle right) and the
R group bearing the diphosphate moiety (bottom).

3.1.1

Stereochemistry and Nomenclature

The MDPs studied here (Figure 3.1) have the following characteristics: no asymmetric
ribose nor Re(I)-binding base (thiamine diphosphate, TDP), an asymmetric ribose but no Re(I)binding base (uridine 5′-diphosphate, 5′-UDP), or an asymmetric ribose and a Re(I)-binding base
(guanosine 5′-diphosphate, 5′-GDP). Although there are potential metal-binding sites on all three
base moieties, both N1′ (thiamine, pKa ∼5) and N3 (uridine, pKa ∼10) are protonated at pH 3.6,
used here; the N7 of guanine (pKa < 2) is available for binding to Re(I).4,21 As the complexity of
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the MDP increases, the number of possible adducts formed by fac-[Re(CO)3(H2O)3]+ increases in
the order, TDP < 5′-UDP < 5′-GDP. Note: in designating the adducts, we omit the 5′- to simplify
the designation, but retain the 5′- when referring to the free nucleotide.

Figure 3.2. Four possible isomers of fac-[Re(CO)3({Pα,Pβ}MDP)]–; RReΔ/SReΛ and RReΛ/SReΔ
are mirror image pairs if the attached ester moiety has no chiral groups. Arrows indicate sense of
rotation defining chirality at Re(I). The blue O and the red O are the pro-Δ and pro-Λ oxygens in
the free nucleotide, respectively.

Unidentate coordination of an MDP (MDP = TDP, 5′-UDP, 5′-GDP) to fac[Re(CO)3(H2O)3]+ could occur in three possible ways. Coordination via the terminal Pβ group of
an MDP would result in the formation of a single isomer, as the Pβ group is not prochiral.
Unidentate coordination of the prochiral Pα group (although unlikely) would create an
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asymmetric Pα center and two isomers. The terminal oxygens of the prochiral Pα group are
labeled pro-Δ and pro-Λ in Figure 3.2. Coordination via N7 of 5′-GDP would lead to a single
isomer.

Figure 3.3. RRe and SRe isomers of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–. Only these two isomers
are possible when Pα is not bound to Re(I). The RRe and SRe isomers are tentatively assigned as
M and m, respectively.
Bidentate coordination to fac-[Re(CO)3(H2O)3]+ by both Pα and Pβ of an MDP, forming
fac-[Re(CO)3(H2O)({Pα,Pβ}MDP)]–, creates asymmetric centers at both Pα and Re(I). Up to four
diastereomers could exist for the MDP used here. Naming the isomers requires designation of the
chirality of these asymmetric centers. First, the asymmetry at Pα depends on which oxygen (proΔ or pro-Λ) binds to Re(I) (Figure 3.2).5-7 Second, designation of the asymmetry of the Re(I)
center is based on the direction of rotation of the MDP around a reference axis defined by a line
passing through the Re(I) atom perpendicular to the chelate ring (assumed to be planar as shown
in Figure 3.2) and passing through the CO (away from the viewer).5-7 The asymmetry at Re(I) is
then designated as RRe and SRe for clockwise and counterclockwise rotation, respectively (Figure
3.2). Although we adhere to the naming protocol described here, we should note that application
of the R,S system (according to Cahn–Ingold–Prelog priority rules) to other metal–chelate
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complexes can lead to reversals of the letter designation.5 In fac-[Re(CO)3(H2O)({Pα,Pβ}MDP)]–
adducts, the four possible diastereomers constitute two enantiomeric pairs (two sets of NMR
signals, RReΔ/SReΛ and RReΛ/SReΔ) for TDP but four NMR-distinct isomers for 5′-UDP (RReΔ,
RReΛ, SReΔ, SReΛ, Figure 3.2). Were 5′-GDP to bind in this manner, there would again be four
NMR-distinct diastereomers. However, we did not detect clear evidence for such a species
because 5′-GDP binds via N7 in all major species we identified; Re(I) coordination via N7 of 5′GDP presents different possibilities for adduct formation. Bidentate coordination through N7 and
Pβ of 5′-GDP creates only one asymmetric center (at Re(I)). If the resulting pair of diastereomers
(RRe and SRe) of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– (Figure 3.3) is conformationally dynamic,
only two sets of NMR signals are expected. Tridentate coordination of N7, Pα, and Pβ of 5′-GDP,
to form the fac-[Re(CO)3{N7,Pα,Pβ}GDP)]– adduct, would result in four NMR-distinct
diastereomers because this adduct contains both Re(I) and Pα asymmetric centers. The number of
possible adducts and NMR-observable distinct sets of signals are summarized in Table 3.1.

Table 3.1. Possible Isomers Formed by the Reaction of fac-[Re(CO)3(H2O)3]+ with MDPs
observed sets
complex
diastereomers mirror pairs possible sets of signals
of signals
4
2
2
2
{Pα,Pβ}TDP
4
0
4
4
{Pα,Pβ}UDP
a
4
0
4
{N7,Pα,Pβ}GDP
2
0
2
2
{N7,Pβ}GDP
a

Not observed.
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3.2

Experimental Section
3.2.1

Materials and Sample Preparation

Stock solutions (10 mM and 50 mM) of fac-[Re(CO)3(H2O)3]OTf in H2O were prepared
by published procedures and maintained at pH ∼1.8.22 5′-GDP, 5′-UDP (disodium salts), TDP,
sodium pyrophosphate (PP), and D2O (99.9%) (Sigma-Aldrich) were used as received.
A typical preparation of samples for 1D NMR spectroscopy involved treatment of an
appropriate amount of MDP in 0.3 mL of H2O with 0.4 mL of an ∼10 mM stock solution of fac[Re(CO)3(H2O)3]OTf; a small amount (0.1 mL) of D2O was added to establish a lock signal. For
2D NMR spectroscopy, samples were prepared by removing H2O from an aqueous 0.4 mL
aliquot of a ∼50 mM stock solution of fac-[Re(CO)3(H2O)3]OTf and adding 0.4 mL of D2O;
then, the appropriate amount of MDP (in 0.4 mL D2O) was added. The pH (uncorrected) of the
samples in NMR tubes was maintained at ∼3.6 by the addition of dilute HCl and NaOH (in H2O)
or DCl and NaOD (in D2O) stock solutions, as required. The pH of each sample was adjusted
before the acquisition of each NMR spectrum. Because spectra were acquired at frequent
intervals relative to the ∼1 day half-life of each reaction, the reactions proceeded at a pH close to
3.6. At early stages of the reactions, the pH changes were larger, and generally the pH dropped.
However, our focus was on the products, not on the reaction rates of product formation.
3.2.2

NMR Spectroscopy

All NMR spectra were obtained on a Varian INOVA500 spectrometer (500.1 MHz)
equipped with a variable-temperature probe that was equilibrated at 25 °C unless otherwise
indicated. A 1 s presaturation pulse was used to reduce the HOD peak in 1D 1H NMR spectra,
and the residual HOD signal was used to reference the spectrum. Each FID was accumulated for
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32 transients, each containing 32K data points. Before Fourier transformation, an exponential
apodization window function with a 0.2 Hz line-broadening was applied. 1D proton-decoupled
31

P NMR spectra ({1H}-31P) were referenced to external trimethyl phosphate (TMP); each FID

was accumulated for 128 transients, each containing 8K data points. Before Fourier
transformation, an exponential apodization window function with a 0.5 Hz line-broadening was
applied.
In general, 32 scans per block (512 blocks) were collected in 1H–1H rotating frame
nuclear Overhauser effect spectroscopy (ROESY) experiments conducted by using a spectral
width of ∼6000 Hz in both dimensions and a mixing time of 500 ms at 25 °C and 32 °C. Protondecoupled 31P–31P nuclear Overhauser effect spectroscopy (NOESY) exchange experiments were
conducted by using 32 scans per block (422 blocks) and a spectral width of ∼5000 Hz in both
dimensions and a mixing time of 500 ms at 32 °C. Proton-decoupled
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P–31P correlation

spectroscopy (COSY) experiments containing 32 scans per block (734 blocks) were conducted
by using a spectral width of ∼4400 Hz in both dimensions and a COSY-45 pulse sequence to aid
in visualizing close coupling patterns. All NMR data were processed with VnmrJ (Varian)
software.
3.2.3

Computational Methods

All models were constructed on a PC equipped with the Hyperchem 7.523 molecular
modeling package, and all computations were performed using AMBER99 force field parameters
and methods described previously.24 Four models (two RRe and two SRe models) of fac[Re(CO)3(H2O)({N7,Pβ}GDP)]– were built by using information obtained through NMR studies
and derived from the X-ray crystal structure of fac-[Re(CO)3(H2O)(9-MeG)2]+.18 The Re–N7
distance in all four models was constrained to ∼2.2 Å. The H2′–C2′–C1′–H1′ angle of one RRe
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and one SRe model was constrained to 67° (equal to a 3JH1′–H2′ value of 1 Hz), and the H2′–C2′–
C1′–H1′ angle of the other RRe and SRe models was constrained to 41° (equal to a 3JH1′–H2′ value
of 4.5 Hz). The H8 proton was oriented close in space to H2′ and H3′ in all four models, as the
NOE data (see above) confirms this close proximity for all adducts formed. The models were
geometrically minimized using Polak–Ribiere conjugate gradient minimization, which was
terminated upon reaching an rms gradient of 0.01 kcal/Å·mol.
3.3

Results and Discussion
Shift changes of the 1H and

31

P NMR signals of the MDP upon coordination are

informative. In general, 1H and 31P NMR signals arising from atoms close to the metal binding
site will shift downfield upon coordination because of an inductive effect of the metal center.
Because deprotonation of fac-[Re(CO)3(H2O)3]+ begins around pH 4 and causes oligomerization,
we conducted most studies at pH 3.6 as in previous work.17,20 In addition, 5′-GDP is protonated
at N7 to a very limited extent at pH 3.6 (see NMR shift data in Appendix B), thereby allowing
metal coordination; also, the low pH assures no significant deprotonation of N1H, thereby
precluding metal binding at N1. Coordination of Re(I) at N7 of 5′-GMP causes a ∼0.4 ppm
downfield shift of the H8 signal and a slight upfield shift (∼0.3 ppm) of the Pα signal, while
coordination of one Re(I) metal center at N7 and another at Pα of the same 5′-GMP leads to a
∼0.4 ppm downfield shift of the H8 signal but a larger ∼4 ppm downfield shift of the Pα signal.17
At pH ∼3.6, the Pβ group of the free MDP is protonated and the phosphate chain carries two
negative charges (Figure 3.1).
Throughout this section, concentrations will be denoted as (__ mM, r = __:__), in which
the fac-[Re(CO)3(H2O)3]+ concentration is stated and r is the ratio of the cation to added
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phosphate ligand. This notation designates both the starting ligand concentration and its ratio to
the starting fac-[Re(CO)3(H2O)3]+ concentration.
As a first step, we employed diprotonated pyrophosphate (PP2–) to assess the effects of
chelate ring formation on 31P NMR shifts at pH ∼3.6. A single product 31P NMR signal, shifted
∼7 ppm downfield from the 31P NMR signal of free PP2– (Table 3.2), was observed 1 day after
mixing fac-[Re(CO)3(H2O)3]+ and PP2– (25 mM, r = 1:1 and 1:2). At equilibrium (no changes
from 3 to 6 days), ∼60% of the PP2– had reacted, indicating incomplete product formation. The
appearance of one signal indicates that fac-[Re(CO)3(H2O)(PP)]–, in which both phosphate
groups chelate Re(I), is the reaction product.

Table 3.2. 1H and 31P NMR Chemical Shifts (ppm), Coupling Constants (Hz) of TDP,
5′-UDP, PP, and Complexes Formed with fac-[Re(CO)3(H2O)3]+ a
δ 1H

complex
PP

δ 31P

—

—

–13.8

—

—

–6.6

H2

H6′

Pα (Jαβ)

Pβ

9.62

7.88

–14.7 (22.3)

–14.0

M pair

9.71

7.79

–9.0 (19.8)

–5.0

m pair

9.67

7.77

–8.4 (19.6)

–4.9

H6

H1′ (3JH1′–H2′)

Pα (Jαβ)

Pβ (Jβα)

5′-UDP

7.94b

5.98 (4.5)c

–14.4 (20.2)

–13.8 (20.3)

M1

7.98b

5.95c

–9.2 (20.6)

–5.4 (20.4)

m1

7.88

b

c

5.95

–8.8 (19.8)

–5.6 (20.7)

M2

7.87b

5.95c

–8.5 (19.8)

–5.7 (20.2)

m2

7.86b

5.95c

–8.5 (19.8)

–5.5 (20.2)

fac-[Re(CO)3(H2O)(PP)]–
TDP

a

25 mM, r = 1:1, pH 3.6. b 3JH5–H6 = 8.1 Hz. cH1′ signals overlap with H5 signals.

47

3.3.1

Overview of Products Formed by fac-[Re(CO)3(H2O)3]+ and MDPs

In describing the results for MDP binding to fac-[Re(CO)3(H2O)3]+, we state the nature of
the adducts formed before presenting all the 1H and

31

P NMR spectral evidence and the

reasoning for adduct designations. We should note that no evidence was found for the formation
of significant amounts of either unidentate adducts (bound through only one phosphate oxygen)
or 1:2 adducts for any MDP, even in r = 1:2 reaction mixtures.
3.3.2

TDP Reaction Products

TDP formed a 1:1 adduct, fac-[Re(CO)3(H2O)({Pα,Pβ}TDP)]–, for which four
diastereomers are possible (Figure 3.2). Because these are two mirror-image pairs (RReΔ/SReΛ
and RReΛ/SReΔ), only two sets of 1H and

31

P NMR signals for bound TDP were observed. The

more intense set is labeled M for the major mirror-image pair, and the other set is labeled m for
the minor mirror-image pair.
Although the 5a and 5b multiplets are for TDP protons close to the metal-binding Pα
phosphate group (Figure 3.1), these multiplets have chemical shifts very close to that of residual
HOD. Thus, the H2 and H6′ singlets, although for protons remote from the metal-binding site,
are also used to provide information about the adducts formed. Approximately 1 day after fac[Re(CO)3(H2O)3]+ and TDP (25 mM, r = 1:1) were mixed, the NMR spectrum showed two new
H2 and two new H6′ singlets, shifted slightly downfield and slightly upfield, respectively, from
the corresponding H2 and H6′ signals of free TDP (Table 3.2). Although partially obscured by
the residual HOD peak, two sets of 5b multiplets (shifted downfield from the 5b multiplet of free
TDP) were observed. At equilibrium (no changes from 3 to 6 days), the ratio of M pair/m pair
was 2:1 and only ∼35% of the TDP had reacted, indicating incomplete product formation.
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(A)

(B)

(C)

Figure 3.4. 31P NMR (A), 31P-31P COSY (B), and 31P-31P NOESY (C) spectra of an equilibrium
mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and TDP at pH 3.6. Asterisk labels indicate
peaks arising from free TDP.

The {1H}-31P NMR spectrum of the (25 mM, r = 1:1) reaction mixture revealed two Pα
doublets at ca. –8.7 ppm and two Pβ doublets at ca. –5.0 ppm, shifted ∼6 and ∼9 ppm downfield
from the respective free TDP signals (Figure 3.4). The Pα vs Pβ assignments were confirmed
with a proton-coupled

31

P NMR spectrum. A proton-decoupled

31

P–31P COSY experiment (25

mM, r = 1:1) showed coupling between doublets at –9.0 ppm (Pα) and –5.0 ppm (Pβ) for the
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major pair (M pair), and doublets at –8.4 ppm (Pα) and –4.9 ppm (Pβ) for the minor pair (m pair,
Figure 3.4). In addition, a

31

P–31P NOESY spectrum showed exchange between the two Pα

doublets and between the Pβ doublets, indicating that interconversion of the isomers does occur,
but in the slow-exchange regime of the NMR time scale (see below).
The Pβ signals of M pair and m pair shifted ∼4 ppm downfield between pH 1.5 and 3.5
during an NMR-monitored titration from pH 1.5 to 6.5, leading to a pKa estimate of ∼2.5 for Pβ
of both the M and m pairs. The low value of the estimated Pβ pKa is likely due to the presence of
a proton on N1′.
3.3.3

5′-UDP Reaction Products

5′-UDP formed a 1:1 adduct, fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]–, exhibiting 1H and

31

P

NMR signals of four diastereomers. (The Re/5′-UDP 1:1 ratio in the adduct was confirmed in the
mixed-nucleotide experiment described below.) Because the H5 and H1′ signals overlap, only
the H6 signals are informative. 1H NMR spectra of fac-[Re(CO)3(H2O)3]+ treated with 5′-UDP
(25 mM, r = 1:1) showed after ∼1 day one large H6 doublet (M1) and three smaller H6 doublets
(M2, m1, m2), shifted slightly downfield and slightly upfield, respectively, from the H6 doublet of
free 5′-UDP (Figure 3.5, Table 3.2). The small size of the shifts indicates no base binding. At
equilibrium (no changes from 3 to 6 days), ∼40% of the 5′-UDP had reacted (17% large H6 and
23% other three H6’s combined), indicating that 5′-UDP product formation is about as favorable
as TDP product formation at r = 1:1. This finding is consistent with the absence of base binding
for both MDPs.
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(A)

(B)

(C)

(D)

Figure 3.5. 1H NMR (A), 31P NMR (B), 31P–31P COSY (C), and 31P–31P NOESY (D) spectra
of an equilibrium mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-UDP at pH 3.6.
Asterisk labels indicate peaks arising from free 5′-UDP.

The {1H}-31P NMR spectrum of the (25 mM, r = 1:1) reaction mixture revealed three wellseparated Pα doublets at ca. –8.8 ppm and four overlapping Pβ doublets at ca. –5.6 ppm, shifted
∼6 and ∼8 ppm downfield from the respective free 5′-UDP signals (Figure 3.5). The Pα doublets
are assigned as follows. Most upfield, M1; intermediate, m1; the most downfield, both M2 and
m2. The Pα vs Pβ assignments were confirmed with a proton-coupled
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31

P NMR spectrum. A

proton-decoupled

31

P–31P COSY experiment (25 mM, r = 1:1) revealed the M1/M2 and m1/m2

connectivities between the Pα and Pβ signals (Figure 3.5). The 31P–31P NOESY spectrum showed
exchange between the downfield overlapped M2 and m2 Pα doublet and the two M1 and m1 Pα
doublets, but no exchange between the M1 and m1 Pα doublets was detected (see below).
3.3.3.1

Mixed-Nucleotide Experiment

To investigate the Re/nucleotide ratio of the products, we treated fac-[Re(CO)3(H2O)3]+
with a mixture of TDP and 5′-UDP (25 mM, r = 1:0.5:0.5 and 1:1:1). If the adducts identified
above as 1:1 adducts were in fact 1:2 adducts or 2:2 adducts, etc., new product NMR signals for
mixed TDP/5′-UDP adducts would be observed. At equilibrium, no unidentified NMR signals
were observed, the ratio of the four product 5′-UDP H6 signals did not change, and the total
amount of reaction was comparable to that found in the (25 mM, r = 1:1) experiment, thus
confirming that only one MDP is bound per Re(I). In addition, monitoring of a fac[Re(CO)3(H2O)3]+ plus 5′-UDP (25 mM, r = 1:1) equilibrated reaction mixture after addition of 3
equiv of TDP confirmed that 5′-UDP dissociation was very slow (t1/2 ≈ 24 h). A reviewer
commented that this type of observation would support the suggested mechanism for the
isomerizations described below. We postulate below that Pβ does not dissociate during the
isomerization process.
3.3.4

5′-GDP Reaction Products

5′-GDP formed mainly three 1:1 adducts: fac-[Re(CO)3(H2O)2({N7}GDP)]– and two
isomers of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– (M and m). Only one set of NMR signals was
observed for each species. The most informative 1H NMR signals of 5′-GDP are H8 (on the
base) and H1′ (on the ribose); extensive studies with metal–G (G = a guanine N9 derivative)
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complexes indicate that, upon coordination of G via N7, the G H8 singlet shifts downfield.25
Because of the inductive effect of the metal center, the H1′ doublet shifts downfield slightly upon
formation of a 1:1 adduct. An {N7,Pα} macrochelate, in which the 5′-nucleotide is coordinated
via both N7 and Pα, has an H1′ signal that appears to be a singlet.12,13,26 The coupling constant,
3

JH1′–H2′, is dependent upon the mole fractions of N and S sugar pucker present in dynamic

equilibrium; typical free MDPs have 3JH1′–H2′ values of ∼6 Hz and %S ≈ 10 × 3JH1′–H2′
(corresponding to ∼60% S pucker).27 As the mole fraction of N sugar increases, the 3JH1′–H2′ value
decreases, approaching 0 Hz near 100% N.27 However, an {N7,Pα} macrochelate is rare,
occurring for 5′- but not for 3′-nucleotides.13,28,29

(B)

(A)

(C)

Figure 3.6. 1H NMR (A), 31P NMR (B) and 31P-31P COSY (C) spectra of an equilibrium
mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-GDP at pH 3.6. Asterisk labels
indicate peaks arising from free 5′-GDP.
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Upon treatment of fac-[Re(CO)3(H2O)3]+ with 5′-GDP (25 mM, r = 1:1), three new H8 NMR
singlets and two new H1′ signals were observed immediately after mixing (Figure 3.6, Table
3.3). The two most downfield product H8 signals (8.79 and 8.67 ppm, M and m, respectively)
integrate as 1:0.86, respectively, at 1 day after mixing and at equilibrium (no changes from 3 to 6
days). The smallest, least downfield product H8 singlet (8.49 ppm) decreased in intensity with
time relative to the two larger H8 product signals; at equilibrium, the M/8.49 ppm signal ratio
was 1:0.17. A number of other small H8 signals are unambiguously due to traces of free 5′-GMP
present in the starting 5′-GDP, and the resulting fac-[Re(CO)3(H2O)2(5′-GMP)] adduct.17 The
finding that at equilibrium 83% of the 5′-GDP has reacted indicates that 5′-GDP binds more
strongly than 5′-UDP or TDP.
Table 3.3. 1H and 31P NMR Chemical Shifts (ppm), Coupling Constants (Hz) of 5′-GDP
and Complexes Formed with fac-[Re(CO)3(H2O)3]+ a
complex

H8

δ 1H
H1′ (3JH1′-H2′)

5′-GDP
fac-[Re(CO)3(H2O)2({N7}GDP)]–

8.21
8.49

5.92 (6.0)
6.03b

δ 31P
Pα (Jαβ)

Pβ

–14.6 (21.5)
–14.6 (19.7)

–13.8
–13.7

8.79
6.03 (4.5)
–14.3 (21.5)
M
8.67
6.00 (1.0)
–12.7 (21.5)
m
a
b
1
1
25 mM, r = 1:1, pH 3.6. Assigned by a H– H ROESY experiment.

–10.8
–10.8

All free 5′-GDP was consumed in an experiment with an excess of Re(I) (25 mM, r =
1:0.5). Five hours after mixing, we observed at least three new H8 signals, shifted ca. 0.4 ppm
downfield from the H8 signal of free 5′-GDP, in addition to the H8 signals of M, m, and fac[Re(CO)3(H2O)2({N7}GDP)]–. M, m, and fac-[Re(CO)3(H2O)2({N7}GDP)]– accounted for 78%
of the reacted 5′-GDP, while the three new H8 signals accounted for 22% of the reacted 5′-GDP.
At r = 1:0.5, the m H8 signal appears to be larger than the M H8 signal, but this result is likely
due to overlap of the m H8 signal with another new H8 signal. The {1H}-31P NMR spectrum
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showed three new Pα doublets between –7.5 and –8.5 ppm; these shifts are within ∼0.5 ppm of
the Pα doublets of the TDP and 5′-UDP adducts (ca. –8.5 ppm for both). Likewise, the shifts of
the two sets of two new Pβ doublets at ca. –4 and –4.5 ppm are within ∼1 ppm of those for the Pβ
doublets of the TDP and 5′-UDP adducts (–5 and –5.5 ppm, respectively). Thus, these results
indicate that the new products all have N7, Pα, and Pβ of 5′-GDP bound to Re(I). An increase in
the amount of these new products upon addition of an excess of fac-[Re(CO)3(H2O)3]+ indicates
that more than one Re(I) is bound per 5′-GDP. Therefore, the new products are undoubtedly
dinuclear species with N7 bound to one Re(I) moiety and Pα and Pβ chelating a second Re(I)
moiety.

(A)

(B)

Figure 3.7. 1H-1H ROESY (A) and 31P-31P NOESY (B) spectra of an equilibrium mixture of
fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-GDP at pH 3.6.
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3.3.5

Further Considerations

Our evidence demonstrates that all three products of the r = 1:1 reaction are N7-bound
1:1 adducts, fac-[Re(CO)3(H2O)x(GDP)]– (x = 1 or 2). There are four types of evidence for N7
binding: First, the downfield shift changes of the H8 singlets (∼0.5 ppm) and the H1′ NMR
signals (∼0.1 ppm) of these products relative to free 5′-GDP are consistent with N7-bound
adducts (Table 3.2).17 Second, the three H8 singlets were insensitive to changing the pH from 3.6
to 1.5 (Appendix B).17 Third, 3JH1′–H2′ decreased from ∼5.6 Hz (free 5′-GDP) to ∼4.5 Hz and ~1
Hz, a feature consistent with metal coordination at N7 (Table 3.2).17 Furthermore, 3JH1′–H2′ ≈ 1 Hz
is indicative of an N7-coordinated, macrochelate-type structure having a highly N-puckered
ribose.27 Fourth, titration of a solution of Mn2+ ion (1 mM) into an equilibrated solution of fac[Re(CO)3(H2O)3]+ and 5′-GDP (5 mM, r = 1:1) confirmed that N7 was bound to Re(I) in all three
products, as none of the three H8 NMR signals of bound 5′-GDP broadened significantly at 5
μM Mn2+ ion, a concentration at which the H8 signal of free 5′-GDP became broadened to the
point of disappearance (Appendix B). Two types of evidence demonstrate that all products have
one Re(I) per 5′-GDP: First, all three H8 signals have different integrals (Appendix B). Two of
the three H8 signals would integrate equally if they were due to a bis adduct, in which both
nucleotides are coordinated to the same Re(I) center.17 Second, addition of a second equivalent
of 5′-GDP to a previously equilibrated sample (25 mM, r = 1:1) such that r = 1:2 resulted in 57%
of the 5′-GDP remaining unbound. Taken together, the above findings leave no doubt that all
three products contain one N7-bound 5′-GDP.
The ribose 1H NMR signals of the fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– isomers were
assigned by using 1H–1H COSY and 1H–13C HMQC experiments (Table 3.4). The H1′ signals at
6.03 and 6.00 ppm belong to M and m, respectively. 3JH1′–H2′ values of ∼4.5 (M) and ∼1 (m) Hz
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correspond to ∼55% and ∼90% N pucker, respectively. Most notably, the H2′ NMR signal of m
is shifted upfield (∼0.3 ppm) relative to the H2′ NMR signals of M or fac[Re(CO)3(H2O)2({N7}GDP)]–. Previous studies have shown that the H2′ NMR signal of cis[Pt(NH2CH3)2({N7,Pα}5′-IMP)] is shifted significantly downfield (0.4 ppm) relative to the H2′
NMR signals of cis-[Pt(NH2CH3)2({N7}5′-IMP)] or free 5′-IMP; in this adduct, the sugar is N,
the base is anti and the anisotropic downfield shift of H2′ is likely due to the placement of H2′ in
the plane of the pyrimidine ring near N3.12,13 Conversely, an upfield shift of H2′ (0.08 ppm) is
seen for N, high anti cis-[Pt(ND2CH3)2({N7,Pγ}5′-ITP)]; the upfield shift of H2′ is likely caused
by anisotropy.12,13 Therefore, these results indicate that in m, the sugar is N, the base is high anti,
and the H2′ proton is not located near N3 of the base pyrimidine ring.

Table 3.4. Ribose 1H NMR Chemical Shifts (ppm) of 5′-GDP and Complexes
Formed with fac-[Re(CO)3(H2O)3]+ a
complex
5′-GDP
fac-[Re(CO)3(H2O)2({N7}GDP)]–
M
a

m
25 mM, r = 1:1, pH 3.6. bNot observed.

H2′
4.70
4.63
4.59

H3′
4.54
4.53
4.48

δ 1H
H4′
4.30
4.36
4.34

4.35

4.43

4.29

H5′/H5″
4.18/4.18
b

4.35/4.15
4.19/4.13

The syn or anti conformation of bound 5′-GDP in the products was evaluated by using
the intensities of the H8–H1′ and H8–H2′ NOE cross-peaks in a 1H–1H ROESY experiment (25
mM, r = 1:1). Weak H8–H1′ and strong H8–H2′ NOE cross-peaks indicate an anti conformation
of 5′-GDP, while the reverse is found for 5′-GDP with a syn conformation. The H8-H1′ NOE
cross-peaks of M, m, and fac-[Re(CO)3(H2O)2({N7}GDP)]– were weak compared to the H8–H2′
NOE cross-peaks, indicating that the nucleotides in all adducts are in the anti conformation. Also
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apparent in the ROESY spectrum were M–m H8–H8 EXSY cross-peaks (Figure 3.7), consistent
with the 31P EXSY data, indicating M-to-m interchange.
3.3.5.1

pH Study of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– Isomers

In an effort to identify differences between the two fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–
isomers, we carried out an NMR-monitored titration from pH ∼1.5 to 6.5 in 1 unit steps. The H8
NMR signals of the two fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– isomers shifted downfield ∼0.2
ppm between pH 3.5 and 5.5; this small downfield shift is most likely a result of deprotonation
of the Pβ group (Appendix B). In addition, the H8 signal of fac-[Re(CO)3(H2O)2({N7}GDP)]–
disappeared around pH 4.5, indicating that this species is not stable at higher pH, converting to
the macrochelate isomers. Previous work has shown that 1:1 complexes containing 5′-GMP
bound to Re(I) via N7 only are unstable above pH 4.17 The Pα signals of M and m are affected
similarly by Pβ deprotonation, shifting downfield slightly (∼0.6 ppm). The Pβ signals of M and m
shifted downfield ∼5 ppm between pH 3.5 and 5.5, indicating that the pKa of this group has been
lowered by ∼2 pH units compared to free 5′-GDP (pKa ∼6.5, Appendix B). The similar behavior
of the

31

P NMR signals over the pH range studied provides additional evidence that M and m

have closely related structures, as expected if they differ mainly in the chirality at the Re(I) metal
center (RRe and SRe, see above).
3.3.5.2

To

Mn2+ Relaxation NMR Titrations of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–
Isomers
investigate

the

possible

differences

between

the

two

fac-

[Re(CO)3(H2O)({N7,Pβ}GDP)]– isomers, Mn2+ ion was used to assess the environment
surrounding the H8 proton of each isomer. For example, the H8 NMR signal will broaden upon
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addition of Mn2+ ion if uncoordinated phosphate groups reside near the H8 proton. The
magnitude of this line-broadening is slight compared to that observed when N7 is not bound to
Re(I), allowing the two phenomena to be distinguished (see above). At increasing concentrations
of Mn2+ ion, the line width of the H8 NMR signals increased more for m than for M, while the
fac-[Re(CO)3(H2O)2({N7}GDP)]– H8 NMR signal line width remained small in comparison
(Appendix B). This result suggests that the H8 protons of M and m are, respectively, farther from
and closer to uncoordinated phosphate groups. The distance from H8 to the uncoordinated
phosphate group is long for fac-[Re(CO)3(H2O)2({N7}GDP)]–, as this signal did not broaden
greatly even at high concentrations of Mn2+ ion (70 μM).
Because the Mn2+ ion titration indicated that phosphate groups are closer to H8 in m than
in M (see above), we used HyperChem23 to construct molecular models, allowing us to estimate
the distance from H8 to each phosphate oxygen (Table 3.5). The results obtained are compared
to computational results reported for cis-[Pt(NH3)2(nucleoside triphosphate)] macrochelate
complexes (Table 3.5).12,13 On the basis of the pseudorotation phase angle (P, calculated from the
endocyclic sugar torsion angles4) and the N-glycosidic bond torsion angle (χ, defined by O4′–
C1′–N7–C4 values4), the 5′-GDP moieties in all four models have N sugars with a high anti
orientation (P = 325–330° and χ = –59° to –67°). We should note that these values are
comparable to the P and χ values reported for models of cis-[Pt(NH3)2({N7,Pβ}5′-GTP)] (Table
3.5). The H8–Pβ distances (Table 3.6) are shorter for the two SRe models of fac[Re(CO)3(H2O)({N7,Pβ}GDP)]– (4.88 Å) than for the two RRe models (5.72 Å). The average H8–
Pα distance was ∼5.30 Å for all models (Table 3.6). Thus, we suggest that m is the SRe isomer.
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Table 3.5. Characteristics of Selected Pt(II) and Re(I) Nucleotide Complexes
complex
P (°)
χ (°)
N/S
syn/anti
a
346
–26.5
N
syn
cis-[Pt(NH3)2({N7,Pγ}5′-GTP)]
a
332
–60.1
N
borderline syn/high anti
cis-[Pt(NH3)2({N7,Pβ}5′-GTP)]
a
327
–81.5
N
high anti
cis-[Pt(NH3)2({N7,Pα}5′-GTP)]
–
fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]
326
–67.8
N
high anti
SRe 3JH1′–H2′ = 1.0 Hzb
3
b
SRe JH1′–H2′ = 4.5 Hz
325
–66.1
N
high anti
–
fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]
RRe 3JH1′–H2′ = 1.0 Hzb
330
–58.9
N
borderline syn/high anti
3
b
RRe JH1′–H2′ = 4.5 Hz
330
–59.1
N
borderline syn/high anti
a
b
Data from ref 12. Calculated from lowest-energy models built and minimized in HyperChem.23

Table 3.6. Distances (Å) between H8 Proton and Phosphate Oxygens of fac[Re(CO)3(H2O)({N7,Pβ}GDP)]– Macrochelate Models
complex

Pα(O/pro–Δ)

Pα(O/pro–Λ)

SRe
3
JH1′–H2′ = 1.0 Hz
5.11
5.40
3
JH1′–H2′ = 4.5 Hz
5.18
5.45
RRe
3
JH1′–H2′ = 1.0 Hz
5.72
4.85
3
JH1′–H2′ = 4.5 Hz
5.78
4.85
a
{Values} represent shortest average distances.

3.3.6

Pα(avg)a

Pβ(O)

Pβ(O)

Pβ(avg)a

{5.26}
5.32

4.49
4.54

5.23
5.27

{4.86}
{4.91}

{5.28}
5.31

6.16
6.19

5.25
5.28

5.71
5.73

Rate Constants of Interchange for TDP, 5′-UDP, and 5′-GDP Products

The rate constants of H2O exchange for fac-[Re(CO)3(H2O)3]+ (∼5.5 × 10–3 s–1) and fac[Re(CO)3(H2O)2(OH)] (∼27 s–1) indicate a large range of exchange rates dependent on the
coordinated ligand; thus, we assessed the rate constants of interchange between isomers of fac[Re(CO)3(H2O)({Pα,Pβ}TDP)]–,

fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]–,

and

fac-

[Re(CO)3(H2O)({N7,Pβ}GDP)]– adducts at 32 °C.30 The rate constants of interchange were
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estimated from 1H–1H ROESY and

31

P–31P NOESY experiments at 500 ms mixing time (tm)

(Table 3.7). The rate constant (k) can be calculated by using the ratio of the relative intensities
(peak amplitude, as measured by integration) of the diagonal peaks (IAA and IBB) and the EXSY
cross-peaks (IAB and IBA) and the following equation:31

k=

Using

31

(I + I )
1 R +1
ln
, where R = AA BB
(I AB + I BA )
tm R −1

P–31P NOESY data for the fac-[Re(CO)3(H2O)({Pα,Pβ}TDP)]– and fac-

[Re(CO)3(H2O)({Pα,Pβ}UDP)]– isomers, we calculated an average k value of ∼0.8 s–1 (Table
3.7). The four isomers of fac-[Re(CO)3(H2O)({Pα,Pβ}MDP)]– (Figure 3.2) can isomerize in four
different ways. If either Pα or Pβ interchanges coordination positions with H2O (and the
phosphate oxygen bound to Re(I) does not change), the Re(I) chirality (RRe or SRe) changes to SRe
or RRe, respectively. If the change is between O(pro-Δ) and O(pro-Λ) of Pα (Figure 3.2), with no
change in coordination position, then the Pα chirality changes. If both types of interchange occur,
for example, via an intermediate in which both O(pro-Δ) and O(pro-Λ) of Pα are bound to Re(I),
then both the Re(I) and Pα chiralities change (Figure 3.8).
Table 3.7. Rate Constants of Interchange Obtained from 1H–1H
ROESY and 31P–31P NOESY Experiments a

complex

R

k (s-1)

TDP (M pair – m pair) - Pα
UDP (M1 – M2) - Pα
UDP (m1 – m2) - Pα
GDP (M – m) - Pα
GDP (M – m) - H8
a
25 mM, r = 1:1, pH 3.6, 32 °C.

3.80
6.37
7.36
9.51
6.38

1.08
0.63
0.55
0.42
0.63

61

The EXSY cross-peak observed between the Pα doublets of the two mirror pairs of fac[Re(CO)3(H2O)({Pα,Pβ}TDP)]– indicates that interchange involves a chirality change only at one
chiral center, either Re(I) or Pα. Thus, simultaneous changes of both the Re(I) and the Pα
chiralities, leading to a synergistic interchange of members of the different mirror pairs, are ruled
out.

Figure 3.8. Possible mode of conversion between the RRe and SRe isomers of fac[Re(CO)3(H2O){N7,Pβ}GDP]–.

For fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]–, EXSY peaks connect each of the two upfield Pα
doublets with the downfield Pα doublet, but no EXSY peak between the two upfield Pα doublets
was detected. Rate constants of interchange calculated from the EXSY peaks for fac[Re(CO)3(H2O)({Pα,Pβ}UDP)]– (∼0.6 s–1) are similar to that found (∼1 s–1) for fac[Re(CO)3(H2O)({Pα,Pβ}TDP)]– isomers (Table 3.7). These results indicate that interchange
among the isomers of fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]– is undoubtedly due to a chirality
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change at only one chiral center, either Re(I) or Pα, as was found for fac[Re(CO)3(H2O)({Pα,Pβ}TDP)]–.
Using

31

P–31P and 1H–1H NOESY data for fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– (Table

3.7), we calculated an average k of ~0.5 s–1 for interchange between the isomers. When Pα is not
bound to Re(I), as in fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–, there can be only one mechanism for
interchange (Figure 3.3). Interchange of Pβ and H2O coordination positions (via an intermediate
in which two oxygens of Pβ are bound to Re(I)) leads to a chirality change only at Re(I) (Figure
3.8).
Because the rate constant for interchange between the RRe and SRe isomers of fac[Re(CO)3(H2O)({N7,Pβ}GDP)]– is similar to the rate constants for interchange for both fac[Re(CO)3(H2O)({Pα,Pβ}TDP)]– and fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]– isomers, the chirality
change at Re(I) for fac-[Re(CO)3(H2O)({Pα,Pβ}TDP)]– and fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]–
isomers most likely occurs by Pβ interchanging coordination positions with H2O, and not by
interchange between O(pro-Δ) and O(pro-Λ) of Pα or by Pα interchanging coordination positions
with H2O. As mentioned above, this suggested mechanism is supported by the very slow
dissociation of 5′-UDP from fac-[Re(CO)3(H2O)({Pα,Pβ}UDP)]– adducts, an indication that Pβ
remains bound to Re(I) during isomerization.
3.4

Conclusions

The nucleotide adducts described in this study and possessing the fac-[Re(CO)3]+ moiety
are sufficiently inert to allow the various products to be distinguished by NMR spectroscopy, but
the adducts are reactive enough for equilibrium amounts to be assessed. In comparison to studies
with other inert metal centers,7,11 the 31P NMR signals found here are notably sharp, allowing the
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coupling to be observed. This relatively rare combination of properties allows us to conclude that
there is little stereochemical preference for a given diastereomer over other possible
diastereomers. Thus, when metal nucleotide complexes act as cofactors with enzymes as part of
their natural biochemical function,6,32-36 the preferred (active) stereochemistry of the metal
nucleotide complex is very likely imparted by the enzyme rather than by any intrinsic
stereochemical preference dictated by the configuration and geometric parameters of the
nucleotide itself. The metals that function in biological roles are generally hard metals such as
Mg2+, which have little affinity for the endocyclic nitrogens of nucleotides.3 Our study suggests
that transition metal ions may not have been selected for this role because the affinity of the
metal for nitrogen leads to nucleobase binding. The resulting complexes have less metal-tophosphate interaction compared to other metal–phosphate complexes,37-39 and thus, the
phosphate hydrolysis needed for the biological activity5 is less favored.
Few other metal centers are likely to possess the useful combination of properties that the
fac-[Re(CO)3]+ center provides. In addition, unlike some metal centers (e.g., Pt(II) adducts
derived from Pt(II) anticancer drugs37) the rate of metal-promoted phosphate hydrolysis is very
slow, thus avoiding complications in spectral analysis caused by formation of adducts of both the
hydrolyzed nucleotide and inorganic phosphate.
3.5
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CHAPTER 4.
fac-[Re(CO)3(H2O)3]+ NUCLEOSIDE TRIPHOSPHATE ADDUCTS INVESTIGATED IN
AQUEOUS SOLUTION BY MULTINUCLEAR NMR SPECTROSCOPY
4.1

Introduction

Nucleoside triphosphates (NTPs) such as adenosine 5′-triphosphate (5′-ATP) and
guanosine 5′-triphosphate (5′-GTP) play a vital role in numerous biochemical reactions.1
Virtually all biological reactions involving NTPs require divalent metal cations, most commonly
Mg2+ or Zn2+.2 NTPs contain a variety of potential metal-binding sites, including the base, ribose
and phosphate moieties.3,4 Because of this complexity, and because of the lability of key metal
ions (such as Mg2+), understanding the solution structure of metal–NTP complexes has captured
the interest of investigators for nearly fifty years.3-16 This lability also impedes crystallization and
makes it risky to use solid-state structural information for interpreting [Mg(ATP)] solution
behavior. The simultaneous interaction of a metal with both purine N7 and the phosphate moiety
(of the same NTP), giving rise to a macrochelate, has been the subject of considerable study.3,4,13
Such macrochelates can be inner- or outer-sphere with respect to metal coordination at N7.4,13
Both types of macrochelates possess direct bonds to a Pβ and a Pγ phosphate group oxygen;
however, inner-sphere macrochelates are proposed to have a direct metal–N7 bond (and a metalbound H2O molecule intervening between metal and the Pα phosphate group). Outer-sphere
macrochelates have a direct bond to a Pα phosphate group oxygen (with an intervening H2O
molecule between the metal and N7).13
Substitution-inert [Co(III)(NTP)] and [Rh(III)(NTP)] complexes have been used as
models for labile metal–NTP complexes.5,10,17 In NMR spectroscopic studies of Co(III) and
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Rh(III) complexes of 5′-ATP, the 5′-ATP is bound as a tridentate {Pα,Pβ,Pγ} chelate, with the
formation of multiple isomers that can be separated chromatographically.5,10,17 Despite this, no
evidence has been found for the formation of inner- or outer-sphere macrochelates in either
system, thus precluding any potential studies providing insight into macrochelate structure. In
addition, the isomers of these relatively inert Co(III) and Rh(III) adducts may not be at
equilibrium, and the distribution of products may be influenced by kinetic pathways. On the
other hand, NTP complexes of labile metals such as Mg(II), while at equilibrium, show NMR
spectra containing only time-averaged signals that are difficult to interpret.5,18
We are particularly interested in the use of the substitution-inert, redox-stable fac[Re(I)(CO)3]+ metal core for assessing nucleoside and nucleotide binding.19,20 Adducts
containing this core typically exhibit favorable characteristics. Previous studies (performed at pH
3.6, to avoid deprotonation and oligomerization of the fac-[Re(CO)3]+ core21) have shown that
reactions of fac-[Re(CO)3(H2O)3]+ and nucleoside mono- and diphosphates attain equilibrium at
a convenient rate, and the products formed undergo exchange slowly on the NMR time scale.19,20
In addition, the products formed are dependent upon the properties of the nucleotide.19,20 When
mixed with guanosine 5′-monophosphate (5′-GMP) or guanosine 5′-diphosphate (5′-GDP), fac[Re(CO)3(H2O)3]+ forms a 1:1 monodentate {N7} complex and a 1:1 bidentate {N7,Pβ}
macrochelate, respectively; we found no evidence of a bidentate {N7,Pα} macrochelate.19,20
These results indicate that a simultaneous interaction of fac-[Re(CO)3]+ with N7 and Pα (of the
same nucleotide) is not favorable. However, the reaction of uridine 5′-diphosphate (5′-UDP) with
fac-[Re(CO)3(H2O)3]+ resulted in a bidentate {Pα,Pβ} chelate, indicating that Pα coordination is
favored when a simultaneous base interaction is absent.20 In this work, we exploit the favorable
properties of the fac-[Re(I)(CO)3]+ core for studying the interaction of fac-[Re(CO)3(H2O)3]+
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with NTPs in aqueous solution at pH 3.6, with the objective of shedding light on [Mg(ATP)]
solution behavior.
4.2

Experimental Section

4.2.1

Materials and Sample Preparation

Stock solutions (10 mM and 50 mM) of fac-[Re(CO)3(H2O)3]OTf in water were prepared
by published procedures and maintained at pH ∼ 1.8.22 5′-UTP, 5′-ATP, 5′-GTP (disodium salts),
sodium tripolyphosphate, and D2O (99.9%) (Sigma-Aldrich) were used as received.
A typical preparation of samples for 1D NMR spectroscopy involved treatment of an
appropriate amount of NTP in 0.3 mL of H2O with 0.4 mL of an ∼10 mM stock solution of fac[Re(CO)3(H2O)3]OTf; a small amount (0.1 mL) of D2O was added to establish a lock signal.
Samples for 2D NMR spectroscopy were prepared by removing H2O from an aqueous 0.4 mL
aliquot of an ∼50 mM stock solution of fac-[Re(CO)3(H2O)3]OTf and adding 0.4 mL D2O; the
appropriate amount of NTP (in 0.4 mL D2O) was then added. The pH (uncorrected) of the
samples in NMR tubes was maintained at ∼3.6 by the addition of dilute HCl and NaOH (in H2O)
or DCl and NaOD (in D2O) stock solutions, as required. The sample pH was adjusted to ∼3.6
immediately after mixing, and before the acquisition of each NMR spectrum.
4.2.2

NMR Spectroscopy

All NMR spectra were obtained on a Varian INOVA500 spectrometer (500.1 MHz)
equipped with a variable temperature probe that was equilibrated at 25 °C unless otherwise
indicated. A 1 s presaturation pulse was used to reduce the HOD peak in 1D 1H NMR spectra,
and the residual HOD signal was used to reference the spectrum. Each FID was accumulated for
32 transients, each containing 32K data points. Before Fourier transformation, an exponential
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apodization window function with a 0.2 Hz line broadening was applied. 1D proton-decoupled
31

P NMR spectra ({1H}–31P) were referenced to external trimethyl phosphate (TMP); each FID

was accumulated for 128 transients, each containing 8K data points. Before Fourier
transformation, an exponential apodization window function with a 0.5 Hz line broadening was
applied.
In general,

31

P–31P nuclear Overhauser effect spectroscopy (NOESY) experiments were

conducted by using 32 scans per block (512 blocks), a spectral width of ∼10K Hz in both
dimensions, and a mixing time of 500 ms at 25 °C.

31

P–31P correlation spectroscopy (COSY)

experiments containing 32 scans per block (734 blocks) were conducted by using a spectral
width of ∼4400 Hz in both dimensions and a COSY–45 pulse sequence to aid in visualizing close
coupling patterns. All NMR data were processed with VnmrJ (Varian) software.
4.2.3

Computational Methods

All models were constructed by using methods described previously20 on a PC equipped
with the Hyperchem 7.523 molecular modeling package, and all computations were performed
using AMBER99 force field parameters and literature methods.24 The Re–N7 and Re–phosphate
oxygen distances in all four models were constrained to ∼2.2 Å. Each model was geometrically
minimized by using Polak-Ribiere conjugate gradient minimization and terminated upon
reaching an rms gradient of 0.01 kcal/Å·mol.
4.3

Results and Discussion

4.3.1

General Considerations, Including Nomenclature

Although the base moieties of uridine 5′-triphosphate (5′-UTP), 5′-ATP, and 5′-GTP
possess potential metal-binding sites, N3 (5′-UTP, pKa ∼9.6) and N1 (5′-ATP, pKa ∼4; 5′-GTP,
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pKa ~9.6) are protonated at pH 3.6, while the N7 atoms of 5′-GTP (pKa ∼2.9) and 5′-ATP (pKa
~2.7)25 are available for binding to Re(I) (Figure 4.1).26 Each NTP also possesses an asymmetric
ribose moiety with potential metal-binding sites; however, Re(I) binding to these sites is unlikely
under the conditions used here.4
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Figure 4.1. 5′-UTP (top), 5′-GTP (middle), and 5′-ATP (bottom). At pH ∼3.6, the Pγ group of the
free NTP is protonated and the phosphate chain carries three negative charges. See text for
protocol used to designate phosphate oxygen atoms.

Unidentate coordination of an NTP to fac-[Re(CO)3(H2O)3]+ can occur in four possible
ways. Coordination via the terminal Pγ group of an NTP would result in the formation of a single
isomer. Unidentate coordination of the prochiral Pα or Pβ groups (although unlikely) would
create an asymmetric Pα or Pβ center and two isomers. Coordination via N7 of 5′-GTP would
lead to a single isomer.
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For the purposes of the following discussion, the terminal phosphate oxygen atoms of Pα
and Pβ are labeled O′ and O″ by utilizing the H5′ and H5″ hydrogens. The O′ and O″ are then
labeled by aligning the O–P–O and H–C5′–H groupings, leading to the designations in Figure
4.1.
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Figure 4.2. The four possible isomers of
fac-[Re(CO)3({Pα,Pβ,Pγ}NTP)]2–.
The
asymmetry of the Re(I) center (RRe or SRe)
is based on the direction of rotation of the
NTP around a reference axis defined by a
line passing through the Re(I) atom
perpendicular to the Pα–Re(I)–Pγ chelate
ring (assumed to be planar as shown
above) and passing through the CO (away
from the viewer). Endo and exo isomers
result from PαO″ and PαO′ coordination to
Re(I), respectively.

CO

SRe endo

Bidentate coordination of an NTP through the Pα and Pβ phosphate groups creates
asymmetric centers at Re(I), Pα and Pβ. Because either O′ and O″ of both Pα and Pβ can
coordinate, eight {Pα,Pβ} isomers are possible. Bidentate coordination through the Pβ and Pγ
phosphate groups creates asymmetric centers at Re(I) and Pβ, leading to four possible {Pβ,Pγ}
isomers. (Bidentate {Pα,Pγ} coordination is unlikely.) Bidentate {N7,Pα} coordination of 5′-GTP
or 5′-ATP is likely to be unfavorable for Re(I), as this sterically strained coordination mode has
not been observed for reactions of fac-[Re(CO)3(H2O)3]+ with 5′-GMP and 5′-GDP.19,20 In
contrast, bidentate {N7,Pβ} or {N7,Pγ} coordination (resulting in four and two possible isomers,
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respectively) is sterically feasible. However, products exhibiting this type of {N7,P} chelation
are unlikely to build up to a detectable level because the adjacent Pγ or Pβ group is brought in
close proximity to a coordination position bearing an aqua ligand, and the {N7,Pβ,Pγ} tridentate
adduct (see below) is favored.

O
O

O''
β
O γ
O
P
P
P α
OH
N7
O
O
O'
Re
C
CO
O
C
O

O

O

γ
P

HO

N7
O

O

O''
β
P
O'

O
α P
O

O
O

Re
C
O

C
C
O

O

S Re exo

RRe exo
O

O

O'
γ
β
O
O
P
P
P α
N7
OH
O
O''
O
Re
C
C
O
O
C
O
O

O

γ
P

O'
O
N7

HO

β

O

P

O

O''

α P
O

O
O

Re
OC

R Re endo

C
O

CO

S Re endo
= ribose

Figure 4.3. The four possible isomers of fac-[Re(CO)3({N7,Pβ,Pγ}NTP)]2–. The asymmetry of
the Re(I) center (RRe or SRe) is based on the direction of rotation of the NTP around a reference
axis defined by a line passing through the Re(I) atom perpendicular to the Pβ–Re(I)–Pγ chelate
ring (assumed to be planar as shown above) and passing through the CO (away from the
viewer). Endo and exo isomers result from PβO″ and PβO′ coordination to Re(I), respectively.

Tridentate coordination of an NTP via the Pα, Pβ and Pγ phosphate groups results in
asymmetric centers at Re(I), Pα and Pβ. For a facial arrangement of a triphosphate moiety, either
PαO′ or PαO″ can coordinate, resulting in endo and exo diastereomers. Furthermore, the
triphosphate chain can “wrap” around the octahedral face of the fac-[Re(CO)3]+ moiety in either
a right-handed or left-handed fashion, resulting in RRe and SRe diastereomers, respectively.
(Previously established nomenclature designates the RRe and SRe diastereomers as Δ and Λ,
respectively.5,7,8) However, binding of only PβΟ″ is possible (coordination through PβΟ′ gives a
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meridional arrangement); thus, the PβΟ″ coordination mode is fixed. Thus, for a given NTP, up
to four diastereomers could exist, designated as RRe exo, RRe endo, SRe exo, and SRe endo (Figure
4.2).
Table 4.1. Possible Isomers Formed by the
Reaction of fac-[Re(CO)3(H2O)3]+ with NTPs
N = U, A N = G

monodentate
a

1

Re{Pα*}NTP

2b

2b

Re{Pβ*}NTP

2b

2b

Re{Pγ}NTP

1

1

Re*{Pα*,Pβ*}NTP

8

8

Re*{Pα*,Pγ}NTP

4c

4c

Re*{Pβ*,Pγ}NTP

4

4

Re*{N7,Pα*}NTP

a

4c

Re*{N7,Pβ*}NTP

a

4

Re*{N7,Pγ}NTP

a

2

Re*{N7,Pα*,Pβ*}NTP

a

8c

Re*{N7,Pβ*,Pγ}NTP

a

4

Re*{N7,Pα*,Pγ}NTP

a

4d

Re*{Pα*,Pβ,Pγ}NTP

4

4

Re{N7}NTP

bidentate

tridentate

*chiral center. anot applicable. bunlikely that only
Pα or Pβ is bound. cunlikely that both N7 and Pα are
bound. dunlikely that Pα and Pγ are bound, and Pβ
remains unbound.

Consequently,

four

NMR-distinct

isomers

are

possible

for

fac-

[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– and fac-[Re(CO)3({Pα,Pβ,Pγ}ATP)]–. (Note: In formulae for the
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nucleotide complexes, the 5′- is omitted to save space.) Were 5′-GTP to bind in this manner,
there would again be four NMR-distinct diastereomers. However, we did not detect clear
evidence for such a species because 5′-GTP binds via N7 in all major species we identified; N7
coordination is also found for the major 5′-ATP adduct. Re(I) coordination via N7 of 5′-GTP (or
5′-ATP) presents different possibilities for adduct formation. Neither {N7,Pα,Pβ} nor {N7,Pα,Pγ}
tridentate coordination is likely because the N7–Re–Pα chelate ring is sterically strained.19,20
{N7,Pβ,Pγ} tridentate coordination of 5′-GTP (or 5′-ATP) creates asymmetric centers at Re(I)
and Pβ; thus, four NMR-distinct isomers are possible for fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– and
fac-[Re(CO)3({N7,Pβ,Pγ}ATP)]– (RRe endo, RRe exo, SRe endo, SRe exo; Figure 4.3). The number
of isomers likely to be formed upon the reaction of the NTPs studied here with fac[Re(CO)3(H2O)3]+ are summarized in Table 4.1.

Table 4.2. 1H and 31P NMR Chemical Shifts (ppm), Coupling Constants (Hz) of
H2PPP3–, 5′-UTP, and Complexes Formed with fac-[Re(CO)3(H2O)3]+ a

δ 1H
complex
H2PPP3–

b
2–

fac-[Re(CO)3(H2PPP)]

b
c

δ 31P
Pα/α′ (Jα/α′β)

Pβ

–13.4 (18.7)

–25.6

–7.0 (18.5)

–16.8
configuration

H6

Pα (Jαβ)

Pβ

Pγ (Jβγ)

5′-UTPd

7.93(5)

–14.5 (19.7)

–26.2

–13.9 (19.4)

1-U

7.85(6)

–10.6 (20.1)

–17.0e

–5.8 (20.1)

SRe exo

2-U

7.86(0)

–10.4 (20.1)

–17.0e

–5.7 (19.9)

RRe exo

3-U

7.89(1)

–9.5 (17.9)

–17.0e

–6.4 (19.6)

RRe endo

b

SRe endo
4-U
7.94(2)
–9.2 (17.2) –17.0e
–6.6 (19.6)
a
b
c
[Re] = 25 mM, pH 3.6. Not applicable. Third decimal place is given to distinguish adducts;
3
JH5–H6 = 8.1 Hz for all species observed. dH6 signals could not be correlated to 31P signals. eAll
Pβ signals are overlapped.
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Table 4.3. 31P NMR Chemical Shift Data (ppm) of Selected Reference Co(III) and
Rh(III) Complexes Compared to Similar Re(I) Complexes

ref
δ 31P
complex
Pβ
Pγ
Pα
3–
d
b
free H2PPP
3
–13.7
–26.2
18
d
[Rh(H2O)3(PPP)]a,e
3
2.8
–9.0
coordination chemical shift (ccs)
16.5
17.2
2–
b
2.5
–14.4
–26.1
–13.9
free ATP
11
2.5
–2.5
–10.5
4.3
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)]a,e
ccs
11.9
15.6
18.2
3–
d
b
free H2PPP
3.6
–13.4
–25.6
d
b
fac-[Re(CO)3(H2PPP)]2–
3.6
–7.0
–16.8
ccs
6.4
8.8
3–
b
free UTP
3.6
–14.5
–26.2
–13.9
b
3.6
–9.9
–17.0
–6.1
fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–
ccs
4.6
9.2
7.8
3–
b
free GTP
3.6
–14.4
–26.1
–13.9
b
3.6
–14.2
–21.2
–7.7
fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–
ccs
0.2
4.9
6.2
2–
b
3.6
–14.4
–26.1
–13.8
free ATP
b
3.6
–14.1
–20.8
–7.9
fac-[Re(CO)3(H2O)({Pβ,Pγ}ATP)]–
ccs
0.3
5.2
5.9
–
b
3.6
–10.0
–16.9
–6.3
fac-[Re(CO)3({Pα,Pβ,Pγ}ATP)]
ccs
4.4
9.1
7.5
3– a,c
17
free ATP
4.8
–14.5
–26.0
–14.5
17
[MgATP]a,c,e
4.8
–14.3
–23.9
–12.2
ccs
0.2
2.1
2.3
3–
b
free ATP
5.8
–14.4
–25.9
–13.2
15
5.8
–4.2
–11.2
1.5
[Co(NH3)3({Pα,Pβ,Pγ}ATP)]a,e
ccs
10.2
14.7
14.7
a 31
P NMR chemical shifts converted to TMP reference by subtracting 3.54 ppm from
the 31P chemical shift measured relative to 85% H3PO4. bThis work. cEstimated from
graphical representation. dNot applicable. eOverall charge on complex is taken from the
corresponding literature reference.
pH
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Previous work with 5′-GDP and 5′-GMP has shown that upon Re(I) coordination via N7
of the nucleotide, both the H8 and H1′ signals of the nucleotide shift downfield, 3JH1′–H2′
decreases in magnitude, and no significant shift change occurs for the Pα and Pβ signals.19,20
Coordination of one Re(I) metal center at N7 and another Re(I) chelating Pα and Pβ of the same
5′-GDP leads to a ∼0.4 ppm downfield shift of the H8 signal but larger (∼6 and ∼10 ppm)
downfield shifts for the Pα and Pβ signals, respectively.20 Re(I) coordination via only the
phosphate moiety of 5′-UDP resulted in negligible shift changes for the NMR signals of uracil;
however, a slight decrease in the magnitude of 3JH1′–H2′ was noted, indicating a decrease in the
percent S character (% S) in the dynamic equilibrium between N and S puckers of the ribose.19,20
As a first step in understanding the effects of coordination on 31P NMR shifts, we studied
the reaction of fac-[Re(CO)3(H2O)3]+ with diprotonated tripolyphosphate (H2PPP3–)27 at pH 3.6.
A

31

P NMR spectrum recorded one day after mixing fac-[Re(CO)3(H2O)3]+ and H2PPP3– (25

mM, r = 1:1 and 1:2) contained a Pβ triplet, shifted ∼9 ppm downfield from the Pβ signal of free
H2PPP3–, and a Pα/Pα′ doublet, shifted ∼7 ppm downfield from the Pα/Pα′ doublet of free H2PPP3–
(Table 4.2). The Pα/P α′ and Pβ signals of the product integrate as 2:1, demonstrating that both
terminal phosphate groups are bound to Re(I). At equilibrium (no changes from 3 to 6 days),
∼85% of the H2PPP3– had reacted and there was only one set of product signals. These results
indicate that fac-[Re(CO)3(H2PPP)]2–, in which all three phosphate groups chelate Re(I), is the
favorable reaction product.
Of particular note, the ~7 ppm downfield shift change for the Pα/Pα′ doublet of fac[Re(CO)3(H2PPP)]2– is similar to the downfield shift change (∼7 ppm) observed for the 31P NMR
signal of the coordinated phosphate groups of fac-[Re(CO)3(H2O)(H2PP)]– at pH 3.6 (H2PP2– =
diprotonated pyrophosphate).20 In general, the coordination shift changes observed here for the
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Pα/α′ and Pβ signals of fac-[Re(CO)3(H2PPP)]2– (and for the coordinated phosphate groups of 5′UTP, 5′-ATP, and 5′-GTP, see below) are smaller than those observed for the related tridentate
chelate adduct, [Rh(H2O)3(H2PPP)] (Table 4.3).17 This result is attributable to the lower
oxidation state (and lower electrophilicity) of Re(I) compared to Rh(III).
4.3.2

Overview of Products Formed by fac-[Re(CO)3(H2O)3]+ and NTPs

Throughout this work, concentrations will be denoted as (__ mM, r = __:__), in which
the fac-[Re(CO)3(H2O)3]+ concentration is stated and r is the ratio of the cation to added
phosphate ligand. This notation designates both the starting ligand concentration and its ratio to
the starting fac-[Re(CO)3(H2O)3]+ concentration.
In the following discussion, we first identify the adducts formed as a result of NTP
binding to fac-[Re(CO)3(H2O)3]+; we then present the 1H and 31P NMR spectral evidence and the
reasoning for such adduct designations. We did not detect any evidence suggesting formation of
a significant amount of either uni- or bidentate adducts (bound through only one or two
phosphate oxygens, respectively), or 1:2 adducts (even in r = 1:2 reaction mixtures) for 5′-UTP,
5′-GTP, or 5′-ATP.
4.3.3

5′-UTP Reaction Products

5′-UTP formed a tridentate 1:1 adduct, fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–, exhibiting 1H
and

31

P NMR signals for four diastereomers. 1H NMR spectra of fac-[Re(CO)3(H2O)3]+ treated

with 5′-UTP (25 mM, r = 1:1) showed after ∼1 day four product H6 doublets; one H6 doublet
was shifted slightly downfield and three H6 doublets were shifted slightly upfield, respectively,
from the H6 doublet of free 5′-UTP (Table 4.2 and Figure 4.4). The small size of the shifts
indicates no base binding. Signal overlap prevented analysis of the H5 and H1′ signals. At
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equilibrium (no changes from 3 to 6 days), ∼70% of the 5′-UTP had reacted, indicating that
formation

of

fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–

is

slightly

less

favorable

than

fac-

[Re(CO)3(PPP)]2– formation at r = 1:1.

(C)

(B)

(A)

Figure 4.4. 1H NMR (A), 31P NMR (B) and expanded region of 31P NMR (C) spectra of an
equilibrium mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-UTP at pH 3.6. Asterisk
labels indicate peaks arising from free 5′-UTP.

The {1H}–31P NMR spectrum of the (25 mM, r = 1:1) reaction mixture (Figure 4.4)
contained two sets of two Pα doublets between –9.0 and –11.0 ppm, overlapping Pβ doublets at –
17.0 ppm, and two sets of two Pγ doublets between –5.0 and –7.0 ppm, shifted ∼4.5, ∼9 and ∼8
ppm downfield from the respective free 5′-UTP signals (Table 4.2). The Pα vs Pγ assignments
were confirmed by a proton-coupled

31

P NMR experiment. The Pα doublets are labeled as

follows from most upfield to most downfield: 1-U, 2-U, 3-U, and 4-U (Figure 4.4). This
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numbering coincidentally reflects the relative abundance of the isomers, 1-U being the most
abundant. On chelate ring formation, the 3Jαβ coupling constants for 3-U and 4-U decreased to
∼17.6 Hz from 19.7 Hz (free 5′-UTP), whereas the 3Jαβ values for 1-U and 2-U increased to 20.1
Hz; the 3Jβγ coupling constants for all four isomers were relatively unaffected by chelate
formation (Table 4.2). The Pα–Pβ and Pβ–Pγ connectivities in a proton-decoupled 31P–31P COSY
experiment (25 mM, r = 1:1) allowed the Pγ doublets to be assigned from most upfield to most
downfield as follows: 4-U, 3-U, 1-U, and 2-U (Figure 4.4, Figure 4.5 and Appendix C).

Figure 4.5. 31P-31P COSY spectrum of an equilibrium mixture of fac-[Re(CO)3(H2O)3]+ (25 mM,
r = 1:1) and 5′-UTP at pH 3.6. Expansion of cross-peaks encircled by dotted line appears in
Appendix C.

No NMR studies of similar 5′-UTP complexes of octahedral metals were found in the
literature. However, [Rh(H2O)3({Pα,Pβ,Pγ}ATP)]10 and [Co(NH3)3({Pα,Pβ,Pγ}ATP)]15 (at pH 2.5
and 5.8, respectively) have been studied by

31

P NMR spectroscopy (Table 4.3). Downfield

coordination shifts (∼10 ppm) for Pα, Pβ, and Pγ of 5′-ATP indicate that all three phosphate
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groups are coordinated in both [Rh(H2O)3({Pα,Pβ,Pγ}ATP)] and [Co(NH3)3({Pα,Pβ,Pγ}ATP)]; the
appearance of four sets of NMR signals for each complex indicates the presence of four
{Pα,Pβ,Pγ} tridentate diastereomers (Δ endo, Λ endo, Δ exo, and Λ exo, see above).8,10,15
Diastereomers of [Rh(H2O)3({Pα,Pβ,Pγ}ATP)] and [Co(NH3)3({Pα,Pβ,Pγ}ATP)] give
characteristic patterns of 31P NMR signals. For example, the Pα signals of endo isomers are more
downfield

than

those

of

exo

isomers

for

both

[Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

and

[Co(NH3)3({Pα,Pβ,Pγ}ATP)].10,15 For [Co(NH3)3({Pα,Pβ,Pγ}ATP)], Pα signals of the Λ isomers
appear downfield from those of the Δ isomers for both the exo and endo configurations.15 For
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)], the Pα signal of the Λ endo isomer appears downfield from that of
the Δ endo isomer.10 (The Pα signals of the two exo isomers have nearly identical chemical shifts;
the downfield and upfield exo Pα signal are assigned as Δ and Λ by using circular dichroism
spectroscopy.10) Also, Speckhard et al. noted that the 3Jαβ coupling constants of the exo isomers
are several Hz larger than those for the endo isomers; the 3Jαβ coupling constants are larger than
the 3Jβγ coupling constants for all isomers.15 Thus, using these patterns, we tentatively assign the
Pα NMR signals of fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– as follows: 1-U and 2-U belong to the RRe
and SRe exo isomers, respectively; and 3-U and 4-U belong to the RRe and SRe endo isomers,
respectively (Figure 4.6).
For [Co(NH3)3({Pα,Pβ,Pγ}ATP)], the Pβ signals of the exo isomers are upfield from those
of the endo isomers.15 However, the Pβ NMR signals of fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–
overlap, thus precluding assignment of signals to individual isomers. In contrast to the behavior
observed

for

the

Pα

signals

of

both

[Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

and

[Co(NH3)3({Pα,Pβ,Pγ}ATP)], the Pγ signals of the endo isomers are upfield from those of the exo
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(C) [Co(NH3)3({Pα,Pβ,Pγ}ATP)]

isomers.10,15 For [Co(NH3)3({Pα,Pβ,Pγ}ATP)] and
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)], the Pγ signals of the Λ
endo isomers are upfield from those of the Δ endo
isomers.10,15 Thus, the two upfield Pγ doublets (4-U
and 3-U) can be assigned to the SRe and RRe endo

(B) fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–

isomers, respectively; and the two downfield Pγ
doublets belong to the exo isomers. For both
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

and

[Co(NH3)3({Pα,Pβ,Pγ}ATP)], the Pγ signals of the
two exo isomers have very similar chemical shifts.
(A) [Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

Thus, Speckhard et al. assigned the most downfield
Pγ exo signal as Λ, while Lu et al. assigned this
signal as Δ.10,15 The Pα and Pγ signals of
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)],

fac-

[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–,

and

[Co(NH3)3({Pα,Pβ,Pγ}ATP)] are depicted graphically
in Figure 4.6. We assign the most downfield Pγ exo
signal as RRe. In summary, the signals of the four

Figure 4.6. Comparison of Pα and Pγ
NMR
signals
of
(A) tridentate
isomers
of
fac[Rh(H2O)3({Pα,Pβ,Pγ}ATP)], (B) fac[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–, and (C) [Re(CO)3({Pα,Pβ,Pγ}UTP)]2– can be identified as
[Co(NH3)3({Pα,Pβ,Pγ}ATP)]. Plots (A)
and (C) are derived from refs 10 and 15, follows: 1-U, RRe exo; 2-U, SRe exo; 3-U, SRe endo;
respectively.
and 4-U, RRe endo (Table 4.2).
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4.3.4

5′-GTP Reaction Products

When treated with fac-[Re(CO)3(H2O)3]+, 5′-GTP formed primarily a tridentate 1:1
adduct, fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–. Immediately after mixing, an NMR spectrum of fac[Re(CO)3(H2O)3]+ mixed with 5′-GTP (25 mM, r = 1:1) showed two new H8 singlets (partially
overlapped at ∼8.43 ppm and shifted ∼0.2 ppm downfield from the H8 singlet of free 5′-GTP,
Table 4.4) and two new H1′ doublets (6.00 and 6.06 ppm) (Figure 4.7). At equilibrium, >90% of
the 5′-GTP has reacted, indicating that 5′-GTP binds more strongly than 5′-UTP or H2PPP3– at
pH 3.6. A number of other small H8 signals are unambiguously assigned to traces of free and
coordinated 5′-GMP and 5′-GDP arising from impurities in the starting 5′-GTP.19,20
The {1H}–31P NMR spectrum of the (25 mM, r = 1:1) reaction mixture supports the 1H
NMR data indicating the presence of mainly two products. An apparent triplet at –21.0 ppm (1G) and a doublet of doublets near –21.4 ppm (2-G) are without question Pβ signals (Figure 4.7).

From broadening seen in a proton-coupled 31P NMR spectrum, the doublets at –14.3 (1-G) and at
–14.0 (2-G) ppm are Pα signals. Thus, the doublets at –7.9 (1-G) and at –7.5 (2-G) ppm are Pγ
signals. The product Pα, Pβ and Pγ signals are shifted ∼0.2, ∼5, and ∼6 ppm downfield from the
respective free 5′-GTP signals (Table 4.4). These results demonstrate that N7, Pβ and Pγ are, and
Pα is not, directly coordinated to Re(I) in both 1-G and 2-G. Because the overlapped H8 singlets
of 1-G and 2-G precluded integration, the approximate product distribution (60% 1-G / 40% 2G) was obtained by integrating the Pβ NMR signals. T1 values for the Pβ signals of 1-G and 2-G

were similar (∼1 s); nevertheless, a relaxation delay of 5 × T1 was used between pulses to
minimize any error introduced by incomplete

31

P relaxation. The product distribution observed

initially was the same as that found at equilibrium (no changes from 3 to 6 days). Thus, product
formation is not influenced noticeably by kinetic control. A proton-decoupled
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31

P–31P COSY

experiment (25 mM, r = 1:1) allowed identification of

31

P nuclei within the same spin system

(Figure 4.7). A 31P–31P NOESY spectrum contained no EXSY peaks, indicating that 1-G and 2G do not interconvert even in the slow exchange regime of the NMR time scale.

(C)

(B)

(A)

Figure 4.7. 1H NMR (A), 31P NMR (B) and 31P-31P COSY (C) spectra of an equilibrium
mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-GTP at pH 3.6. Asterisk labels
indicate peaks arising from free 5′-GTP.

Several types of evidence demonstrate that both 1-G and 2-G are N7 bound, 1:1 fac[Re(CO)3(GTP)]2– adducts. First, the downfield shift changes of the H8 singlets (∼0.2 ppm) and
the H1′ NMR signals (∼0.1 ppm) of these products relative to free 5′-GTP are consistent with
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N7-bound adducts (Table 4.4).19 Second, both H8 singlets were insensitive to a decrease in pH
from 3.6 to 1, indicating that Re(I) coordination blocks N7 protonation.19 Third, 3JH1′–H2′
decreased from ∼5.7 Hz (free 5′-GTP) to ∼5.5 Hz and ∼4.0 Hz, a feature consistent with metal
coordination at N7 (Table 4.4).19 Fourth, titration of a 1 mM solution of Cu2+ ion into a
previously equilibrated solution containing 1-G and 2-G did not result in broadening of the H8
signals of the products at 15 μM Cu2+ ion, a concentration at which the H8 signal of free 5′-GTP
is broadened to the point of disappearance; thus N7 is bound to Re(I) in both 1-G and 2-G.

Table 4.4. 1H and 31P NMR Chemical Shifts (ppm), Coupling Constants (Hz) of 5′GTP and Complexes Formed with fac-[Re(CO)3(H2O)3]+ a

δ 1H
complex
5′-GTP
1-G

H8
8.26
8.43(2)

H1′ (JH1′–H2′)
5.93 (5.7)
6.00 (4.0)

δ 31P
Pα (Jαβ)
–14.4 (19.7)
–14.3 (20.0)

Pβ
–26.1
–21.0

Pγ
–13.9
–7.9

8.43(0)
6.06 (5.5) –14.0 (16.7) –21.3, –21.4
–7.5
2-G
[Re] = 25 mM, pH 3.6. b3JH1′–H2′ (free 5′-GTP) = ~6 Hz and ~60% S pucker (estimated
by % S ≈ 10 × 3JH1′–H2′).42

a

Two types of evidence demonstrate that both 1-G and 2-G have one Re(I) per 5′-GTP.
First, a 1:2 adduct would have two H8 signals and the two H8 signals would integrate equally.19
The observed signals do not have the same intensity. Second, addition of a second equivalent of
5′-GTP to a previously equilibrated sample (25 mM, r = 1:1) such that r = 1:2 resulted in ∼50%
of the 5′-GTP remaining unbound. (The amount of the GDP adduct decreased.) Taken together,
the above findings leave no doubt that the two H8 signals are from two 1:1 adducts and that both
contain one N7-bound 5′-GTP. This result also rules out the very remote possibility that the
NMR data reflect a mixture of 1:1 and 1:2 adducts with overlapping H8 signals.
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4.3.5
Effect of Re(I) Binding on Pγ pKa of the fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– and
fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– Adducts

The effect of pH changes on the chemical shifts of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– and
fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– were assessed by monitoring the NMR spectrum as the pH was
raised from ~1 to ~7 in steps of 1 pH unit (Appendix C). No significant shift changes were
observed for the H8 and Pα signals of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– over the pH range
studied. However, the Pβ and Pγ signals of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– shifted ∼1.5 and
∼3.5 ppm downfield, respectively, between pH 3 and 5 (Appendix C). This suggests a Pγ pKa
decrease to ∼4.5 for fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– compared to the Pγ pKa of free 5′-GTP
(pKa ∼6.5, Appendix C), which is undoubtedly due to direct Re(I)–phosphate binding.
No significant shift changes were observed for the H6 or Pα signals of fac[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– over the pH range in experiments performed as described above for
5′-GTP. The Pβ and Pγ signals of fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2– were more affected, shifting
∼1.5 and ∼3.5 ppm downfield, respectively, between pH 1.4 and 4.3 (Appendix C). These data
suggest a Pγ pKa of ∼4, a decrease compared to that of free 5′-UTP (pKa ~7, Appendix C). These
results are consistent with previous findings that metal coordination to the triphosphate chain
lowers the Pγ pKa by ~2-4 units vs the Pγ pKa value for free NTP.10,11,26,28
4.3.6

Nature of the GTP Products

The similar dependence of the 1H and 31P NMR signals of 1-G and 2-G on pH provides
evidence for a close structural relationship between the 1-G and 2-G products. However, as
discussed above, four diastereomers (RRe endo, RRe exo, SRe endo and SRe exo) (and four sets of
NMR signals) are possible for fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–. However, only two sets of
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NMR signals are observed, and the lack of exchange between the NMR signals of 1-G and 2-G
(see above) suggests that the products have the same chirality about the Re(I) metal center. We
have

previously

established

that

the

RRe

and

SRe

diastereomers

of

fac-

[Re(CO)3(H2O)({N7,Pβ}GDP)]– interchange in the slow exchange regime of the NMR time
scale, giving rise to EXSY cross-peaks.20
Lower energy diastereomers were identified by using HyperChem23 to construct models
of the four conceivable diastereomers of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–; the results of the
modeling are shown in Figure 4.8 and Table 4.5. We found that the two SRe diastereomers of
fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– are 10-20 kcals/mol lower in energy than the two RRe
diastereomers, and the SRe endo and SRe exo diastereomers differ in energy by ~1.5 kcals/mol.
These

results

indicate

that

the

two

sets

of

NMR

signals

observed

for

fac-

[Re(CO)3({N7,Pβ,Pγ}GTP)]2– can be attributed to the SRe endo and SRe exo diastereomers; it is
unlikely that the RRe diastereomers are formed.
The

5′-GTP

moieties

in

the

SRe

endo

and

SRe

exo

models

of

fac-

[Re(CO)3({N7,Pβ,Pγ}GTP)]2– have N sugars with N-glycosidic bond torsion angles (given by χ,
O4′–C1′–N9–C4) in the anti (χ = –91.9°, χrange = 180° ± 90°) and high anti (χ = –81.5°, χrange = –
60° to –90°) ranges, respectively.27 The conformation of the sugar-phosphate linkage is
determined by the torsion angle γ (O5′–C5′–C4′–C3′); γ values of 43° and 41° for the SRe endo
and SRe exo models of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–, respectively, indicate that the preferred
conformation of the sugar-phosphate linkage is gauche, gauche (gg, γrange = 30° to 90°).27 Past
modeling studies have shown that the SRe diastereomer of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–
has an N sugar with a high anti conformation around the glycosidic bond (χ = –67.4°), and the
preferred conformation of the sugar-phosphate linkage is gg (γ = 51.0°).20
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Table
4.5.
Characteristics
of
fac2–
[Re(CO)3({N7,Pβ,Pγ}GTP)] Model Complexes a
χ (deg)
γ (deg)

SRe
–91.9 (anti)

43.0 (gg)

–81.5 (high anti)

45.0 (gg)

endo
exo
a

Angles χ and γ are defined by torsion angles
O4′–C1′–N9–C4
and
O5′–C5′–C4′–C3′,
27
respectively.

The

results

presented

above

for

the

SRe

diastereomers

of

both

fac-

[Re(CO)3(H2O)({N7,Pβ}GDP)]– and fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2– are in good agreement
with results found for other metal-nucleotide macrochelate complexes.29 NMR spectroscopic
studies

cis-[Pt(ND2CH3)2({N7,Pγ}ITP)]12),

(of

molecular

mechanics

studies

(of

cis-

[Pt(NH3)2({N7,Pγ}GTP)12] and cis-[Pt(NH3)2({N7,Pα}GMP)]12) and X-ray structural studies (of
the cyclic trimer [{(η6-p-MeC6H4Pri)Ru({N7}AMP)}3]30) have demonstrated a nearly exclusive
preference for N sugars with an anti (or high anti) conformation around the glycosidic bond and
a gg conformation of the sugar-phosphate linkage.
During this study, we noted that the ∼0.2 ppm downfield shift of the H8 signals of fac[Re(CO)3({N7,Pβ,Pγ}GTP)]2– upon Re(I) coordination (free 5′-GTP, 8.26 ppm; 1-G and 2-G,
8.43 ppm) is considerably smaller than the ∼0.5 ppm downfield shift of the H8 signals of fac[Re(CO)3(H2O)({N7,Pβ}GDP)]– (free 5′-GDP, 8.21 ppm; products, ~8.74 ppm).20 Distance
measurements

taken

from

fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–

and

fac-

[Re(CO)3(H2O)({N7,Pβ}GDP)]– model complexes show that the H8 proton is ~1 Å closer to the
phosphate

backbone

in

the

SRe

endo
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and

SRe

exo

diastereomers

of

fac-

[Re(CO)3({N7,Pβ,Pγ}GTP)]2– (average H8-O5′ distances = 2.5 Å), compared to the SRe
diastereomer of fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]– (H8-O5′ distance = 3.2 Å). This proximity
may result in a larger shielding effect near the H8 proton of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–
compared to fac-[Re(CO)3(H2O)({N7,Pβ}GDP)]–, resulting in a larger downfield shift of the H8
proton of the latter upon Re(I) coordination.

RRe

RRe

SRe exo

SRe

Figure 4.8. Models of four possible diastereomers of fac-[Re(CO)3({N7,Pβ,Pγ}GTP)]2–.

4.3.7

5′-ATP Reaction Products

When treated with fac-[Re(CO)3(H2O)3]+, 5′-ATP formed primarily a macrochelate 1:1
adduct,

fac-[Re(CO)3({N7,Pβ,Pγ}ATP)]–;

the
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tridentate

1:1

phosphato

chelate

fac-

[Re(CO)3({Pα,Pβ,Pγ}ATP)]– was also formed as a minor product. One hour after mixing fac[Re(CO)3(H2O)3]+ with 5′-ATP (25 mM, r = 1:1), five new H8 1H NMR singlets were present.
Two H8 signals of nearly equal intensity at 8.84 and 8.86 ppm are approximately three times
more intense than an apparent H8 triplet centered at 8.64 ppm (it is likely that the apparent H8
triplet is the result of four overlapping H6 signals); these products are thus designated as the
major (1-A) and minor (2-A) products, respectively (Table 4.6). The shift changes upon
coordination of the H8 signals of 1-A and 2-A are ~0.15 ppm downfield, and ~0.1 ppm upfield,
respectively. Two new H2 signals (at 8.45 and 8.48 ppm) and two new H1′ signals (at 6.31 and
6.37 ppm) were observed; these signals can be assigned to 1-A. The H2 and H1′ signals of 1-A
are only slightly shifted compared to the same signals of free 5′-ATP (Table 4.6). The H2 and
H1′ signals of 2-A are small and are obscured by the respective signals of the free nucleotide. At
equilibrium, 1-A and 2-A account for 60% and 20% of the total 5′-ATP, respectively; ~20% of
the added 5′-ATP remains unreacted. Under pH 3.6 conditions, 5′-ATP binding is more favorable
than 5′-UTP or H2PPP3– binding, but slightly less favorable than 5′-GTP binding.

Table 4.6. 1H and 31P NMR Chemical Shifts (ppm), Coupling Constants (Hz) of 5′-ATP and
Complexes Formed with fac-[Re(CO)3(H2O)3]+ a

δ 1H
complex

H8

H2

δ 31P
H1′ (JH1′–H2′)

Pα (Jαβ)

Pβ

Pγ

–
13.8
–7.7
–14.1b –20.8 –8.0
1-A
–9.0 (17.3), –9.2 (18.0)
–5.9
c
c
8.64
–10.2 (18.1), –10.4 (20.0) –16.9 –6.5
2-A
a
[Re] = 25 mM, pH 3.6. bCoupling not observed due to signal overlap. cSignals obscured by
signals of free 5′-ATP.
5′-ATP

8.71
8.84
8.86

8.48
8.45
8.48

6.25 (5.2)
6.31 (3.1)
6.36 (3.6)
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–14.4 (18.6)

–25.9

The {1H}–31P NMR spectrum of the (25 mM, r = 1:1) reaction mixture supports the 1H
NMR data indicating the presence of two products (Table 4.6). Two multiplets, due to their
presence in the most upfield region of the 31P NMR spectrum, are without question Pβ signals. A
large Pβ multiplet (–20.8 ppm) and a small Pβ multiplet (–16.9 ppm) can be assigned to 1-A and
2-A, respectively. Broadening observed in a proton-coupled
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P NMR spectrum confirmed that

two large doublets near –14.1 ppm and four smaller doublets near –10.0 ppm are Pα signals.
Thus, two large doublets at –8.0 ppm and two smaller (apparent) triplets (it is likely that the two
triplets result from overlapping of four doublets) near –6.0 ppm are Pγ signals. The Pα–Pβ and
Pβ–Pγ connectivities observed in a proton-decoupled 31P–31P COSY experiment (25 mM, r = 1:1)
allowed identification of 31P nuclei within the same spin system. Thus, the Pβ multiplet at –20.8
ppm, two Pα doublets at –14.1 ppm and two Pγ doublets at –8.0 ppm can be assigned to 1-A; and
the Pβ multiplet at –16.9 ppm, four Pα doublets at –10.0 ppm and two Pγ (apparent) triplets at –
6.0 ppm can be assigned to 2-A. Compared to the respective free 5′-ATP signals, the Pα, Pβ and
Pγ signals are shifted downfield by ∼0.3, ∼5, and ∼6 ppm for 1-A, and ∼4.5, ∼9, and ∼7.5 ppm for
2-A (Table 4.6). These results demonstrate that Pβ and Pγ are directly coordinated to Re(I) in

both 1-A and 2-A; however, Pα is directly coordinated to Re(I) only in 2-A. The downfield shift
upon Re(I) coordination for the two H8 signals of 1-A indicates that Re(I) is bound via N7 of the
adenine base; the slight upfield shift upon Re(I) coordination for the H8 signals of 2-A indicates
that Re(I) is likely not bound via N7 of the adenine base. Thus, we can conclude that 1-A is fac[Re(CO)3({N7,Pβ,Pγ}ATP)]–, and 2-A is fac-[Re(CO)3({Pα,Pβ,Pγ}ATP)]–.
Raising the pH of a sample containing 60% 1-A, 20% 2-A, and 20% free 5′-ATP from
~3.6 to ~7 resulted in significant sharpening of the 31P NMR signals of 1-A and 2-A. At pH ~7,
the sample contained 75% 1-A, 19% 2-A, and 6% free 5′-ATP. Thus, as the pH of the sample is
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increased, unbound 5′-ATP reacts with fac-[Re(CO)3(H2O)3]+ to form more of the tridentate
macrochelate 1-A. The amount of 2-A in the sample decreased slightly from 20% to 19% on
raising the pH from ~3.6 to ~7; this result indicates that formation of 2-A is not pH-dependent.
No change in the chemical shift of the Pα signals of 1-A and 2-A was observed on raising the pH
to ~7. However, the Pβ signals shift ~1 and ~0.5 ppm for 1-A and 2-A, respectively; and the Pγ
signals shift ~1.5 and ~1.2 ppm for 1-A and 2-A, respectively.
4.3.8

Considerations Regarding the Solution Structure of [Mg(ATP)]

The [Mg(ATP)] complex is the natural substrate for a variety of enzymatic processes.
Thus, determining the coordination mode of the nucleotide in [Mg(ATP)] has been the focus of a
large number of investigations. The results of these experiments have been analyzed to suggest
that Mg2+ binds 5′-ATP only via Pβ and Pγ oxygen atoms,18 while results from other experiments
have been interpreted to suggest that Mg2+ binds 5′-ATP via Pα, Pβ, and Pγ oxygen atoms.31 Early
31

P NMR spectroscopic studies performed by Cohn et al. showed that the addition of Mg2+

caused the Pα, Pβ, and Pγ 31P NMR signals of 5′-ATP to shift ~0.2, 2.1 and 2.3 ppm downfield
(Table 4.3), leading these researchers to suggest that the [Mg(ATP)] complex exists
predominantly as a bidentate {Pβ,Pγ} phosphato chelate in solution.18 Later, broadening observed
in 17O NMR spectroscopic studies was interpreted as an indication that Pα was also involved in
chelation of Mg2+, leading to a tridentate {Pα,Pβ,Pγ} phosphato chelate.31 In addition, molecular
dynamics studies of the conformational equilibria of [Mg(ATP)] in aqueous solution have
suggested that [Mg(ATP)] is equally likely to exist as either the {Pα,Pβ,Pγ} or the {Pβ,Pγ}
phosphato chelate.32 Originally proposed by Szent-Györgyi in 195616, Martin and Mariam4 also
suggested that [Mg(ATP)] exists as a {N7,Pβ,Pγ} macrochelate, in which Mg2+ has an inner-
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sphere interaction with N7, Pβ, and Pγ. However, space-filling models, generated by Sigel et al.,
have indicated that a simultaneous inner-sphere interaction of both N7 and Pα is possible without
“much” strain.33,34 Despite this, Sigel and coworkers have recently interpreted stability constant
data as indicating no direct Mg2+ to adenine base interaction.2
Several researchers have suggested that the use of Rh(III) and Co(III) complexes of 5′ATP as models for [Mg(ATP)].

31

P NMR spectroscopic studies of [Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

and [Co(NH3)3({Pα,Pβ,Pγ}ATP)] have shown that the Pα, Pβ, and Pγ signals shifted between 10
and 18 ppm downfield from the same

31

P NMR signals of 5′-ATP upon metal coordination

(Table 4.3).8,10,15 These results demonstrate that Pα, Pβ, and Pγ are directly bound to the Rh(III)
(or Co(III)) metal center in both [Rh(H2O)3({Pα,Pβ,Pγ}ATP)] and [Co(NH3)3({Pα,Pβ,Pγ}ATP)].
Also, the magnitude of the downfield shift upon coordination is significantly larger in
[Rh(H2O)3({Pα,Pβ,Pγ}ATP)]

and

[Co(NH3)3({Pα,Pβ,Pγ}ATP)],

compared

to [Mg(ATP)],

indicating that Rh(III) and Co(III) have a much greater deshielding effect than Mg(II). These
results demonstrate that Rh(III) and Co(III) complexes of 5′-ATP are not accurate models for the
[Mg(ATP)] complex.
The results presented here suggest that the fac-[Re(CO)3]+ core could be used as a more
accurate model for the biologically relevant [Mg(ATP)] complex. The fac-[Re(CO)3]+ core is
both octahedral and exchange-inert, and is not prone to oligomer formation.
4.4

Conclusions

The nucleoside triphosphate adducts described here contain the kinetically inert,
octahedral fac-[Re(CO)3]+ core. When fac-[Re(CO)3(H2O)3]+ is allowed to react with NTPs, an
equilibrium distribution of product diastereomers is established, and sharp
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31

P NMR signals

arising from each diastereomer can be distinguished. Thus, we can conclude that when all three
phosphate groups are coordinated to Re(I), as in fac-[Re(CO)3({Pα,Pβ,Pγ}UTP)]2–, there is a
significant stereochemical preference for diastereomers with the base moiety directed away from
the coordinated phosphate chain (exo) compared to those diastereomers with the base directed
toward the phosphate chain (endo). We found no evidence indicating a preference for one Re(I)
chirality over the other for {Pα,Pβ,Pγ} chelate complexes. Thus, these results provide additional
support for our suggestion that when metal nucleotide complexes act as enzyme cofactors,6,7,35-38
the preferred stereochemistry of the active, enzyme-bound metal-nucleotide complex is likely to
be controlled by the enzyme and not by the stereochemical preference of the nucleotide adduct.20
Metals ions in biological roles, such as Mg2+, are generally hard metals that have little
affinity for the endocyclic nitrogens of nucleotides.3 Placement of the fac-[Re(CO)3]+ cation in
Pearson’s hard-soft acids and bases39 scheme, using a modification by Martin,40 indicates that
Re(I) is a “borderline” metal center.41 Such a classification is somewhat unexpected for a
monovalent third-row transition metal, as these metals are typically quite soft. However, a
significant amount of electron density is displaced onto the three π–backbonding CO ligands,
effectively increasing the hardness of Re(I). The “borderline” hardness of Re(I) most likely
increases the affinity of the metal center for the phosphate oxygen atoms of a nucleotide, but
does not preclude an interaction between Re(I) and N7 of the base moiety.
Only one clear example of an NTP macrochelate having a direct metal–N7 bond has been
reported; [Ru(η6-C6H6)]2+ forms a tridentate {N7,Pβ,Pγ} macrochelate when allowed to react
with 5′-ATP.30 However, this system is not suitable as a general model for macrochelates
containing an octahedral metal center, because [Ru(η6-C6H6)]2+ readily forms oligomers in
aqueous solution, and the
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P NMR signals of the resulting [(Ru(η6-C6H6)({N7,Pβ,Pγ}ATP)]–
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complex are not well defined.30 We have demonstrated that the fac-[Re(CO)3]+ core could be
used as a general model for further investigations into the structure of macrochelates, as fac[Re(CO)3({N7,Pβ,Pγ}GTP)]2– and fac-[Re(CO)3({N7,Pβ,Pγ}ATP)]– are both stable and easily
accessible via the reaction of fac-[Re(CO)3(H2O)3]+ with 5′-GTP or 5′-ATP.
4.5

References

1. Lippard, S. J.; Berg, J. M. Principles of Bioinorganic Chemistry; University Science Books:
Mill Valley, CA, 1994.
2. Sigel, H.; Griesser, R. Chem. Soc. Rev. 2005, 34, 875-900.
3. Marzilli, L. G. In Prog. Inorg. Chem.; Lippard, S. J., Ed.; John Wiley and Sons: New York,
1977; Vol. 23, pp 255-278.
4. Martin, R. B.; Mariam, Y. H. Met. Ions Biol. Syst. 1979, 8, 57-124.
5. Cleland, W. W. Methods Enzymol. 1982, 87, 159-179.
6. Cleland, W. W.; Mildvan, A. S. In Advances in Inorganic Biochemistry; Eichhorn, G. L.,
Marzilli, L. G., Eds.; Elsevier / North-Holland: New York, 1979; Vol. 1, pp 163-191.
7. Cornelius, R. D.; Cleland, W. W. Biochemistry 1978, 17, 3279-3286.
8. Cornelius, R. D.; Hart, P. A.; Cleland, W. W. Inorg. Chem. 1977, 16, 2799-2805.
9. Korn, S.; Sheldrick, W. S. Inorg. Chim. Acta 1997, 254, 85-91.
10. Lu, Z.; Shorter, A. L.; Lin, I.; Dunaway-Mariano, D. Inorg. Chem. 1988, 27, 4135-4139.
11. Pecoraro, V. L.; Hermes, J. D.; Cleland, W. W. Biochemistry 1984, 23, 5262-5271.
12. Reily, M. D.; Hambley, T. W.; Marzilli, L. G. J. Am. Chem. Soc. 1988, 110, 2999-3007.
13. Sigel, H. Eur. J. Biochem. 1987, 165, 65-72.
14. Sigel, H. Pure Appl. Chem. 2004, 76, 375-388.
15. Speckhard, D. C.; Pecoraro, V. L.; Knight, W. B.; Cleland, W. W. J. Am. Chem. Soc. 1986,
108, 4167-4171.

95

16. Szent-Györgyi, A. In Enzymes, Units of Biological Structure and Function; Gaebler, O. H.,
Ed.; Academic Press: New York, 1956, pp 393-397.
17. Lin, I.; Knight, W. B.; Ting, S.-J.; Dunaway-Mariano, D. Inorg. Chem. 1984, 23, 988-991.
18. Cohn, M.; Hughes Jr., T. R. J. Biol. Chem. 1962, 237, 176-181.
19. Adams, K. M.; Marzilli, L. G. Inorg. Chem. 2007, 46, 4926-4936.
20. Adams, K. M.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2007, 46, 9172-9181.
21. Egli, A.; Hegetschweiler, K.; Alberto, R.; Abram, U.; Schibli, R.; Hedinger, R.; Gramlich,
V.; Kissner, R.; Schubiger, P. A. Organometallics 1997, 16, 1833-1840.
22. He, H.; Lipowska, M.; Xu, X.; Taylor, A. T.; Carlone, M.; Marzilli, L. G. Inorg. Chem.
2005, 44, 5437-5446.
23. HyperChem Version 7.5, Hypercube, Inc., Gainesville, FL.
24. He, H.; Lipowska, M.; Christoforou, A. M.; Marzilli, L. G.; Taylor, A. T. Nucl. Med. Biol.
2007, 34, 709-716.
25. Sigel, H., details to be published; personal communication, Nov. 2007.
26. Sigel, H.; Bianchi, E. M.; Corfù, N. A.; Kinjo, Y.; Tribolet, R.; Martin, R. B. J. Chem. Soc.,
Perkin Trans. 2 2001, 507-511.
27. Saenger, W. Principles of Nucleic Acid Structure; 1st ed.; Springer-Verlag: New York,
1984.
28. Tribolet, R.; Malini-Balakrishnan, R.; Sigel, H. J. Chem. Soc., Dalton Trans. 1985, 22912303.
29. Aoki, K. Met. Ions Biol. Syst. 1996, 32, 91-134.
30. Korn, S.; Sheldrick, W. S. J. Chem. Soc., Dalton Trans. 1997, 12, 2191-2199.
31. Huang, S. L.; Tsai, M.-D. Biochemistry 1982, 21, 951-959.
32. Liao, J.-C.; Sun, S.; Chandler, D.; Oster, G. Eur. Biophys. J. 2004, 33, 29-37.
33. Sigel, H.; Scheller, K. H. Eur. J. Biochem. 1984, 138, 291-299.
34. Sigel, H.; Tribolet, R.; Malini-Balakrishnan, R.; Martin, R. B. Inorg. Chem. 1987, 26, 21492157.

96

35. Dunaway-Mariano, D.; Cleland, W. W. Biochemistry 1980, 19, 1506-1515.
36. Lu, Z.; Shorter, A. L.; Dunaway-Mariano, D. Biochemistry 1993, 32, 2378-2385.
37. Bakhtina, M.; Lee, S.; Wang, Y.; Dunlap, C.; Lamarche, B.; Tsai, M.-D. Biochemistry 2005,
44, 5177-5187.
38. Yang, L.; Arora, K.; Beard, W. A.; Wilson, S. H.; Schlick, T. J. Am. Chem. Soc. 2004, 126,
8441-8453.
39. Pearson, R. G. Chemical Hardness: Applications from Molecules to Solids; Wiley-VCH
Verlag GmbH: Weinheim, Germany, 1997.
40. Martin, R. B. Inorg. Chim. Acta 2002, 339, 27-33.
41. Salignac, B.; Grundler, P. V.; Cayemittes, S.; Frey, U.; Scopelliti, R.; Merbach, A. E.;
Hedinger, R.; Hegetschweiler, K.; Alberto, R.; Prinz, U.; Raabe, G.; Kölle, U.; Hall, S. Inorg.
Chem. 2003, 42, 3516-3526.
42. Altona, C.; Sundaralingam, M. J. Am. Chem. Soc. 1973, 95, 2333-2344.

97

CHAPTER 5.
PROGRESS TOWARDS X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF
COMPLEXES CONTAINING 5-6 BICYCLIC BIOLIGANDS BOUND TO THE fac[Re(CO)3]+ CORE
5.1

Introduction

In recent years, the great success of the antineoplastic agent cisplatin has fueled the
search for other metal-based cytotoxic agents having high levels of efficacy with fewer toxic
effects. Although much of the focus has been directed towards complexes based on the squareplanar, inert, and redox-stable Pt(II) metal center, octahedral metal centers are more likely to
form kinetically inert, redox-stable complexes. Several octahedral metal complexes have shown
modest anticancer properties; some of the most promising complexes contain Ru(II) and
dinuclear Rh(II)/Rh(II) metal centers.1-9
Complexes containing the fac-[Re(CO)3]+ core have also displayed modest cytotoxic
activity against a number of murine and human leukemia and lymphoma tumor cell lines.10
However, the mechanism of action of octahedral metal-containing complexes is generally not
well understood. A broader understanding of the behavior of fac-[Re(CO)3]+ complexes in
biological systems, and that displayed by other octahedral metal-based complexes, can be gained
by exploring interactions of the fac-[Re(CO)3]+ core with nucleotides and other bioligands in
both the solid and solution states.11-17
Recently, the first cis-bis(G) (G = guanine base derivative) complexes containing the fac[Re(CO)3]+ core, fac-[Re(CO)3(MeG)2(H2O)]ClO4, were characterized by X-ray crystallography
(MeG = 9-methylguanine, 7-methylguanine).16,17 X-ray structural evidence confirmed that the
fac-[Re(CO)3]+ moiety can bind two guanine bases in a cis fashion, and the two bases can
assume either a head-to-head (HH) or a head-to-tail (HT) orientation around the Re(I) metal
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center.16,17 Although some researchers have noted18 that the purine O6 can become sterically
demanding in octahedral complexes, the ~2.2 Å Re–N7 bond (~0.2 A longer a Pt–N7 bond)
lessens the steric effect imposed by the purine O6. In conclusion, these studies found that
rotation about the Re–N7 bond is unrestricted by steric hindrance imposed by O6 of the
coordinated guanines, and that neither steric hindrance nor intramolecular H-bonding were
factors deciding the preferred conformation of the product cis-bis(MeG) complexes.17
Chart 5.1. Structure of Bzm
Ligands with Numbering of
Relevant Atoms
R 12
N

7

R'

8

1

6

3

5

2

N

9
4

Bzm
MeBzm
Me2Bzm
Me3Bzm

10

R"
11

R = R′ = R′′ = –H
R = –CH3, R′ = R′′ = –H
R = –H, R′ = R′′ = –CH3
R = R′ = R′′ = –CH3

Planar aromatic N-donor ligands (L) containing a five-membered imidazole ring, such as
purine bases and benzimidazoles, constitute an important class of bioligands. Benzimidazole
(Bzm), the simplest of these ligands, possesses no exocyclic groups, while the more complex
purine base analog 1,5,6-trimethylbenzimidazole (Me3Bzm) is non-C2-symmetric (i.e. lopsided,
Chart 5.1). Previous studies of octahedral Ru(II) cis-bis(Me3Bzm) complexes have shown that
the orientation of the Me3Bzm ligands is dependent upon both steric and electronic factors.19,20
The N2CH proton (H2) of the imidazole ring is somewhat acidic and bears a partial positive
charge, and the amount of the positive charge on H2 increases upon imidazole ring binding to
metal centers.19,20 The positively charged H2 can be electrostatically attracted to nearby
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negatively charged ligands (such as halides), thus exerting electrostatic control over the observed
conformation of the product complex.20 In order to gain greater understanding of the steric and
electronic forces controlling the orientation of N-donor ligands in cis-bis(L) complexes
containing the fac-[Re(CO)3]+ core, we have synthesized and crystallized a series of fac[Re(CO)3(L)2Br] and fac-[Re(CO)3(L)2(O-donor)]+ complexes, where L = Bzm, 1methylbenzimidazole (MeBzm), 5,6-dimethylbenzimidazole (Me2Bzm), and Me3Bzm; and Odonor = H2O or OTf. Specifically, the compounds reported here include: fac-[(Bzm)2Re(CO)3Br]
(5.1),

fac-[(MeBzm)2Re(CO)3Br]

[(Me3Bzm)2Re(CO)3Br]

(5.4),

(5.2),

fac-[(Me2Bzm)2Re(CO)3Br]

fac-[(Bzm)2Re(CO)3(H2O)]OTf

(5.3),
(5.5),

facfac-

[(MeBzm)2Re(CO)3(H2O)]OTf (5.6), fac-[(Me2Bzm)2Re(CO)3(H2O)]OTf (5.7), and fac[(Me3Bzm)2Re(CO)3(H2O)]OTf (5.8). The crystal structures of 5.1-5.3, 5.6 and 5.7 have been
determined, as has that of fac-[(Me2Bzm)2Re(CO)3(OTf)] (5.7a).
5.2

Experimental Section

5.2.1

Starting Materials

[Re(CO)5Br]21, [Re(CO)5OTf]22 (OTf = trifluoromethanesulfonate), and Me3Bzm23 were
prepared as described in the literature. Bzm, MeBzm, and Me2Bzm and all solvents were
obtained from Sigma-Aldrich and were used as received.
5.2.2

Synthetic Procedures

fac-[Re(CO)3(L)2(H2O)]OTf and fac-[Re(CO)3(L)2Br]. Method A. A benzene solution

(20 mL) containing either [Re(CO)5Br] or [Re(CO)5OTf] (0.137 mmol) was treated with L
(0.274 mmol), and the reaction mixture was heated at reflux for ~4 h. After allowing the reaction
mixture to cool to room temperature, the volume of the solvent was reduced to ~1 ml under a
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stream of N2. The resulting white powdery solids were precipitated with hexanes, filtered,
washed with hexanes, and dried in vacuo. Use of this method resulted in high yields of powdered
fac-[Re(CO)3(L)2(H2O)]OTf and fac-[Re(CO)3(L)2Br] complexes that required no further
purification.
fac-[(Bzm)2Re(CO)3Br] (5.1). Method A gave a white precipitate: yield, 33 mg (41%).

X-ray quality crystals were obtained by recrystallization from benzene/hexanes. 1H NMR (ppm)
in CDCl3: 9.93 (s, 2H, N1H), 8.28 (s, 2H, B2H), 7.54 (d, 2H, B4H), 7.40 (d, 2H, B7H), 7.20 (m,
4H, B5H/B6H).
fac-[(MeBzm)2Re(CO)3Br] (5.2). Method A gave a white precipitate: yield, 63 mg

(75%). X-ray quality crystals were obtained by recrystallization from benzene/hexanes. 1H NMR
(ppm) in CDCl3: 8.44 (s, 2H, B2H), 7.63 (d, 2H, B4H), 7.41 (d, 2H, B7H), 7.30 (m, 4H,
B5H/B6H), 3.78 (s, 6H, B12H3).
fac-[(Me2Bzm)2Re(CO)3Br] (5.3). Method A gave a white precipitate: yield, 37 mg

(43%). X-ray quality crystals were obtained by recrystallization from benzene/hexanes. 1H NMR
(ppm) in CDCl3: 9.69 (s, 2H, N1H), 8.04 (s, 2H, B2H), 7.22 (s, 2H, B4H), 7.10 (s, 2H, B7H),
2.25 (s, 6H, B10H3), 2.17 (s, 6H, B11H3).
fac-[(Me3Bzm)2Re(CO)3Br] (5.4). Method A gave a white precipitate: yield, 75 mg

(81%). 1H NMR (ppm) in CDCl3: 8.29 (s, 2H, B2H), 7.35 (s, 2H, B4H), 7.14 (s, 2H, B7H), 3.71
(s, 6H, B12H3), 2.37 (s, 6H, B10H3), 2.24 (s, 6H, B11H3).
fac-[(Bzm)2Re(CO)3(H2O)]OTf (5.5). Method A gave a white precipitate: yield, 49 mg

(54%).
fac-[(MeBzm)2Re(CO)3(H2O)]OTf (5.6). Method A gave a white precipitate: yield, 41

mg (42%). X-ray quality crystals were obtained by recrystallization from benzene/hexanes. 1H
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NMR (ppm) in CDCl3: 8.10 (s, 2H, B2H), 7.63 (d, 2H, B4H), 7.41 (d, 2H, B7H), 7.30 (m, 4H,
B5H/B6H), 3.83 (s, 6H, B12H3).
fac-[(Me2Bzm)2Re(CO)3(H2O)]OTf (5.7). Method A gave a white precipitate; yield, 83

mg (85%). Colorless, block-shaped, X-ray quality crystals of [(Me2Bzm)2Re(CO)3(H2O)]OTf (7)
were collected directly from the reaction solution, after allowing the open vessel to stand
overnight at room temperature. The reaction vessel was then sealed and allowed to stand
overnight once more. Colorless plate-like crystals, identified as [(Me2Bzm)2Re(CO)3OTf] (5.7a)
by X-ray crystallography, were deposited after ~24 h.
fac-[(Me3Bzm)2Re(CO)3(H2O)]OTf (5.8). Method A gave a white precipitate; yield, 91

mg (93%).
5.2.3

NMR Spectroscopy

All NMR spectra were obtained on either a Bruker DPX400 spectrometer (400.1 MHz) or
a Varian INOVA500 spectrometer (500.1 MHz); both were equipped with a variable temperature
probe that was equilibrated at 25 °C unless otherwise indicated. 1D 1H NMR spectra were
referenced to the residual HOD peak, and presaturation was used to reduce the residual HOD
peak. Each FID was accumulated for 64 transients, each containing 16K data points. Before
Fourier transformation, an exponential apodization window function with a 0.2 Hz line
broadening was applied. All NMR data were processed with either XWINNMR (Bruker) or
VnmrJ (Varian) software.
5.2.4

X-Ray Crystallographic Data Collection and Structure Determination

Single crystals were mounted in a cooled N2 gas stream at 90 K (or 297 K for complex
5.2) on a Nonius Kappa CCD diffractometer (equipped with an Oxford Cryostream cooler) with
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graphite-monochromated Mo-Kα (λ = 0.71073 Å) radiation. Data reduction included absorption
corrections by the multi-scan method, using HKL DENZO and SCALEPACK.24 All X-ray
structures were solved by direct methods and refined by full-matrix least-square on F2 using the
SIR9725 and SHELXL9726 crystallographic software packages. All non-hydrogen atoms were
refined anisotropically. Hydrogen atoms were visible in difference maps, but were placed in
idealized locations. All non-hydrogen atoms were refined anisotropically.
5.3

Results and Discussion

5.3.1

X-ray Characterization

All complexes have a slightly distorted octahedral structure with three CO ligands
occupying one face. Two of the three other coordination sites are occupied by an imidazole
nitrogen of L, while the third site is occupied by either a bromide ligand (as in 5.1, 5.2 and 5.3)
or an oxygen atom (of H2O, as in 5.6 and 5.7; or of OTf, as in 5.7a) (Figure 5.1).
Crystallographic data and structure refinement parameters for complexes 5.1-5.3, 5.6-5.7, and
5.7a are listed in Table 5.1. Selected bond lengths and angles are given in Table 5.2.

In all complexes, the Re–N and Re–O bond lengths (~2.2 Å) and the N–Re–N bond
angles (~85°) are comparable to values for other complexes containing similar N-donor
ligands.16,17,27 The near bisection of the CO–Re–CO angle by the plane of the benzimidazole
ligands is another universal feature of the crystal structures studied here. This feature is
commonly observed in other cis-bis(G) and cis-bis(L) complexes of octahedral metals such as
Re(I) and Ru(II).16,17,19,20 However, it is quite interesting to note that, for all complexes except
for 5.3, the benzimidazole ligands are in the HH orientation (with the H2's on the same side of
the N–Re–N coordination plane). A unique example, complex 5.3 crystallizes with an HH (5.3a)
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and an HT (5.3b, Figure 5.2) conformer in the unit cell. A more detailed analysis of the solid
state conformation of complexes 5.1-5.3, 5.6, 5.7 and 5.7a appears below in Section 5.2.1.3.

Figure 5.1. Perspective drawings of [(Bzm)2Re(CO)3Br] (5.1), [(MeBzm)2Re(CO)3Br] (5.2),
[(Me2Bzm)2Re(CO)3Br]
(HH,
5.3a),
[(MeBzm)2Re(CO)3(H2O)]OTf
(5.6),
[(Me2Bzm)2Re(CO)3(H2O)]OTf (5.7) and [(Me2Bzm)2Re(CO)3OTf] (5.7a). Counter ions have
been omitted for clarity. Thermal ellipsoids are drawn with 50% probability.

Figure 5.2. Perspective drawing of [(Me2Bzm)2Re(CO)3Br] (HT, 5.3b). Thermal ellipsoids are
drawn with 50% probability.
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Table 5.1. Crystal Data and Structure Refinement for [(Bzm)2Re(CO)3Br] (5.1),
[(MeBzm)2Re(CO)3Br] (5.2), [(Me2Bzm)2Re(CO)3Br] (5.3), [(MeBzm)2Re(CO)3(H2O)]OTf
(5.6), [(Me2Bzm)2Re(CO)3(H2O)]OTf (5.7), and [(Me2Bzm)2Re(CO)3(OTf) (5.7a)
Crystal data

5.1

5.2

5.3

5.6

5.7

5.7a

Chemical formula C17H12BrN4O C19H16BrN4O C21H20BrN4O3 C19H18N4O4R C21H22N4O4Re· C22H20F3N4O
e·CF3O3S·C6 CF3O3S·0.5(C6 6ReS·C6H6
3Re·2.5(C6H6) 3Re·1.5(C6H6) Re·C6H6
H6
H6)·H2O
Mr

781.69

720.63

779.75

Cell setting, space Triclinic, P-1 Monoclinic,
group
C2/c

Monoclinic,
P21/n

Triclinic, P-1 Monoclinic,
C2/c

Monoclinic,
P21/n

Temperature (K)

90

90

90

90

a, b, c (≈)

10.9826 (14), 32.2569 (14), 13.2275 (10), 11.1993 (16), 25.414
(2), 11.4329 (15),
11.6453 (15), 9.3265
(2), 13.4881 (10), 12.200
(2), 17.994
(2), 23.594 (3),
12.1719 (16) 22.9218 (10) 30.793 (3)
12.696 (2)
15.5564 (15)
11.4625 (10)

β (∞)

97.756
(6), 126.1351 (11) 95.183 (4)
99.657
(7),
100.375 (6)

69.105
(7), 123.510 (5)
64.011
(8),
87.796 (9)

91.015 (7)

V (≈3)

1487.5 (3)

5569.3 (4)

5471.4 (8)

1442.3 (4)

5931.5 (10)

3091.5 (6)

2

8

8

2

8

4

Dx (Mg m )

1.745

1.745

1.750

1.795

1.764

1.697

Radiation type

Mo Kα

Mo Kα

Mo Kα

Mo Kα

Mo Kα

Mo Kα

5.47

5.83

5.94

4.36

4.24

4.06

Needle,
colorless

Lath, colorless Lath,
colorless

Fragment,
colorless

Plate,
colorless

Z
–3

–1

μ (mm )
Crystal
colour

form, Parallelepipe
d, colorless

731.63

297

787.77

789.79

90 (2)

Crystal size (mm) 0.25 ◊ 0.20 ◊ 0.25 ◊ 0.05 ◊ 0.20 ◊ 0.12 ◊ 0.20 ◊ 0.12 ◊ 0.12 ◊ 0.10 ◊ 0.18 ◊ 0.10 ◊
0.10
0.04
0.03
0.03
0.07
0.03
Data collection
Diffractometer

Nonius
Nonius
KappaCCD
KappaCCD
(with Oxford
Cryostream)

Nonius
KappaCCD
(with Oxford
Cryostream)

Nonius
KappaCCD
(with Oxford
Cryostream)

Nonius
KappaCCD
(with Oxford
Cryostream)

Nonius
KappaCCD
(with Oxford
Cryostream)

Data
collection ω scans with ω scans with ω scans with κ ω scans with ω scans with κ ω scans with
method
offsets
offsets
κ offsets
κ offsets
κ offsets
κ offsets
Absorption
correction

Multi-scan
(based
on
symmetryrelated
measurement
s)

Multi-scan
(based
on
symmetryrelated
measurement
s)

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurement
s)

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurement
s)

(Table 5.1 continued)
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Tmin

0.342

0.323

0.383

0.476

0.630

0.528

Tmax

0.611

0.800

0.842

0.880

0.756

0.888

No. of measured, 45519,
independent
and 13429,
observed
11734
reflections

32826, 8538, 67503, 19619, 34655, 7555, 48785,
5013
12814
6783
7536

Criterion
observed
reflections

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

for I > 2σ(I)

9210, 48513, 7439,
5090

Rint

0.033

0.047

0.055

0.023

0.026

0.047

θmax (∞)

35.7

30.8

32.6

30.0

30.8

29.2

F2

F2

F2

F2

F2

F2

Refinement
Refinement on

R[F2 > 2σ(F2)], 0.033, 0.077, 0.046, 0.064, 0.042,
1.04
1.00
0.95
wR(F2), S

0.086, 0.028, 0.062, 0.033,
1.04
1.03

0.077, 0.040, 0.069,
1.01

No. of relections

13429
reflections

8538
reflections

19619
reflections

7555
reflections

9210
reflections

7439
reflections

No. of parameters

371

337

657

382

396

393

H-atom treatment

Constrained Constrained
to parent site to parent site

Constrained to Constrained
parent site
to parent site

Weighting scheme

Calculated w
= 1/[σ2(Fo2)
+ (0.0362P)2
+ 1.2027P]
where P =
(Fo2
+
2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0032P)2 +
12.1288P]
where P =
(Fo2 + 2Fc2)/3

Calculated w =
+
1/[σ2(Fo2)
(0.0336P)2]
where P = (Fo2
+ 2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0263P)2 +
2.6506P]
where P =
(Fo2 + 2Fc2)/3

Calculated w =
+
1/[σ2(Fo2)
(0.0337P)2 +
24.730P]
where P = (Fo2
+ 2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0271P)2]
where P =
(Fo2 + 2Fc2)/3

(Δ/σ)max

0.002

0.003

0.003

0.001

0.005

0.001

0.84, –0.91

2.63, –3.79

2.69, –1.47

2.73, –1.21

1.27, –1.91

Δρmax, Δρmin (e ≈–3) 2.21, –3.15

Mixture
of Constrained
independent
to parent site
and
constrained
refinement

Extinction method

SHELXL

SHELXL

SHELXL

SHELXL

Extinction
coefficient

0.0012 (2)

0.00070 (19)

0.00021 (2)

0.00058 (8)

5.3.1.1

Crystal Packing

As shown in Table 5.2, the average distance between Re(I) centers in adjacent complexes
ranges from 6.60 Å (complex 5.3) to 9.27 Å (complex 5.2), with an average Re–Re separation of
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8.39 Å. The shorter than average distance between Re(I) centers observed for complex 5.3 is
likely because the solid state structure is highly stabilized by both π-stacking interactions and Hbonding (see next section). In 5.3, one Me2Bzm ligand in an HT complex is π-stacked nearly
parallel to a Me2Bzm ligand in an HH complex. The stacked benzimidazoles are slightly tilted
relative to one another, as the C2 atoms are separated by 3.4 Å, but the C6 and C5 atoms are
separated by 3.8 Å and 3.9 Å, respectively.

Table 5.2. Selected Bond Distances (Å) and Angles (°) for [(Bzm)2Re(CO)3Br] (5.1),
[(MeBzm)2Re(CO)3Br]
(5.2),
[(Me2Bzm)2Re(CO)3Br]
(HH,
5.3a;
HT,
5.3b),
[(MeBzm)2Re(CO)3(H2O)]OTf
(5.6),
[(Me2Bzm)2Re(CO)3(H2O)]OTf
(5.7)
and
[(Me2Bzm)2Re(CO)3OTf] (5.7a)
5.1

5.2

5.3a

5.3b

5.6

5.7

5.7a

2.171 (3)
2.182 (2)
2.185 (2)a
8.96

2.178 (3)
2.183 (3)
2.205 (2)a
8.89

2.174 (3)
2.182 (3)
2.211 (3)a
8.73

86.07 (9)

84.09 (10)

83.34 (12)

bond distances
Re–N1
Re–N3
Re–Br
Re–Reb

2.194 (2)
2.196 (2)
2.6511 (4)
7.86

2.190 (3)
2.202 (3)
2.6442 (5)
9.27

2.185 (3)
2.192 (3)
2.196 (3)
2.192 (3)
2.6583 (4) 2.6724 (4)
6.60
bond angles

N1–Re–N3
a

84.41 (7)

85.37 (12)

84.99 (12)

84.53 (11)

b

Re–O4 distance. average distance between Re(I) metal centers.
Despite having a less than average separation between Re(I) centers (7.86 Å), no

evidence for π-stacking interactions between benzimidazole ligands was found in the solid state
structure of complex 5.1. Conversely, the solid state structure of 5.2 is stabilized only by
antiparallel π-stacking between the benzimidazole ligands of two adjacent HH molecules, with a
mean separation of 3.59 Å, leading to a longer than average distance between Re(I) centers.
These results indicate that the distance between Re(I) centers is shorter in complexes having both
types of interactions, while the presence of only H-bonding interactions or only π -stacking
results in a greater distance between Re(I) centers. In contrast to complexes containing Br, no
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evidence for π -stacking interactions was found for complexes 5.6, 5.7 and 5.7a (in which the
sixth coordination position is occupied by an oxygen atom of H2O, in 5.6 and 5.7; and of OTf in
5.7a).
5.3.1.2

Hydrogen Bonding

A complete table of hydrogen bonding interactions appears in Table 5.3. As mentioned
above, the solid state structure of complex 5.3 is highly stabilized by H-bonds; both N1H's of a
HT molecule are H-bonded to the Br ligand of an adjacent HH molecule (average N to Br
distance = 3.34 Å); likewise, both N1H's of an HH molecule are H-bonded to the Br ligand of an
adjacent HT molecule (average N to Br distance = 3.36 Å). Complex 5.1 is stabilized only by
intermolecular H-bonds between the N1H's of the Bzm ligands and the Br ligands of adjacent
molecules (average N to Br distance = 3.51 Å). Conversely, complex 5.2 (the remaining Brcontaining complex) is the only complex studied here lacking H-bonding interactions. The lack
of H-bonds leads to a longer than average separation between Re(I) centers (9.27 Å) in 5.2.
The three OTf-containing solid state structures (complexes 5.6, 5.7 and 5.7a) possess a
number of H-bonds, leading to slightly longer than average distances between Re(I) centers.
Complex 5.6 is stabilized by two H-bonds between the H2O ligand and adjacent counter ion OTf
oxygen atoms (average O to O distance = 2.68 Å). In complex 5.7, the N1H of each coordinated
Me2Bzm has an H-bond to a counter ion OTf oxygen atom (average N to O distance = 2.96 Å).
In addition, the coordinated H2O ligand in 5.7 is stabilized by one H-bond to a solvent H2O
oxygen (O to O distance = 2.90 Å) and one H-bond to a counter ion OTf oxygen (O to O
distance = 2.73 Å). In complex 5.7a, intermolecular H-bonding is observed between the
coordinated OTf oxygen atoms and the N1H of adjacent molecules in the unit cell (average N to
O distance = 2.89 Å).
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Table 5.3. Hydrogen bond geometry
D–H· · ·Aa
D–H (Å) H· · ·A (Å)
5.1
N2–H2N· · ·Br1(a)

2.85
2.98

3.503(2)
3.518(2)

132.0
121.0

0.88
0.88
0.88
0.88

2.58
2.57
2.59
2.53

3.404 (3)
3.307 (3)
3.356 (3)
3.328 (4)

156.2
141.4
145.5
151.8

0.82
0.82

1.84
1.89

2.656 (3)
2.709 (3)

173
173

0.84
0.84
0.84 (4)
0.80 (4)

1.89
2.07
2.46 (4)
2.09 (4)

2.730 (4)
2.900 (4)
3.033 (4)
2.888 (4)

176.6
167.7
127 (3)
172 (4)

0.88
0.88

2.04
2.06

2.881 (4)
2.898 (4)

159.1
158.8

5.3
N2–H2N· · ·Br2(c)

N4–H4N· · ·Br2(d)
N6–H6N· · ·Br1(e)
N8–H8N· · ·Br1(f)
5.6
O4–H1W· · ·O5(g)

O4–H2W· · ·O7

O4–H4B· · ·O9(h)
N2–H2N· · ·O6(h)
N4–H4N· · ·O5(i)

D–H· · ·A (º)

0.88
0.88

N4–H4N· · ·Br1(b)

5.7
O4–H4A· · ·O5

D· · ·A (Å)

5.7a
N2–H2N· · ·O5(j)

N4–H4N· · ·O6(k)
a

Symmetry codes: (a) 2-x, 1-y, 1-z; (b) 1-x, 1-y, 1-z; (c) 1/2-x, 1/2+y, 3/2-z;
(d) x, 1+y, z; (e) x, y-1, z; (f) 3/2-x, y-1/2, 3/2-z; (g) -x+1, -y+1, -z; (h) 1-x, 1y, 1-z; (i) x, 1-y, z-1/2; (j) x-1/2, 3/2-y, 1/2+z; (k) x-1/2, 3/2-y, z-1/2.

5.3.1.3

Base Orientation

For an octahedral complex with three facial CO ligands, each cis-coordinated L can have
two possible orientations, “up” or “down” (Figure 5.3). (“Up” and “down” refer to the direction
H2 is pointing, towards the axial CO in the former case and towards X in the latter.) Thus, there
are a total of four possible isomers for a cis-bis(L) complex containing the fac-[Re(CO)3]+ core.
Because the H2 atom experiences a different chemical environment in the “up” and “down”
positions, the HHu and HHd conformers are distinguishable both by X-ray crystallography and
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NMR spectroscopy. However, for complexes containing two identical nonchiral L’s (such as
those studied here), the ΔHT and ΛHT conformers are distinguishable only by X-ray
crystallography, as both conformers would give identical NMR spectra.
As noted previously, the ligands are in

R 12
N

7

1

6

3

5

2

N

OC

O
C

R'

8

here (with the exception of complex 5.3, see

9

R"

above). Furthermore, the H2 atoms of both

11

4
CO

the HH orientation for all complexes reported

10

O

O
C
C

C

Re

Re

toward the axial X (for X = Br or O),

X

X

indicating that all HH complexes show
(b) ΛHT

(a) HHu

OC

coordinated ligands are directed downwards,

O

O
C

X = Br, H2O, OTf
CO

OC

exclusively the HHd conformation (Figure
5.3). In the only HT complex found here (in

O
C

the same unit cell as the HHd conformer of

CO

Re

Re

complex 5.3), the H2 of Me2Bzm in position

X

X

B is directed downwards, while the H2 of

(c) ΔHT

(d) HHd

ligand B′ is directed upwards; this pattern
Figure 5.3. The arrow and its head represent
the 6-membered ring and B2H, respectively. describes the ΛHT conformation (Figure 5.3).
The red and blue arrows represent ligands B
and B′; these designations are used in the text to
refer to coordination positions occupied by
benzimidazole ligands.

In the solid state structure of the HT conformer of fac-[Re(CO)3(9-MeG)2(H2O)]+ (9MeG = 9-methylguanine), the H2 of base B points down towards the axial H2O ligand, while the
H2 of base B′ points up, towards the axial CO ligand (the ΛHT orientation, Figure 5.3). In this
ligand arrangement, two stabilizing intra- and intermolecular H-bonds are formed; the
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coordinated H2O ligand has an intramolecular H-bond to the O6 atom of the ligand in the B′
position and an intermolecular H-bond to an O6 atom in an adjacent complex.17 In addition, the
positively charged H2 of the B ligand is electrostatically attracted to the negatively charged
oxygen atom of the axial H2O ligand (H· · ·O = 2.57 Å). In both solid state and solution studies
of cis-bis(Me3Bzm) complexes of Ru(II), the electrostatic interaction between the negatively
charged axial ligand and the positively charged H2 proton on the imidazole ring was found to be
the most important factor determining the specific orientation of one Me3Bzm ligand;19,20,28,29
thus, the exclusive formation of the HHd conformation for complexes 5.1, 5.2, 5.3a, 5.6, 5.7,
5.7a in the solid state corroborates this previous finding. However, it seems that with the lack of

any exocyclic H-bonding groups (e.g., O6 for purine bases) on the ligands used here, the
electrostatic interaction between the H2 protons of both benzimidazole ligands and the
negatively charged X ligand controls the specific orientation (namely, HHd) of the product
complexes in the solid state.
5.3.1.4

Dihedral Angles

Several useful parameters have been developed to compare the structural features of
square-planar metal-purine complexes; these same parameters can also be used to describe and
compare

octahedral

metal-purine

complexes

of

other

5-6

bicyclic

ligands

(e.g.,

benzimidazoles).17,28,30 The B/B′ dihedral angle is measured at the intersection of the planes
passing though the cis-coordinated ligands. The B/CP and B′/CP angles are measured at the
intersection of the plane passing through the B and B′ ligands, respectively, and the plane
defined by Re, the two N’s of the coordinated ligands, and the two C’s trans to the coordinated
N’s (CP = coordination plane).
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As shown in Table 5.4, the B/B′ dihedral angle for the complexes described herein ranges
from 50° to 71°, with an average B/B′ angle of 61°. This average B/B′ angle is comparable to
that reported for fac-[Re(CO)3(9-MeG)2(H2O)]ClO4 and fac-[Re(CO)3(9-MeG)2(H2O)]Br.17 The
B/CP angles observed in the benzimidazole complexes do not vary significantly, however, it is

notable that complex 5.3 possesses both the smallest (5.3a) and the largest (5.3b) B/CP angles
(40° and 52°, respectively). The B′/CP angles are slightly more diverse, ranging from 42° (5.3b)
to 56° (5.7).

Table 5.4. Relevant Conformational Parameters for [(Bzm)2Re(CO)3Br] (5.1),
[(MeBzm)2Re(CO)3Br]
(5.2),
[(Me2Bzm)2Re(CO)3Br]
(HH,
5.3a;
HT,
5.3b),
[(MeBzm)2Re(CO)3(H2O)]OTf
(5.6),
[(Me2Bzm)2Re(CO)3(H2O)]OTf
(5.7)
and
[(Me2Bzm)2Re(CO)3OTf] (5.7a)
dihedral angles (°)
bite angle (°)
close contacts (Å)
B/B′ B/CP
B′/CP
NB-Re-NB′ conformation X-BH2 X-B′H2
67
49
47
84.41 (7)
HHd
2.91
3.09
5.1
71
50
47
85.37 (12)
HHd
2.96
2.97
5.2
59
40
45
84.99(12)
HHd
3.02
3.18
5.3a
61
52
42
84.53 (11)
2.92
4.85
ΛHT
5.3b
56
44
46
86.07 (9)
HHd
2.87
2.98
5.6
50
46
56
84.09 (10)
HHd
2.63
2.91
5.7
64
51
51
83.34 (12)
HHd
2.53
2.76
5.7a
a
66
48
50
83.06(17)
2.57
4.43
5.A
ΛHT
b
57
51
46
81.9(4)
HHu
4.50
4.50
5.B
17 b
a
17
5.A = fac-[Re(CO)3(9-MeG)2(H2O)]ClO4 ; 5.B = fac-[Re(9-MeG)2(H2O)(CO)3]Br .

Previous studies of the effects of intra- and interligand interactions on the solid state
molecular

conformation

of

cis-[(en)(1,3,9-TMX)2Pt]2+

cations

(1,3,9-TMX

=

1,3,9-

trimethylhypoxanthine) found that intermolecular H-bonding favors a small B/CP angle, while
interligand steric factors favor a larger B/CP angle.30 Indeed, this trend is apparent in this work,
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as the smallest B/CP and B′/CP angles belong to complex 5.3, a structure that is highly stabilized
by both π-stacking and interligand H-bonds (see above). It has been suggested that π-stacking
interactions result in large B/CP angles;17 however, we do not find this to be the case for Re(I)
complexes containing benzimidazole ligands. For example, complex 5.2 is stabilized only by
antiparallel π-stacking interactions between the MeBzm ligands of two adjacent HH molecules;
the B/CP and B′/CP angles for 5.2 are nearly identical to those of complex 5.1, in which no π stacking interactions are present (Table 5.4).
5.4

Conclusions

The results presented here demonstrate clearly that benzimidazole and similar methylsubstituted ligands can have either a HH or an HT conformation within an octahedral complex
containing the fac-[Re(CO)3]+ core. However, the HH conformation appears to be preferred in
the solid state, with the positively charged H2 of each ligand electrostatically attracted to the
negatively charged axial X (for X = Br or O) ligand; thus, the HH complexes show exclusively
the HHd conformation. The solid state HHd conformation of cis-bis(L) complexes of Re(I) is
stabilized by either π-stacking interactions or H-bonding, or a combination of both factors. It is
generally accepted that the G bases in the cytotoxic intrastrand Pt-DNA cross-link have the HH
orientation; thus, any potential metal drugs should show accessibility to an HH conformation.
These results offer hope that novel drugs based on the fac-[Re(CO)3]+ core can be developed,
having fewer toxic side effects in conjunction with increased cytotoxic activity.
5.5
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CHAPTER 6.
PROGRESS TOWARDS SYNTHESIS, CHARACTERIZATION AND X-RAY
CRYSTALLOGRAPHIC STUDIES OF fac-[Re(CO)3]+ COMPLEXES CONTAINING
N,N′-BIDENTATE AROMATIC N-DONOR LIGANDS
6.1

Introduction

The success of cisplatin (cis-[Pt(NH3)2Cl2]) as an antineoplastic agent has fueled the
search for other highly efficacious metal-based cytotoxic agents with fewer toxic side effects.
Complexes based on the square-planar, inert Pt(II) metal center have historically been the
primary focus of the search for new drugs. However, we and others have recognized that
complexes containing octahedral metal centers are more likely to form kinetically inert, redoxstable complexes. Several complexes containing Re(I), Ru(II), and dinuclear Rh(II)/Rh(II) metal
centers have displayed modest cytotoxic activity.1-10 Despite this, the mechanism of action of
octahedral metal-based complexes has not been extensively studied and thus is generally not well
understood.
Recent studies performed in our laboratory have focused on the structural aspects of
square-planar Pt(II) complexes containing N,N′-bidentate aromatic N-donor ligands (N–N) such
as 2,2′-bipyridine (and derivatives thereof).11-13 In an effort to learn more about the solid-state
structure of octahedral complexes containing N,N′-bidentate aromatic N-donor ligands, we
undertook the synthesis of a series of Re(I) complexes having the general formula fac-[(N–
N)Re(CO)3X], where N–N = 4,4′-dimethyl-2,2′-bipyridine (4,4′-Me2bpy), 5,5′-dimethyl-2,2′bipyridine (5,5′-Me2bpy), 6,6′-dimethyl-2,2′-bipyridine (6,6′-Me2bpy), and 2,2′-bipyridine (bpy)
(Figure 6.1); and X = Br, H2O, and OTf. In this chapter, the synthesis and NMR characterization
of several fac-[(N–N)Re(CO)3X] complexes is reported, along with X-ray crystallographic
structure determinations for fac-[(5,5′-Me2bpy)Re(CO)3Br] (6.1), fac-[(6,6′-Me2bpy)Re(CO)3Br]
116

(6.2), fac-[(2,9-Me2phen)Re(CO)3Br] (6.5). Also reported are X-ray crystallographic structure
determinations

for

fac-[(4,4′-Me2bpy)Re(CO)3(H2O)]OTf

(6.6),

fac-[(5,5′-

Me2bpy)Re(CO)3(H2O)]OTf (6.7), and fac-[(6,6′-Me2bpy)Re(CO)3(H2O)]OTf (6.8). In addition,
a unique case is presented in which the triflate anion is coordinated to the Re(I) metal center, and
the resulting fac-[(6,6′-Me2bpy)Re(CO)3(OTf)] complex crystallizes in two different crystal
morphologies (6.9a and 6.9b). Finally, deviations from planarity of the N–N ligand in the
abovementioned complexes are presented and then compared to the calculated deviations from
planarity of published Pt complexes containing N–N ligands.
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Figure 6.1. Graphical representation and atom numbering schemes for coordinated (A)
dimethyl-2,2′-bipyridine derivatives, and (B) 2,9-dimethyl-1,10-phenanthroline (2,9-Me2phen).

6.2

Experimental Section

6.2.1

Starting Materials

2,2′-Bipyridine (bpy), 4,4′-dimethyl-2,2′-bipyridine (4,4′-Me2bpy), 5,5′-dimethyl-2,2′bipyridine (5,5′-Me2bpy), 6,6′-dimethyl-2,2′-bipyridine (6,6′-Me2bpy), and 2,9-dimethyl-1,10phenanthroline (2,9-Me2phen) were used as received (Aldrich). [Re(CO)5Br]14 and
[Re(CO)5OTf]15 were prepared as described in the literature. Other reagents were of analytical
grade from commercial sources and were used without further purification.
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6.2.2

Synthetic Procedures

fac-[(bpy)Re(CO)3Br] Complexes. Method A. A methanol solution (10 mL) containing

[Re(CO)5Br] (0.10 g, 0.05 M) and the desired N–N ligand (0.05 M) was heated at reflux for 4
hrs. After reducing the volume of the solvent by evaporation, the resulting yellow crystalline
solid was precipitated with water, washed successively with methanol and diethyl ether, and
dried in vacuo. Use of this method resulted in high yields, and no further purification of the
product complex was required. X-ray quality crystals of 6.1 and 6.2 were obtained by mixing
equimolar quantities (0.1 M) of the N–N ligand and [Re(CO)5Br] in 1 mL methanol in an NMR
tube, and allowing the capped tube to stand undisturbed for ~2 weeks. All other complexes were
recrystallized from a mixture of acetone/diethyl ether.
Bromo(5,5′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)

([(5,5′-

Me2bpy)Re(CO)3Br], 6.1). Method A gave a yellow powdery precipitate: yield, 90 mg (68%).

Recrystallization afforded yellow block-shaped crystals. C15H12BrN2O3Re: 1H NMR (CDCl3,
ppm): 8.87 (s, H6/6′), 8.02 (d, H3/3′), 7.82 (d, H4/4′), 2.51 (s, 5/5′–CH3).
Bromo(6,6′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)

([(6,6′-

Me2bpy)Re(CO)3Br], 6.2). Method A gave a yellow powder: yield, 70 mg (53%).

Recrystallization afforded yellow prisms. C15H12BrN2O3Re: 1H NMR (CDCl3, ppm): 8.00 (d,
H3/3′), 7.88 (t, H4/4′), 7.46 (d, H5/5′), 3.14 (s, 6/6′–CH3).
Bromo(4,4′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)

([(4,4′-

Me2bpy)Re(CO)3Br], 6.3). Method A gave a yellow powder: yield, 100 mg (76%). 1H NMR

(CDCl3, ppm): 8.89 (d, H6/6′), 8.00 (s, H3/3′), 7.33 (d, H5/5′), 2.58 (s, 4/4′–CH3).
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Bromo(2,2′-bipyridyl)tricarbonylrhenium(I) ([(bpy)Re(CO)3Br], 6.4). Method A

gave a yellow powder: yield, 90 mg (72%). 1H NMR (CDCl3, ppm): 9.10 (d, H6/6′), 8.21 (d,
H3/3′), 8.07 (m, H4/4′), 7.55 (m, H5/5′).
Bromo(2,9-dimethyl-1,10-phenanthroline)tricarbonylrhenium(I)

([(2,9-

Me2phen)Re(CO)3Br], 6.5). Method A gave a yellow powder. Recrystallization afforded X-ray

quality, thin yellow needles.
fac-[(bpy)Re(CO)3(H2O)]OTf Complexes. Method B. A methanol solution (10 ml) of

[Re(CO)5OTf] (0.24 g, 0.1 M) and the desired N–N ligand (0.09 g, 0.1 M) was heated at reflux
overnight. After cooling, the yellow solid was precipitated with diethyl ether, collected via
gravity filtration, washed with diethyl ether and dried in vacuo. The resultant complexes (in
powder form) required no further purification. X-ray quality crystals were obtained by
recrystallization from a mixture of acetone/diethyl ether and allowing the open vessel to stand for
~1 week.
Aquo(4,4′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)

triflate

([(4,4′-

Me2bpy)Re(CO)3(H2O)]OTf, 6.6). Method B gave a yellow-orange powdery precipitate: yield,

130 mg (41%). Recrystallization afforded X-ray quality, thin yellow lath-shaped crystals.
C16H14F3N2O7SRe: 1H NMR (CD3OD, ppm): 8.95 (d, H6/6′), 8.56 (s, H3/3′), 7.64 (d, H5/5′),
2.64 (s, 4/4′–CH3).
Aquo(5,5′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)

triflate

([(5,5′-

Me2bpy)Re(CO)3(H2O)]OTf, 6.7). Method B gave a light yellow powdery precipitate: yield,

170 mg (54%). Recrystallization afforded X-ray quality, thin yellow lath-shaped crystals.
C16H14F3N2O7SRe: 1H NMR (CD3OD, ppm): 8.95 (s, H6/6′), 8.50 (d, H3/3′), 8.19 (d, H4/4′),
2.56 (s, 5/5′–CH3).
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Aquo(6,6′-dimethyl-2,2′-bipyridyl)tricarbonylrhenium(I)
Me2bpy)Re(CO)3(H2O)]OTf,

6.8)

and

triflate

([(6,6′-

triflato(6,6′-dimethyl-2,2′-

bipyridyl)tricarbonylrhenium(I) ([(6,6′-Me2bpy)Re(CO)3(OTf)], 6.9) Method B gave a

yellow crystalline precipitate of 6.8: yield, 220 mg (70%). Recrystallization afforded X-ray
quality, thin yellow lath-shaped crystals. C16H14F3N2O7SRe: 1H NMR (CD3OD, ppm): 8.46 (d,
H3/3′), 8.18 (t, H4/4′), 7.76 (d, H5/5′), 3.12 (s, 6/6′–CH3). A further recrystallization of 6.8 from
a mixture of acetone/diethyl ether kept isolated from the environment yielded [(6,6′Me2bpy)Re(CO)3(OTf)] (6.9). X-ray quality crystals having two different morphologies were
isolated from the mother liquor. Complexes 6.9a and 6.9b are characterized by yellow lathshaped crystals and by yellow block-shaped crystals, respectively.
6.2.3

NMR Spectroscopy

All NMR spectra were obtained on a Varian INOVA500 spectrometer (500.1 MHz)
equipped with a variable temperature probe that was equilibrated at 25 °C unless otherwise
indicated. 1D 1H NMR spectra were referenced to the residual HOD peak, and presaturation was
used to reduce the residual HOD peak. Each FID was accumulated for 64 transients, each
containing 16K data points. Before Fourier transformation, an exponential apodization window
function with a 0.2 Hz line broadening was applied. All NMR data were processed with VnmrJ
(Varian) software.
6.2.4

X-Ray Crystallographic Data Collection and Structure Determination

Single crystals were mounted in a cooled N2 gas stream at 110 K on a Nonius Kappa
CCD diffractometer (equipped with an Oxford Cryostream cooler) with graphitemonochromated Mo-Kα (λ = 0.71073 Å) radiation. Data reduction included absorption
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corrections by the multi-scan method, using HKL DENZO and SCALEPACK.16 All X-ray
structures were solved by direct methods and refined by full-matrix least-square on F2 using the
SIR9717 and SHELXL9718 crystallographic software packages. All non-hydrogen atoms were
refined anisotropically. Hydrogen atoms were visible in difference maps, but were placed in
idealized locations. All non-hydrogen atoms were refined anisotropically.
6.3

Results and Discussion

6.3.1

X-Ray Characterization

In general, the complexes discussed here have a distorted octahedral geometry, with three
CO ligands occupying one face of the molecule in each complex. Two of the three other
coordination sites are occupied by the nitrogen atoms of a chelating N–N ligand, resulting in the
formation of a five-membered ring. The sixth coordination site is occupied by either a bromide
ligand (as in 6.1, 6.2 and 6.5), or an oxygen atom (of H2O, as in 6.6, 6.7 and 6.8, Figure 6.2; or of
OTf, as in 6.9a and 6.9b, Figure 6.3). Crystallographic data and structure refinement parameters
are listed in Table 6.1 for complexes 6.1, 6.2, and 6.5-6.8; and selected bond lengths and angles
are given in Table 6.2. A unique example, complex 6.9 crystallizes with the OTf counter ion
coordinated to the Re(I) metal center, giving rise to two different crystal morphologies. The –CF3
moiety of the OTf counter ion is directed towards a pyridyl ring of 6,6′-Me2bpy in 6.9a ([(6,6′Me2bpy)Re(CO)3(OTfup)]), and away from the pyridine rings of 6,6′-Me2bpy in 6.9b ([(6,6′Me2bpy)Re(CO)3(OTfdown)], Figure 6.3). Crystallographic data and structure refinement
parameters are listed in Table 6.3 for complexes 6.9a and 6.9b; selected bond lengths and angles
are given in Table 6.4.
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Figure 6.2. Perspective drawings of [(5,5′-Me2bpy)Re(CO)3Br] (6.1), [(6,6′-Me2bpy)Re(CO)3Br]
(6.2), [(2,9-Me2phen)Re(CO)3Br] (6.5), [(4,4′-Me2bpy)Re(CO)3(H2O)]OTf (6.6), [(5,5′Me2bpy)Re(CO)3(H2O)]OTf (6.7), and [(6,6′-Me2bpy)Re(CO)3(H2O)]OTf (6.8). Counter ions
have been omitted for clarity. Thermal ellipsoids are drawn with 50% probability.
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Table 6.1. Crystal Data and Experimental Details for [(5,5′-Me2bpy)Re(CO)3Br] (6.1), [(6,6′Me2bpy)Re(CO)3Br] (6.2), [(2,9-Me2phen)Re(CO)3Br] (6.5), [(4,4′-Me2bpy)Re(CO)3(H2O)]OTf
(6.6), [(5,5′-Me2bpy)Re(CO)3(H2O)]OTf (6.7), and [(6,6′-Me2bpy)Re(CO)3(H2O)]OTf (6.8)
complex

6.1

6.2

6.5

6.6

6.7

6.8

Crystal data
Chemical
formula

C15H12BrN2O3 C15H12BrN2O3 C17H12BrN2O3 C15H14N2O4Re C15H14N2O4R C15H14N2O4R
1+
e1+.CF3O3S1– e1+.CF3O3S1–
Re
Re
Re
.CF3O3S1–

Mr

534.38

534.38

558.40

621.55

621.55

621.55

Cell setting

Monoclinic

Monoclinic

Monoclinic

Monoclinic

Monoclinic

Monoclinic

Space group

P21/c

P21/c

P21/c

P21/n

P21/n

P21/n

Temperature
(K)

110

110

90

90

90

110

a, b, c (Å)

14.755
(3), 7.7268 (10), 7.8414 (10), 10.8811 (15), 11.197
(2), 12.998
(2),
11.4799 (15), 20.891
(3), 21.825
(3), 9.8466 (14), 10.4487 (12), 8.0981 (10),
9.3441 (10)
9.8144 (12)
9.5633 (12)
19.125 (2)
16.846 (3)
19.344 (3)

α, β, γ (°)

90,
105.609 90,
106.440 90,
104.012 95.249 (6)
(8), 90
(7), 90
(7), 90

91.883 (6)

100.102 (5)

V (Å3)

1524.4 (4)

1519.5 (4)

1588.0 (4)

2040.5 (5)

1969.8 (5)

2004.6 (5)

4

4

4

4

4

4

Dx (Mg m )

2.328

2.336

2.336

2.023

2.096

2.060

Radiation type

Mo Kα

Mo Kα

Mo Kα

Mo Kα

Mo Kα

Mo Kα

10.61

10.64

10.19

6.13

6.35

6.24

Lath, yellow

Fragment,
yellow

Z
–3

–1

μ (mm )
Crystal
colour

form, Parallelepiped, Prism, yellow
yellow

Crystal
(mm)

Needle, yellow Fragment,
yellow

size 0.22 ◊ 0.10 ◊ 0.22 ◊ 0.13 ◊ 0.22 × 0.08 × 0.20 × 0.10 × 0.20 × 0.05 × 0.17 × 0.12 ×
0.10
0.07
0.03
0.07
0.02
0.10

Data collection
Diffractometer

KappaCCD
KappaCCD
Nonius
(with Oxford (with Oxford KappaCCD
Cryostream)
Cryostream)
(with Oxford
Cryostream)

Nonius
KappaCCD
(with Oxford
Cryostream)

Nonius
KappaCCD
KappaCCD
(with Oxford
(with Oxford Cryostream)
Cryostream)

Data collection ω scans with κ ω scans with κ ω scans with κ ω scans with κ ω scans with ω scans with
method
offsets
offsets
offsets
offsets
κ offsets
κ offsets
Absorption
correction

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurements)

Multi-scan
(based
on
symmetryrelated
measurement
s)

Multi-scan
(based
on
symmetryrelated
measurement
s)

(Table 6.1 continued)
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Tmin

0.169

0.203

0.213

0.374

0.363

0.417

Tmax

0.346

0.523

0.750

0.674

0.884

0.574

No.
of 34647,
measured,
5487
independent and
observed
reflections
Criterion
observed
reflections

6965, 23986,
5312

for I > 2σ(I)

6256, 28246,
3907

4932, 28845,
7555

9230, 24469, 6058, 32486, 6085,
5250
5313

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

I > 2σ(I)

Rint

0.038

0.030

0.035

0.029

0.023

0.023

θmax (∞)

35.7

34.2

30.8

35.6

30.8

30.5

F2

F2

F2

F2

F2

F2

Refinement
Refinement on

R[F2 > 2σ(F2)], 0.032,
1.03
wR(F2), S

0.067, 0.029,
1.03

0.067, 0.037,
1.04

0.091, 0.029,
1.04

0.071, 0.029, 0.066, 0.021, 0.041,
1.02
1.03

No.
relections

of 6965
reflections

6256
reflections

4932
reflections

9230
reflections

6058
reflections

6085
reflections

No.
parameters

of 202

202

221

274

274

280

H-atom
treatment

Constrained to Constrained to Constrained to Constrained to Constrained
parent site
parent site
parent site
parent site
to parent site

Mixture
of
independent
and
constrained
refinement

Weighting
scheme

Calculated w
= 1/[σ2(Fo2) +
(0.0291P)2]
where P = (Fo2
+ 2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0256P)2 +
3.1813P]
where P = (Fo2
+ 2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0471P)2 +
3.0843P]
where P = (Fo2
+ 2Fc2)/3

Calculated w
= 1/[σ2(Fo2) +
(0.0346P)2 +
0.1045P]
where P = (Fo2
+ 2Fc2)/3

Calculated
w = 1/[σ2(Fo2)
+ (0.0243P)2
+ 6.5687P]
where P =
(Fo2 + 2Fc2)/3

Calculated
w = 1/[σ2(Fo2)
+ (0.0025P)2
+ 1.7752P]
where P =
(Fo2 + 2Fc2)/3

(Δ/σ)max

0.002

0.001

0.002

0.003

0.002

0.003

Δρmax, Δρmin (e 1.89, –1.99
Å–3)

2.22, –1.77

2.31, –2.85

1.84, –1.91

1.96, –2.14

0.66, –1.01

Extinction
method

SHELXL

SHELXL

SHELXL

SHELXL

SHELXL

Extinction
coefficient

0.00137 (10)

0.00137 (12)

0.00086 (12)

0.00107 (10)

0.00072 (6)
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Table 6.2. Selected Bond Distances (Å) and Angles (°) for [(5,5′-Me2bpy)Re(CO)3Br] (6.1),
[(6,6′-Me2bpy)Re(CO)3Br
(6.2)],
[(2,9-Me2phen)Re(CO)3Br]
(6.5),
[(4,4′Me2bpy)Re(CO)3(H2O)]OTf (6.6), [(5,5′-Me2bpy)Re(CO)3(H2O)]OTf (6.7), and [(6,6′Me2bpy)Re(CO)3(H2O)]OTf (6.8)
6.1

6.2

6.5

6.6

6.7

6.8

2.170 (3)
2.163 (3)

2.1968 (19)
2.1948 (18)

2.199 (3)
7.64

a

2.1852 (16)
7.74

75.15 (11)

76.08 (7)

bond distances
Re–N1
Re–N2

2.187 (2)
2.178 (3)

2.218 (3)
2.224 (3)

2.212 (4)
2.227 (4)

2.178 (2)
2.172 (2)

Re–Br
Re–Reb

2.6352 (5)
6.29

2.6271 (4)
6.46

2.6104 (6)
6.28

2.1916 (17)
6.28

a

a

bond angles
N1–Re–N2
a

75.14 (9)

75.59 (10)

75.84 (15)

75.11 (8)

b

Re–O4 distance. average distance between Re(I) metal centers.

Figure 6.3. Perspective drawings of [(6,6′-Me2bpy)Re(CO)3(OTf)] (6.9a and 6.9b). Thermal
ellipsoids are drawn with 50% probability.

In all complexes, the Re–N and Re–O bond lengths (~2.2 Å) are comparable to values for
other complexes containing similar N-donor ligands.19 The N–Re–N bond angles are
considerably smaller than 90° (~75°); this result is a consequence of the small bite angle between
pyridyl rings of the bipyridine ligand.
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Table 6.3. Crystal Data and Experimental Details for
[(6,6′-Me2bpy)Re(CO)3(OTf)] (6.9a and 6.9b)
6.9a

complex

6.9b

Crystal data
Chemical formula

C16H12F3N2O6ReS

C16H12F3N2O6ReS

Mr

603.54

603.54

Cell setting

Monoclinic

Monoclinic

Space group

P21/n

P21/c

Temperature (K)

110

110

a, b, c (Å)

8.3897 (10), 14.738 13.551 (3), 10.168
(2), 15.026 (2)
(3), 13.543 (3)

α, β, γ (°)

91.166 (7)

96.109 (13)

3

1857.5 (4)

1855.4 (8)

4

4

Dx (Mg m )

2.158

2.161

Radiation type

Mo Kα

Mo Kα

6.72

6.73

V (Å )
Z
–3

–1

μ (mm )

Crystal form, colour Lath
yellow
Crystal size (mm)

fragment, Paralellepiped,
yellow

0.33 ◊ 0.22 ◊ 0.10

0.27 ◊ 0.25 ◊ 0.20

Data collection
Diffractometer
Data
method

(with
KappaCCD
(with KappaCCD
Oxford Cryostream) Oxford Cryostream)

collection ω scans
offsets

Absorption
correction

with

κ ω scans
offsets

with

κ

Multi-scan (based on Multi-scan (based on
symmetry-related
symmetry-related
measurements)
measurements)

Tmin

0.215

0.264

Tmax

0.553

0.346

No. of measured, 35351, 7366, 5618
independent
and
observed reflections

20370, 5492, 4630

Criterion
for I > 2σ(I)
observed reflections

I > 2σ(I)

Rint

0.033

0.023

(Table 6.2 continued)
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θmax (∞)

33.7

30.5

F2

F2

Refinement
Refinement on
R[F2 >
wR(F2), S

2σ(F2)], 0.033, 0.093, 1.04

No. of relections

7366 reflections

5492 reflections

No. of parameters

265

265

H-atom treatment

Constrained to parent Constrained to parent
site
site

Weighting scheme

Calculated
w
1/[σ2(Fo2)
(0.0504P)2
2.5873P] where P
(Fo2 + 2Fc2)/3

(Δ/σ)max

0.001

0.001

Δρmax, Δρmin (e Å )

2.40, –3.67

1.23, –1.19

Extinction method

SHELXL

SHELXL

Extinction
coefficient

0.0028 (2)

0.00085 (11)

–3

6.3.2

0.025, 0.059, 1.03

=
+
+
=

Calculated
w =
+
1/[σ2(Fo2)
(0.020P)2 + 1.2029P]
where P = (Fo2 +
2Fc2)/3

Distortion of Re(I) Complexes Containing Bipyridine Ligands

The two pyridyl rings of an uncoordinated bipyridine ligand are anti to one another; thus,
an uncoordinated bipyridine ligand is essentially planar because any steric repulsion between H3
and H3′ (see Figure 6.1 for atom numbering scheme) is minimized. However, upon bidentate
coordination to a metal center (M), the two pyridyl rings become syn and H3–H3′ repulsive
forces can cause significant distortions from planarity in complexes with M−N distances of ~2.0
to 2.2 Å.20 Distortions from planarity can occur both in and out of the plane of the coordinated
bipyridine ligand. In-plane distortion is described in terms of in-plane bending (θP) (Figure
6.4).21 Out-of-plane distortions can be described in terms of bowing (θB) and twisting (θT) and to
a lesser extent in terms of an S-shaped distortion (dS) (Figure 6.4).21
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θT

θP

(A)

(B)

θB
(C)

dS
(D)
Figure 6.4. Distortions in N–N ligands as defined by Hazell: (A) in-plane bending (θP, in deg);
(B) twisting (θT, in deg); (C) bowing (θB, in deg); (D) S-shaped distortion (dS, in Å). θT, θB and
θP are the angles between the best straight lines (ax + c = z) through each pyridyl ring of the
bipyridine ligand in the XY, YZ, and XZ projections, respectively.

Table 6.4. Selected Bond Distances (Å) and
Angles (°) for [(6,6′-Me2bpy)Re(CO)3(OTf)]
(6.9a and 6.9b)
6.9a
6.9b
bond distances

Re–N1
Re–N2
Re–O
Re–Reb
N1–Re–N2
a

2.196 (2)
2.205 (3)
2.201 (2)

2.194 (3)
2.192 (3)
2.203 (2)

bond angles
75.64 (9) 75.09 (10)

average distance between Re(I) metal centers.
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In a recent comprehensive study, Hazell compared 551 metal complexes containing bpy
or substituted bpy ligands from the Cambridge Structural Database22 and calculated θT, θB, dS,
and θP for each metal complex.21 The values of θT and θB ranged from 0.0° to 26.1° and from
0.0° to 19.8°, respectively. The least significant parameter, dS, ranged from 0.0 to 0.127 Å, with
nearly 90% of the values being less than 0.053 Å. The θP angles ranged from +2.9 Å to +12.5 Å,
with a mean value of +7.8 Å (positive sign indicates that distortion is directed toward the metal).

Table 6.5. Ligand Deformation in Octahedral Re(I) and Square-Planar Pt(II)/Pd(II) Complexes
Twist
angle
(θT)

Bow
angle
(θB)

S-shaped
distortion
(dS)

In-plane
distortion
(θP)

[(5,5′-Me2bpy)Re(CO)3Br] (6.1)

2.3

2.0

0.011

+6.5

[(6,6′-Me2bpy)Re(CO)3Br] (6.2)

9.0

0.8

0.065

+2.8

[(2,9-Me2phen)Re(CO)3Br] (6.5)

–

–

–

–

[(4,4′-Me2bpy)Re(CO)3(H2O)]OTf
(6.6)

2.9

2.1

0.012

+5.9

[(5,5′-Me2bpy)Re(CO)3(H2O)]OTf
(6.7)

0.9

0.1

0.007

+7.7

[(6,6′-Me2bpy)Re(CO)3(H2O)]OTf
(6.8)

15.2

9.4

0.060

+3.6

[(6,6′-Me2bpy)Re(CO)3(OTfup)]
(6.9a)

6.6

10.1

0.076

+4.3

[(6,6′-Me2bpy)Re(CO)3(OTfdown)]
(6.9b)

10.3

18.0

0.032

+5.2

[(bpy)Re(CO)3(H2O)]OTf

2.2

0.1

0.034

+7.1

[(4,4′-Me2bpy)PtCl2]
[(5,5′-Me2bpy)PtCl2]

2.4
5.5

0.1
0.0

0.02
0.075

+5.9
+8.9

[(6,6′-Me2bpy)PtCl2]
[(bpy)PtCl2]
[(bpy)PdCl2]

6.1
0.0
2.3

19.2
0.0
1.9

0.000
0.000
0.009

+10.9
+8.8
+8.9

complex

a

M−N
distance
(Å)
2.187 (2)
2.178 (3)
2.218 (3)
2.224 (3)
2.211
2.227
2.178 (2)
2.172 (2)
2.170 (3)
2.163 (3)
2.196 (8)
2.194 (8)
2.196 (2)
2.205 (3)
2.194 (3)
2.192 (3)
2.161
2.165
2.023 (3)
2.027 (3)
2.017 (3)
2.028 (2)
2.030 (2)
2.009 (6)
2.03 (1)

Dihedral
angle
(θdi)

Ref

3.1

b

9.1

b

–

b

3.6

b

0.9

b

18.1

b

12.1

b

21.0

b

2.3

19

2.8 (6)
5.56 (6)

13

20.18 (14)
0.0
3.0

13

13

23
24

θT, θB, dS, θP, and θdi values were calculated by using a FORTRAN program provided by Dr.
Alan Hazell. θdi angles for complexes reported in this work were checked using Mercury; in all
cases, the two θdi values were comparable within 0.1 Å. bThis work.
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6.3.2.1

Out-of-Plane Distortions

In general, the Re(I) complexes in Table 6.5 have θT angles ranging from 0.9º to 15.2º,
and an average θT angle of 6.7º. While these values are within the range reported by Hazell21, the
average θT angle is somewhat larger than the θT angle of 2.2º for the reference compound,
[(bpy)Re(CO)3(H2O)]OTf (Table 6.5).19 Complexes containing bpy, 4,4′-Me2bpy or 5,5′-Me2bpy
ligands have smaller θT angles than complexes having 6,6′-Me2bpy ligands; in fact, the
magnitude of θT is greatly increased for these latter complexes (Table 6.5). This result can be
attributed to steric repulsion between the 6,6′ methyl groups and the cis CO ligands (Figure 5.2).
Of the complexes containing 6,6′-Me2bpy ligands, [(6,6′-Me2bpy)Re(CO)3(OTfup)] has the
smallest θT angle (6.6º). In contrast, [(6,6′-Me2bpy)Re(CO)3(OTfdown)] has a θT angle of 10.3º.
The smaller θT angle for [(6,6′-Me2bpy)Re(CO)3(OTfup)] indicates that the interaction between
the –CF3 moiety with the 6,6′-Me2bpy ligand results in less twisting about the central C–C bond
of the 6,6′-Me2bpy ligand.
A comparison of θT angles for square-planar Pt(II)/Pd(II) vs octahedral Re(I) complexes
reveals that the magnitude of θT depends primarily upon the nature of the bipyridine ligand; the
coordination geometry of M plays a minor role in determining the magnitude of θT. Inspection of
Table 6.5 shows that the θT angles are nearly equal for Pt(II) and Re(I) complexes of 4,4′Me2bpy. However, the Re(I) complexes of 5,5′-Me2bpy and 6,6′-Me2bpy have smaller and larger

θT angles, respectively, when compared to Pt(II) complexes of the same ligands.
The Re(I) complexes studied here have θB angles ranging from 0.1º to 18.0º (Table 6.5).
The average θB angle is 6.1º, indicating that these complexes are significantly more bowed than
complexes containing unsubstituted bpy ligands (θB = 0.1º for [(bpy)Re(CO)3(H2O)]OTf, Table
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6.5). These values for θB are within the range reported by Hazell; however, the θB angle
calculated for [(6,6′-Me2bpy)Re(CO)3(OTfdown)] (18.0º) is near the upper limit of 19.8º.21 As was
discussed above for twist distortions, complexes containing bpy, 4,4′-Me2bpy or 5,5′-Me2bpy
ligands have smaller θB values than complexes having 6,6′-Me2bpy ligands. However, [(6,6′Me2bpy)Re(CO)3Br] is one exception, with a θB value of 0.8º (Table 6.5). The two highest θB
values belong to [(6,6′-Me2bpy)Re(CO)3(OTfup)] (10.1º) and [(6,6′-Me2bpy)Re(CO)3(OTfdown)]
(18.0º). This result indicates that the presence of OTf in the coordination sphere of Re(I) causes
substantial bowing of the bpy ligand. The smaller θB value for [(6,6′-Me2bpy)Re(CO)3(OTfup)]
indicates that an interaction between the –CF3 moiety and 6,6′-Me2bpy results in less bowing of
the 6,6′-Me2bpy ligand, as compared to [(6,6′-Me2bpy)Re(CO)3(OTfdown)].
An overall comparison of θB angles for square-planar Pt(II)/Pd(II) vs octahedral Re(I)
complexes reveals greater θB angles for the latter (Table 6.5); indicating that the coordination
geometry of M has a more significant effect on θB as compared to θT. However, [(6,6′Me2bpy)PtCl2] has the largest θB angle (19.2º) in Table 6.5. This result is most likely due to
significant steric repulsion between the 6,6′ methyl groups and the chloride ligands of [(6,6′Me2bpy)PtCl2].13 It is likely that longer Re–N bonds alleviate some of the steric strain upon
forming Re(I) complexes of 6,6′-Me2bpy.
The dS values range from 0.007 Å to 0.076 Å (for [(5,5′-Me2bpy)Re(CO)3(H2O)]OTf and
[(6,6′-Me2bpy)Re(CO)3(OTfup)], respectively; Table 6.5). Thus, the Re(I) complexes discussed
herein do not have a significant amount of S-shaped deformity. The dS values for square-planar
Pt(II) and Pd(II) complexes are equally negligible (Table 6.5), a result indicating that the
magnitude of dS is not significantly dependent upon the coordination geometry of M, or upon the
M–N bond length.
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Distortion of coordinated bipyridine ligands can also be described in terms of the dihedral
angle between the best planes through each of the two pyridyl rings, θdi.13 The magnitude of θdi
is influenced by both θT and θB; thus, θdi is a descriptor of the overall distortion of the
coordinated bipyridine ligand. The θdi angles range from 0.9º to 21.0º for Re(I) complexes, and
from 0.0º to 20.18º for Pt(II)/Pd(II) complexes (Table 6.5). The largest θdi angles are for
complexes containing 6,6′-Me2bpy ligands (θdi for Re(I) and Pt(II)/Pd(II) complexes are nearly
equal), indicating that the magnitude of θdi is mostly independent of the M coordination
geometry and the M–N bond length.
6.3.2.2

In-plane Bending Distortions

The Re(I) complexes reported here have θP angles ranging from +2.8º to +7.7º (Table
6.5). The average θP angle is +5.1º, indicating that Re(I) complexes with substituted bpy ligands
have less in-plane distortion than those complexes containing unsubstituted bpy ligands (θP =
+7.1º for [(bpy)Re(CO)3(H2O)]OTf, Table 6.5). Generally, Re(I) complexes containing 4,4′Me2bpy or 5,5′-Me2bpy ligands have larger θP angles than those with 6,6′-Me2bpy ligands. It is
likely that the interaction of the 6,6′ methyl groups with the cis CO ligands in an octahedral
coordination environment prevents significant in-plane bending in complexes containing 6,6′Me2bpy.
A comparison of the magnitude of θP and the M–N bond length in Table 6.5 shows that,
as observed by Hazell21, the magnitude of θP decreases with increasing M–N bond length. This
effect is illustrated by comparing data for the Re(I) and Pt(II)/Pd(II) complexes in Table 6.5. The
average θP angle is +8.7º for the Pt(II)/Pd(II) complexes (average M-N bond length of 2.05 Å),
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compared to an average θP angle of +5.1º for the Re(I) complexes (average M-N bond length of
2.19 Å).
6.4

Conclusions

The Re(I) complexes described here have longer than average M–N distances of ~2.2 Å;
thus, these complexes cannot be considered as general models for pseudo-octahedral metal
complexes of bipyridine and other similar ligands. However, comparison of the data collected
here with literature data for square-planar Pt(II) and Pd(II) complexes allows for some
conclusions to be made about the effect of M–N bond length and coordination geometry on
intramolecular interactions that can result in the distortion of bipyridine-type ligands.
Although five different parameters (θT, θB, dS, θP, θdi) have been introduced to describe
distortions of bipyridine-type ligands coordinated to metal centers, distortions in both octahedral
and square-planar complexes can be described primarily in terms of θT and θB. The similar
magnitudes of θT and θB calculated for Re(I) and Pt(II)/Pd(II) complexes indicates that
interligand interactions between the 6,6′ substituents and the cis-coordinated ligands play a
significant role in determining θT and θB, while M coordination geometry and length of the M–N
bond appear to have only a minor effect on θT and θB. These results offer hope that novel drugs
based on the fac-[Re(CO)3]+ core can be developed with similar levels of antineoplastic activity,
but lower toxicity, than cisplatin.
6.5

References

1. Alessio, E.; Mestroni, G.; Bergamo, A.; Sava, G. Curr. Top. Med. Chem. 2004, 4, 1525-1535.
2. Chifotides, H. T.; Dunbar, K. R. Acc. Chem. Res. 2005, 38, 146-156.
3. Chifotides, H. T.; Koshlap, K. M.; Pérez, L. M.; Dunbar, K. R. J. Am. Chem. Soc. 2003, 125,
10714-10724.
133

4. Frausin, F.; Scarcia, V.; Cocchietto, M.; Furlani, A.; Serli, B.; Alessio, E.; Sava, G. J.
Pharmacol. Exp. Ther. 2005, 313, 227-233.
5. Galanski, M.; Arion, V. B.; Jakupec, M. A.; Keppler, B. Curr. Pharm. Des. 2003, 9, 20782089.
6. Guichard, S. M.; Else, R.; Reid, E.; Zeitlin, B.; Aird, R.; Muir, M.; Dodds, M.; Fiebig, H.;
Sadler, P. J.; Jodrell, D. I. Biochem. Pharmacol. 2006, 71, 408-415.
7. Hayward, R. L.; Schornagel, Q. C.; Tente, R.; Macpherson, J. S.; Aird, R. E.; Guichard, S.;
Habtemariam, A.; Sadler, P.; Jodrell, D. I. Cancer Chemother. Pharmacol. 2005, 55, 577-583.
8. Velders, A. H.; Bergamo, A.; Alessio, E.; Zangrando, E.; Haasnoot, J. G.; Casarsa, C.;
Cocchietto, M.; Zorzet, S.; Sava, G. J. Med. Chem. 2004, 47, 1110-1121.
9. Yan, Y.-K.; Cho, S. E.; Shaffer, K. A.; Rowell, J. E.; Barnes, B. J.; Hall, I. H. Pharmazie
2000, 55, 307-313.
10. Yan, Y. K.; Melchart, M.; Habtemariam, A.; Sadler, P. J. Chem. Commun. 2005, 4764-4776.
11. Bhattacharyya, D.; Marzilli, P. A.; Marzilli, L. G. Inorg. Chem. 2005, 44, 7644-7651.
12. Maheshwari, V.; Bhattacharyya, D.; Fronczek, F. R.; Marzilli, P. A.; Marzilli, L. G. Inorg.
Chem. 2006, 45, 7182-7190.
13. Maheshwari, V.; Carlone, M.; Fronczek, F. R.; Marzilli, L. G. Acta Crystallogr., Sect. B:
Struct. Sci. 2007, B63, 603-611.
14. Schmidt, S. P.; Trogler, W. C.; Basolo, F. Inorg. Synth. 1990, 28, 160-165.
15. Schmidt, S. P.; Nitschke, J.; Trogler, W. C. Inorg. Synth. 1989, 26, 113-117.
16. Otwinowski, Z.; Minor, W. Methods Enzymol. 1997, 276, 307-326.
17. Altomare, A.; Burla, M. C.; Camalli, M.; Cascarano, G. L.; Giacovazzo, C.; Guagliardi, A.;
Moliterni, A. G. G.; Polidori, G.; Spagna, R. J. Appl. Crystallogr. 1999, 32, 115-119.
18. Sheldrick, G. M. SHELXL-97, A Program for the Solution of Crystal Structures from X-ray
Data; 1997, University of Göttingen: Göttingen, Germany.
19. Salignac, B.; Grundler, P. V.; Cayemittes, S.; Frey, U.; Scopelliti, R.; Merbach, A. E.;
Hedinger, R.; Hegetschweiler, K.; Alberto, R.; Prinz, U.; Raabe, G.; Kölle, U.; Hall, S. Inorg.
Chem. 2003, 42, 3516-3526.
20. Hazell, A.; Simensen, O.; Wernberg, O. Acta Crystallogr., Sect. C: Cryst. Struct. Commun.
1986, C42, 1707-1711.
134

21. Hazell, A. Polyhedron 2004, 23, 2081-2083.
22. Allen, F. H. Acta Crystallogr., Sect. B: Struct. Sci. 2002, B58, 380-388.
23. Connick, W. B.; Henling, L. M.; Marsh, R. E.; Gray, H. B. Inorg. Chem. 1996, 35, 62616265.
24. Canty, A. J.; Skelton, B. W.; Traill, P. R.; White, A. H. Aust. J. Chem. 1992, 45, 417-422.

135

CHAPTER 7.
CONCLUSION

In general, this work represents a significant contribution to the current body of
knowledge surrounding the coordination chemistry of the biologically relevant fac-[Re(CO)3]+
core. The fac-[Re(CO)3]+ core has potential chemotherapeutic applications; and complexes
containing unstable rhenium isotopes have additional applications, such as radiolabeling,
radiodiagnostics and radiotherapy.
We found that, unlike cisplatin, equilibrium is achieved in reaction mixtures containing
fac-[Re(CO)3(H2O)3]+ and nucleotides, thus allowing measurement of the relative stability of the
adducts formed under both kinetic and thermodynamic conditions. In addition, the adducts
formed are dependent upon the nature of the base moiety and the number of phosphate groups.
Notably, fac-[Re(CO)3(H2O)3]+ was found to have a higher affinity for oxygen donors, but a
much lower affinity for sulfur donors than cisplatin. This result offers hope that
chemotherapeutic agents based on the fac-[Re(CO)3]+core could be developed with higher
efficacy, and lower toxicity, than cisplatin, as the latter side effect has been linked to platination
of sulfur-containing proteins and peptides.
Studying the adducts formed in the reaction between the fac-[Re(CO)3]+core and N-donor
ligands such as benzimidazoles and bipyridines revealed that the fac-[Re(CO)3]+core prefers to
bind to two N-donor ligands in a cis fashion, in a manner reminiscent of cisplatin binding to two
adjacent guanine bases. In addition, two coordinated benzimidazole ligands preferentially adopt
a head-to-head orientation (as opposed to a head-to-tail arrangement); access to the HH
orientation has been suggested to be responsible for the cytotoxic activity observed for cisplatin.
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APPENDIX A
SUPPORTING INFORMATION FOR CHAPTER 2
A.1

Sugar Pucker of Nucleotides Coordinated to fac-[Re(CO)3(H2O)3]+

Clearly resolved H1′ signals allowed measurement of 3JH1′–H2′ coupling constants, which
are useful for assessing the degree of S or N sugar pucker. Literature values for 3J H1′–H2′ of a
typical NMP range from 6.2 to 6.9 Hz at pH ~7;2 we found 3JH1′–H2′ = ~6.0 Hz at pH 3.6. The
3

JH1′–H2′ coupling constant decreased by ~2.3 Hz upon coordination of one 5′-GMP (3.7 Hz) or

one 3′-GMP (3.6 Hz) to fac-[Re(CO)3(H2O)3]+ (Table 2.1). Similar results were found for the
coordination of one 5′-IMP (3.0 Hz) or one 3′-IMP (3.5 Hz) to fac-[Re(CO)3(H2O)3]+. The
decrease in 3JH1′–H2′ upon adduct formation indicate that coordination causes an increase in the
population of nucleotides possessing an N pucker.2,3
In general, the 3JH1′–H2′ coupling constants for each of the coordinated nucleotides in the
1:2 adducts are approximately the same as the 3JH1′–H2′ coupling constants for the nucleotides in
the 1:1 adducts. However, the observation of different 3JH1′–H2′ values (5.1 Hz and 3.9 Hz, Table
2.1) for each of the two 5′-GMP's of fac-[Re(CO)3(H2O)(5′-GMP)2]– indicates that the ribose
ring of one coordinated 5′-GMP has more N character than the ribose ring of the other
coordinated 5′-GMP.
A.2

Exclusion of the Presence of 2:2 Cyclic Dimer

Two different experiments were used to exclude the possibility that a 2:2 cyclic dimeric
adduct is formed in the reaction between fac-[Re(CO)3(H2O)3]+ and 5′-GMP. First, we utilized
an increased concentration of both Re and 5′-GMP (r = 1:1, [Re] = 100 mM). The spectra from
this experiment, in contrast to spectra when r = 4:1, have no signals previously ascribed to the
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dinuclear adduct, fac-[Re2(CO)6(H2O)4(5′-GMP)]+. The relative intensity of these dinuclear
signals would have increased if they were due to a 2:2 cyclic dimeric adduct.
We also used a mixture of 5′- and 3′-GMP, which helps to assess the presence of a cyclic
2:2 dimeric adduct (Figure 2.3) because of the formation of isomers. If two GMP's are
coordinated to two fac-[Re(CO)3(H2O)]+ moieties in a cyclic 2:2 dimeric adduct, three different
adducts with a Re/GMP ratio of 2:2 are possible for a mixture of 5′-GMP and 3′-GMP. In
addition to the 1:2 adducts of 5′-GMP and 3′-GMP found above, a new Re/5′-GMP/3′-GMP
cyclic 2:2 dimeric adduct can form, resulting in two new H8 singlets.
The H8 signal previously attributed to a dinuclear species (but which could be due to the
formation of a cyclic 2:2 dimeric adduct) is largest when there is a large excess of Re over GMP;
therefore, the formation reaction was carried out by mixing fac-[Re(CO)3(H2O)3]+ (100 mM)
with 12.5 mM 5′-GMP and 12.5 mM 3′-GMP, for a total Re/GMP ratio of 4:1. No new 1H or 31P
NMR signals were observed, indicating that no new mixed-nucleotide cyclic 2:2 dimeric adduct
was formed. Because the different positions of the 3′-phosphate and the 5′-phosphate groups
could possibly prevent formation of the mixed cyclic dimeric adduct (because of different
distances spanning the Re atoms), we examined a similar reaction but with a mixture of 5′-GMP
and 5′-IMP. Again, no new 1H or 31P NMR signals were observed. These results confirm that no
cyclic 2:2 dimeric adducts are formed in the reaction of fac-[Re(CO)3(H2O)3]+ with 5′- or 3′nucleotides.
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Figure A.1. Chemical shift vs. pH for the Pα signals of fac-[Re(CO)3(H2O)2(5′-GMP)], fac[Re2(CO)6(H2O)4(5′-GMP)] and fac-[Re3(CO)9(H2O)6(5′-GMP)]+. The Pα signals of the 1:2
Re:GMP adduct do not shift over the pH range studied and therefore the curve(s) are not shown
because these signals flank the Pα signal of the 1:1 Re:5′-GMP adduct.
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2.91 Å

2.68 Å

3.08 Å

Figure A.2. Idealized model (constructed using HyperChem1) of proposed favored fac[Re(CO)3(H2O)(5′-GMP)(3′-GMP)]+ adduct, showing the possibility for an ΔHT conformer with
three H-bonding contacts. N7–Re bond lengths and N7–Re–N7 bond angle are fixed using values
found in the crystal structure of fac-[Re(CO)3(H2O)(9-MeG)2]– (9-MeG = 9-methylguanine).4
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APPENDIX B
SUPPORTING INFORMATION FOR CHAPTER 3
9.2
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Figure B.1. Chemical shift vs pH for the H8 NMR signals of M, m, fac[Re(CO)3(H2O)2({N7}GDP)]– and free 5′-GDP2–. Because fac-[Re(CO)3(H2O)2({N7}GDP)]– is
unstable above pH ~4, no data could be obtained above this pH. Charges indicated in the
captions of Figures B.1-B.4 are those for each species at pH 3.6.
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Figure B.2. Area under peak (integral) vs pH for the H8 NMR signals of M, m, fac[Re(CO)3(H2O)2({N7}GDP)]– and free 5′-GDP2–.
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Figure B.3. Linewidth at full width half height (fwhh, in Hz) vs concentration of Mn2+ (in μM)
for the H8 NMR signals of M, m and fac-[Re(CO)3(H2O)2({N7}GDP)]–.
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Figure B.4. Chemical shift vs pH for the Pβ NMR signals of M, m and fac[Re(CO)3(H2O)({N7,Pβ}GDP)]–. Note the change in pKa of the terminal Pβ group, from ~6.5 for
free 5′-GDP2– to ~4.5 for M and m.
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APPENDIX C
SUPPORTING INFORMATION FOR CHAPTER 4

Figure C.1. Expansion of the Pα-Pβ and Pβ-Pγ cross-peak region in the 31P-31P COSY spectrum
of an equilibrium mixture of fac-[Re(CO)3(H2O)3]+ (25 mM, r = 1:1) and 5′-UTP at pH 3.6
(Figure 5, main text). Pα and Pγ cross-peaks with identical Pβ chemical shifts arise from the
same diastereomer (1-U, 2-U, 3-U and 4-U).
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Figure C.2. Chemical shift vs pH for the Pα, Pβ and Pγ NMR signals of 1-U, 2-U, 3-U, and 4-U.
Note the decrease in the Pγ pKa, from ∼7 in free 5′-UTP to ∼4 for the products. Literature values
for phosphate pKa’s of free 5′-UTP from ref 25.

Figure C.3. Chemical shift vs pH for the Pα, Pβ and Pγ NMR signals of 1-G and 2-G. The Pγ pKa
has decreased from ∼7 in free 5′-GTP to ∼4.5 for 1-G and 2-G. Literature values for phosphate
pKa’s of free 5′-GTP from ref 25.
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APPENDIX D
REGARDING THE SYNTHESIS, PURIFICATION, AND CHARACTERIZATION OF
THIAMINE TRIPHOSPHATE
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Figure D.1. Synthesis of thiamine triphosphate from thiamine diphosphate and H3PO4.

D.1

Synthesis, Purification and Characterization of Thiamine Triphosphate

Methods of phosphorylation often require strictly anhydrous conditions.1 These methods
are typically not successful if attempted outside of a glovebox or without the use of a Schlenk
line. Thus, we were quite intrigued to find a piece of literature claiming the successful
phosphorylation of nucleoside monophosphates and thiamine diphosphate (to form nucleoside
triphosphates and thiamine triphosphate, respectively) in reaction mixtures containing added
water.2 As a result, we set out to reproduce the literature claim.
Thiamine triphosphate was prepared from thiamine diphosphate (TDP) as follows (Figure
D.1).2 First, TDP (0.5 g) was added to a round-bottom flask containing 1.05 mL tributylamine
(≥98.5%), 82.5 μL 85% H3PO4 (99.999%, 85 wt % solution in H2O), and 0.75 mL H2O (HPLC
grade). The flask was then strongly agitated until all solid TDP went into solution. With stirring,
200 mL DMSO (anhydrous, ≥99.9%) and 178 mL pyridine (anhydrous, ≥99.9%) were added to
the round-bottom flask. In a separate beaker, 1,3-dicyclohexyl carbodiimide (DCC, 18 g) was
dissolved in 7 mL pyridine and subsequently added to the round-bottom flask containing TDP.
The clear reaction mixture was stirred overnight at room temperature, over which time the color
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of the solution changed from colorless to orange. A large excess of diethyl ether was added to
precipitate out the reaction product as a gelatinous, extremely hygroscopic orange solid.
After filtration and collection of the orange solid, the filter paper was washed thoroughly
with H2O (HPLC grade, 10 mL) and the orange, aqueous solution was poured into a separation
funnel. The orange aqueous solution was then extracted with (4) 100 mL aliquots of CHCl3 (to
remove residual DMSO and pyridine). The volume of the resulting aqueous solution was then
reduced to ~2 mL using rotary evaporation and applied to the top of a 2.5 cm×5 cm Dowex
50W×8 (200-400 mesh) column (previously prepared in a 60 mL disposable syringe). The
column was then eluted with H2O (HPLC grade, pH 4, adjusted with HCl), and 10 mL aliquots
were collected. NMR spectroscopic analysis showed that the first fraction contained
predominantly H3PO4, and fractions 2-4 contained mainly DMSO. Fractions 5-8 contained pure
thiamine triphosphate, free of contamination by pyridine, DMSO, and H3PO4. Fractions 5-8 were
then pooled and the volume of the solution was reduced to ~1 mL using rotary evaporation. After
addition of ~4 mL of absolute ethanol, the flask is covered and placed in a freezer (–20 °C)
overnight. The mixture is then filtered, and the product thiamine triphosphate is retained on the
filter paper as a white powder (yield: 125 mg, 25%; 31P NMR (ppm): –14.8 (d, Pα, 3Jαβ = 19.8
Hz), –26.7 (Pβ, t), –14.2 (d, Pγ, 3Jβγ = 18.5 Hz)).
While phosphorylation was effected using the literature procedure, we were able to
increase the overall yield and purity of the product thiamine triphosphate by (1) using ultrapure,
high-quality reagents; (2) extracting the crude reaction mixture with a large volume of CHCl3 to
remove residual DMSO and pyridine from the product; and (3) using a cation-exchange column
to further reduce the amount of contaminating pyridine, DMSO and unreacted H3PO4 remaining
in the final product.
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